col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


2275 Results       Page 1

 [1]  [2] [ Next > ]
Oxford University Press: Open Forum Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2023―Nov―30 Innate and Adaptive Cell-Mediated Immune Responses to a COVID-19 mRNA Vaccine in Young Children Adriana Weinberg, Michael J Johnson, Krystle Garth, Elena W Y Hsieh, Ross Kedl, Daniela Weiskopf, et al. (+5)
2 [GO] 2023―Nov―29 Incidence of SARS-CoV-2 breakthrough infections after vaccination in adults: A population-based survey through March 1, 2023 Stacia M DeSantis, Ashraf Yaseen, Tianyao Hao, Luis León-Novelo, Yashar Talebi, Melissa A Valerio-Shewmaker, et al. (+13)
3 [GO] 2023―Nov―29 Using a Health Information Exchange to Characterize Changes in HIV Viral Load Suppression and Disparities During the COVID-19 Pandemic in NYC Emma Tucker, Harry Reyes Nieva, Kayla Schiffer, Michael T Yin, Delivette Castor, Peter Gordon, et al. (+2)
4 [GO] 2023―Nov―29 Effectiveness of Sotrovimab in Preventing COVID-19-related Hospitalizations or Deaths Among U.S. Veterans during Omicron BA.1 Yinong Young-Xu, Caroline Korves, Gabrielle Zwain, Sacha Satram, Myriam Drysdale, Carolina Reyes, et al. (+5)
5 [GO] 2023―Nov―29 Nasopharyngeal Viral Load is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection Meng Xu, Meagan P O’Brien, Andrea T Hooper, Eduardo Forleo-Neto, Flonza Isa, Peijie Hou, et al. (+7)
6 [GO] 2023―Nov―27 279. Inhaled Sargramostim (rhu GM-CSF) Leads to Enhanced SARS-CoV-2 Virus-Specific Immune Response and Viral Clearance: Results of the Biomarker Cohort of a Randomized, Double-Blind, Placebo-Controlled Phase 2b Trial in Non-Hospitalized Patients with COVID-19 Ila Joshi, Fiona Garner, Debasish F Roychowdhury, Lorinda Simms, Sanjeev Ahuja, John L McManus, et al. (+4)
7 [GO] 2023―Nov―27 2700. Reducing the Dose of Mycophenolate in Solid Organ Transplant Recipients Diagnosed with SARS-CoV-2 Infection Increases the Risk of Severe COVID-19 Marion Gillcrist, Stephen Waller, Ryan M Taylor, Nathan C Bahr, Diane M Cibrik, Zubair Shah, Albert Eid
8 [GO] 2023―Nov―27 2316. SARS-CoV-2 N-antibody Seropositivity in Healthcare Personnel without a Known History of COVID-19 Sajal K Tiwary, Carrie O’Neal, Kate Peacock, Rachel Bosserman, Candice Cass, Mostafa Amor, et al. (+12)
9 [GO] 2023―Nov―27 448. Real World Evaluation of Clinical Outcomes for Short-Duration Remdesivir Therapy in Hospitalized Patients with Mild-Moderate COVID-19 Kelsey N Williams, Timothy P Gauthier, Stacey W Baker, Jefferson Cua
10 [GO] 2023―Nov―27 2502. Best Practice Alert for Hepatitis C Virus Screening Demonstrates Importance of Reminders during Disruptive Times (COVID-19) Alec R Mason, A L exander P Radunsky, Stephanie M Reyes, Jennifer McBryde, Mamta K Jain
11 [GO] 2023―Nov―27 2338. Robust and Persistent B Cell Responses Following Third Dose SARS-CoV-2 Vaccine Determine Protection from COVID-19 Joanne Byrne, Lili Gu, Alejandro García-León, Colette Marie Gaillard, Julen Tomás-Cortázar, Riya Negi, et al. (+22)
12 [GO] 2023―Nov―27 2290. Neurological Symptoms of Long - COVID in Mexican Ambulatory Adults with Mild COVID-19 Jorge-Baruch Díaz-Ramírez, Jorge Bryan Ortega Marquez, Yazmín González-Valadez, Luis-Alberto Cortazar-Maldonado, José-Antonio Morales-Fernández, Miguel A Pérez-Sastré, et al. (+12)
13 [GO] 2023―Nov―27 249. SARS-CoV-2 Spike Immune Complexes Induce NETosis in COVID-19 Kiana C Allen, Marcos J Ramos-Benitez, Heather Teague, Daniel S Chertow, Jeffrey R Strich, Seth Warner
14 [GO] 2023―Nov―27 509. A Comparison of Tocilizumab and Baricitinib for Hospitalized Patients with Severe COVID-19 Priyanka Aytoda, Benjamin Albrecht, Sarah B Green, Gavin Harris, Lindsay M Busch, Mary Elizabeth Sexton, et al. (+2)
15 [GO] 2023―Nov―27 472. The impact of sarcopenia on unfavorable outcomes in lung transplant patients with COVID-19 Min Han, Jung Ah Lee, Su Jin Jeong, Jung Ho Kim, Jin Young Ahn, Jun Yong Choi, et al. (+2)
16 [GO] 2023―Nov―27 422. Impact of Respiratory Virus Co-Infection in Pediatric COVID-19 Manvita Mareboina, Katrina Bakhl, James Fisher, Simrat Jassal, Jessica E Ericson, Patrick Gavigan
17 [GO] 2023―Nov―27 511. Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment For COVID-19 Ashish Bhargava, Susan M Szpunar, Mamta Sharma, Louis Saravolatz
18 [GO] 2023―Nov―27 535. Risk Factors for Seeking Medical Care Following Monoclonal Antibody Treatment For COVID-19 I S M A I L O MALIK, Susan M Szpunar, Natali Salaytah, Ashish Bhargava, Mamta Sharma
19 [GO] 2023―Nov―27 502. Telemedicine Service for Evaluation of Pediatric Outpatients at High Risk for Severe COVID-19 Kathryn E Weakley, Kristina Bryant
20 [GO] 2023―Nov―27 513. Evaluating the safety of baricitinib versus tocilizumab in hospitalized patients with COVID-19 Kendall Brickel, Lyndsi Meyenburg, Dusten T T Rose, Neil Pan
21 [GO] 2023―Nov―27 2374. Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir against COVID-19 Hailey J Park, Sophia T Tan, Tomás M León, Seema Jain, Robert Schechter, Nathan C Lo
22 [GO] 2023―Nov―27 439. Impact of viral load in HIV adult patients hospitalized with COVID-19 Alberto Romero Garcia, Chee Yao Lim, Jorge Gutierrez, Afsheen Afzal, Dwayvania Miller, Alexander La Fortune, et al. (+2)
23 [GO] 2023―Nov―27 505. Drug-drug Interaction Profiling of Obeldesivir, A Promising Oral Treatment for COVID-19 Elham Amini, Mark Shelton, Anuja Raut, Anna Kwan, Deqing Xiao, Shuguang Chen, et al. (+4)
24 [GO] 2023―Nov―27 506. Resistance Analyses from the Remdesivir Phase 3 REDPINE Study in Participants with Severely Reduced Kidney Function Who Were Hospitalized for COVID-19 Kristen Andreatta, Jiani Li, Lauren Rodriguez, Dong Han, Simin Xu, Jason K Perry, et al. (+3)
25 [GO] 2023―Nov―27 2456. Methicillin-Resistant Staphylococcus aureus Bacteremia 30-Day Mortality During 2020 Compared to 2016-2019: Assessing the Impact of COVID-19 Holly Biggs, Kelly A Jackson, Joelle Nadle, Susan Petit, Susan M Ray, Ghinwa Dumyati, et al. (+5)
26 [GO] 2023―Nov―27 2486. Winners and Losers: MDROs In The Time of COVID-19 Hwang Ching Chan, Geraldine Tingting Foo, Ka Lip Chew, Paul Ananth Tambyah, Jyoti Somani
27 [GO] 2023―Nov―27 1794. Analysis of Antimicrobial Resistance Patterns in a Large Sample of US Hospitals Before and After COVID-19 Tarjani M Ranade, Meggie Griffin, Rebecca Schwei, Michael Pulia
28 [GO] 2023―Nov―27 1346. Genetic Variation at the Interferon λ Locus and Association with Clinical Outcome and Severity of COVID-19 Dana Alalwan, Riya Negi, Alejandro García-León, Gurvin Saini, Colette Marie Gaillard, Grace Kenny, et al. (+10)
29 [GO] 2023―Nov―27 1357. Initial and Peak Serum Levels of Krebs von den Lungen-6 for Prediction of Prognosis in Patients with COVID-19 Geonui Kim, Hyeonwoo Kwon, Sang Hyun Ra, Eui Jin Chang, Seongman Bae, Jiwon Jung, et al. (+6)
30 [GO] 2023―Nov―27 2310. Shifting COVID-19 admission screening practices- An Interrupted Time Series Analysis Rossana M Rosa, Mayan Gilboa, Adriana Jimenez, David Andrews, Huy Dinh, Katiuska Parra, et al. (+2)
31 [GO] 2023―Nov―27 1823. Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from the First Year of the Pandemic Upton D Allen, Michelle Barton, Julia Upton, Annette Bailey, Aaron Campigotto, Mariana Abdulnoor, et al. (+16)
32 [GO] 2023―Nov―27 2283. COVID-19 among Febrile Patients Presenting without Respiratory Symptoms in Six Hospitals along the Thai-Lao and Thai-Myanmar Borders, 2021-2011 Saithip Bhengsri, Emily Bloss, Beth Skaggs, Pongpun Sawatwong, Nuttagarn Chuenchom, Tanaphat Lertwitayakumjorn, et al. (+7)
33 [GO] 2023―Nov―27 471. In-Depth Characterization of SARS-CoV-2 Variants Causing Breakthrough COVID-19 Among Hospitalized Immunocompromised (IC) Patients with or without Prior Exposure to Tixagevimab-Cilgavimab (T/C) Pre-Exposure Prophylaxis (PrEP) Ghady Haidar, Jana L Jacobs, Erin Salese, Justin Ludwig, Amy Heaps, Urvi Parikh, et al. (+18)
34 [GO] 2023―Nov―27 469. Outcomes of COVID-19 among hospitalized patients under Rituximab: the experience of a Portuguese hospital Maria João M S Gonçalves, Eduarda Pena, Frederico Duarte, Susana Oliveira, Clara Batista, Mário Guimarães, et al. (+3)
35 [GO] 2023―Nov―27 2333. Knowledge, attitudes, and practices regarding vaccination against COVID-19 among medical students at a private university in Lima - Peru Benjamin Ramos-Rojas, Sebastian Lopez-Rivera, Karla Tafur-Bances, Jose A Gonzales-Zamora, Jorge Alave
36 [GO] 2023―Nov―27 470. Clinical Effectiveness of The Monoclonal Antibody Combination Tixagevimab-Cilgavimab (T/C) as Pre-Exposure Prophylaxis (PReP) of COVID-19 among Patients (pts) with Moderate to Severe Immunocompromised (IC) Conditions across a Large U.S. Healthcare System: A Propensity Score-Matched Retrospective Cohort Study Ghady Haidar, Justin Ludwig, Donald M Yealy, Haley Camacho, Tina Chinakarn, Kevin Kip, et al. (+14)
37 [GO] 2023―Nov―27 501. Risk Factors for Persistent Active COVID-19 Among Patients Receiving B-Cell Depleting Therapy versus Non-B-Cell Immunosuppression Kevin Voll, Jacob Kartes, Emily S Spivak, Hannah Imlay
38 [GO] 2023―Nov―27 504. Individual and Neighborhood Factors Associated with Failure to Vaccinate Against COVID-19 Among Pregnant Persons Ousseny Zerbo, Thomas Ray, Bruce Fireman, Evan Layefsky, Kristin Goddard, Pat Ross, et al. (+2)
39 [GO] 2023―Nov―27 476. Increased Depression and Anxiety Associated with COVID-19 among Recipients of HIV Healthcare Services at Sexual Health Clinic in NYC Simian Huang, Jason Zucker, Delivette Castor, Caroline Carnevale, Elijah LaSota, Joshua Klein, et al. (+7)
40 [GO] 2023―Nov―27 2705. Predictors of Severe COVID-19 among Solid Organ Transplant Recipients Marion Gillcrist, Stephen Waller, Ryan M Taylor, Nathan C Bahr, Diane M Cibrik, Zubair Shah, et al. (+2)
41 [GO] 2023―Nov―27 409. Unvaccinated Adolescents Bear the Majority of Disease Burden of Severe COVID-19 Among Those Admitted to the Intensive Care Unit (ICU) Ashlesha Kaushik, Corey Thieman, Sandeep Gupta
42 [GO] 2023―Nov―27 2623. Persistence of SARS-CoV-2 S IgG Antibodies in Children that suffered from COVID-19 and Association of Antibody Levels with Vaccination Status Federico Di Gregorio, María S Tineo, Florencia A Bonnin, Lidia Torrado, María F Pavan, Lorena I Ibañez, et al. (+6)
43 [GO] 2023―Nov―27 433. Thromboinflammation in COVID-19 and association with death in patients on ECMO Andrew Platt, Viviane Callier, Zonghui Hu, Seth Warner, Syndey R Stein, Megan Anders, et al. (+21)
44 [GO] 2023―Nov―27 2328. COVID-19 and CLABSI: Riding the Pandemic Waves with an Active Infection Prevention Intervention Rama Thyagarajan, Kristin E Mondy, Lisa K Sturm, Coutney Watson, Karl Saake, Collin Miller, et al. (+2)
45 [GO] 2023―Nov―27 1108. Severity of Illness among Adults Hospitalized with Respiratory Syncytial Virus Compared with COVID-19 and Influenza - IVY Network, 25 Hospitals, 20 U.S. States, January 31, 2022 - April 11, 2023 Katharine Yuengling, Diya Surie, Jennifer DeCuir, Yuwei Zhu, Manjusha Gaglani, Adit A Ginde, et al. (+19)
46 [GO] 2023―Nov―27 412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020 Daewi Kim, Kimberly Yousey-Hindes
47 [GO] 2023―Nov―27 2347. Factors Associated with COVID-19 and Influenza Vaccine Coadministration in Rhode Island Lisa M Gargano, Dora M Dumont
48 [GO] 2023―Nov―27 1937. Use of Paxlovid for Treatment of Acute COVID-19 and Occurrence of Post-COVID Conditions among Children and Adults at High-Risk for Severe COVID-19, April 1 - December 31, 2022 Alexandra F Dalton, Sarah Baca, Julia Raykin, Cria Perrine, Tegan Boehmer, Emilia Koumans, et al. (+2)
49 [GO] 2023―Nov―27 1834. Impact of COVID-19 and Socioeconomic Status on Food Insecurity in the US Adult Population: Analysis of the 2021 National Health Interview Survey Jincong Q Freeman, Xinyi Li, Yong Gun Lee, Adam W Scott, Yijin Xiang
50 [GO] 2023―Nov―27 1349. Unveiling the Link between COVID-19 and the Gut Microbiome in an Outpatient Cohort with Mild to Moderate Illness Isin Y Comba, Ruben A Mars, Mitchell Dumais, Trena Van Gorp, Jonathan Harrington, John C O’Horo, Purna C Kashyap
51 [GO] 2023―Nov―27 1847. A mixed methods approach to understanding the perceived risk of COVID-19 and vaccination perceptions among people living with HIV in Nebraska Titilola Labisi, Nada Fadul, Moses New-Aaron, Jason Coleman, Anthony Podany, Keyonna King
52 [GO] 2023―Nov―27 458. Risk of COVID-19 and vaccine immunogenicity in pediatric solid organ transplant recipients - a single center study in South Korea Jee Yeon Baek, Kyoung Ihn, Hong Koh, Keum Hwa Lee, Min Young Kim, Sinyoung Kim, et al. (+4)
53 [GO] 2023―Nov―27 527. A Descriptive, Retrospective Analysis of COVID-19 Antibody Therapy and its Effects on Morbidity and Mortality in Patients Receiving B-cell Depleting Therapies G O R D A N A SIMEUNOVIC, Liam R Sullivan, Heather Brooks, Sonia K Gentile
54 [GO] 2023―Nov―27 2317. The Impact of Universal versus Targeted Symptomatic COVID-19 Arrival Testing in Basic Military Trainees Marquise Westbrook, James Aden, John Kieffer, Erin Winkler, Theresa Casey, Dianne Frankel, et al. (+4)
55 [GO] 2023―Nov―27 393. Comparison of COVID-19 Associated Complications in Children during the First and Second Omicron Waves in Taiwan Jiun-An Chen, Huan-Cheng Lai, Yu-Lung Hsu, Hsiao-Chuan Lin, Chien-Heng Lin, Hsiu-Mei Wei, et al. (+3)
56 [GO] 2023―Nov―27 1368. In-hospital and post-discharge mortality among adults with COVID-19 associated hospitalization, COVID-NET, March 2020-April 2021. Kadam Patel, Pam Daily Kirley, Breanna Kawasaki, James Meek, Kyle P Openo, Maya Monroe, et al. (+12)
57 [GO] 2023―Nov―27 405. Incidence and Potential Risk Factors of COVID-19 Associated Pulmonary Aspergillosis (CAPA) Waki Imoto, Koichi Yamada, Yukihiro Kaneko, Hiroshi Kakeya
58 [GO] 2023―Nov―27 514. Nirmatrelvir/ritonavir or Molnupiravir for Treatment of Non-hospitalized Patients with COVID-19 at Risk of Disease Progression Adeel A Butt, Peng Yan, Obaid Shaikh
59 [GO] 2023―Nov―27 2353. SARS-CoV-2 Variants among US Veterans after COVID-19 Bivalent Vaccine Administration Mark Holodniy, Ying Pei, Gary Stack, Christopher L Wade, Yashpal Agrawal, Nicholas Barasch, et al. (+4)
60 [GO] 2023―Nov―27 1034. COVID-19 Bloodstream Infection Outcomes Stratified by Social Determination Index (SDI) in NYC Public Hospital System Chee Yao Lim, Kenneth Johan, Jorge Gutierrez, Alberto Romero Garcia, Afsheen Afzal, Mohannad Al-Khateeb Al-Khateeb, et al. (+8)
61 [GO] 2023―Nov―27 2334. The effectiveness of bivalent COVID-19 booster among patients with hematologic malignancies Muneerah M Aleissa, Sonya Davey, Rebecca Rooks, Natalie E Izaguirre, Bridget Yates, Urwah Kanwal, et al. (+3)
62 [GO] 2023―Nov―27 2379. An Urban Detroit Clinic’s Experience in Bivalent COVID-19 Booster Uptake in People Living with HIV Jahanavi M Ramakrishna, Abdullah Yesilyaprak, Lea M Monday, Gretchen Snoeyenbos Newman
63 [GO] 2023―Nov―27 2354. Factors associated with COVID-19 booster vaccine hesitancy: a nation-wide, cross-sectional survey in Japan Hitoshi Honda, Akane Takamatsu, Toshiki Miwa, Yasuharu Tokuda
64 [GO] 2023―Nov―27 2366. Profile and Outcomes of Vaccinated Adult Individuals with COVID-19 Breakthrough Infections Hospitalized in a Tertiary Hospital in the Philippines Mark Ramon Victor B Llanes, Regina Berba
65 [GO] 2023―Nov―27 303. Tissue-compartment specific differences in T-cell response found in 44 fatal COVID-19 cases Trevor M Stantliff, Andrew Platt, Syndey R Stein, Cihan Oguz, Kevin M Vannella, Sabrina Ramelli, et al. (+2)
66 [GO] 2023―Nov―27 2320. Impact of Lifting School Mask Mandates on Community COVID-19 Cases and Hospitalizations: A Nationwide, Retrospective Cohort Study with an Event Study Design Zeynep Ertem, Anesh Danesharasteh, Elissa Schechter-Perkins, Richard Nelson, Lloyd Fisher, Shira Doron, Westyn Branch-Elliman
67 [GO] 2023―Nov―27 1380. Machine Learning-based Estimation of Unconfirmed COVID-19 Cases from a 10,000-Household Survey in Gilgit-Baltistan, Pakistan Daniel S Farrar, Lisa G Pell, Yasin Muhammad, Sher Hafiz, Lauren Erdman, Diego G Bassani, et al. (+12)
68 [GO] 2023―Nov―27 2329. What Causes a Cluster to Grow? Factors Associated with a Nosocomial COVID-19 Cluster at a University Hospital in Central Tokyo Hilary Osaka, Yasuaki Tagashira, Yoshiaki Gu, Kunihiko Takahashi
69 [GO] 2023―Nov―27 1369. Effect of COVID-19 on Antibiotic Consumption: An Analysis of the COVID-19 Community Research Partnership Olivia Randazza, Michael E DeWitt, John C Williamson
70 [GO] 2023―Nov―27 420. Prevalence of comorbidities and COVID-19 vaccination among COVID-19 deaths Zin Lyons, Lauren DiBiase, Emily Sickbert-Bennett, David J Weber
71 [GO] 2023―Nov―27 2485. Candida auris Hospital Cluster: Were Our Unwelcome Guests Driven Away by the COVID-19 Delta Surge? Jyoti Somani, Nazira Muhammad Fauzi, Revathi Sridhar, Hwang Ching Chan, Isaac Taoyang Low, Ka Lip Chew, Dale Fisher
72 [GO] 2023―Nov―27 2472. Hospital Onset Antibiotic Resistant Infections among Patients without COVID-19 Diagnosis in Pre-Pandemic and Pandemic Periods James Baggs, Natalie McCarthy, Sujan Reddy, Hannah Wolford
73 [GO] 2023―Nov―27 521. A phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease Geoffrey Dow
74 [GO] 2023―Nov―27 541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression Moritz Platzer, David Totschnig, Christoph Wenisch, Alexander Zoufaly
75 [GO] 2023―Nov―27 547. Molnupiravir and Nirmatrelvir/Ritonavir Effectiveness in Reducing the Risk for COVID-19 Disease Progression and Death Dimitrios Paraskevis, Mary Gkova, Kassiani Mellou, Kassiani Mellou, Kassiani Gkolfinopoulou, Evangelia Georgia Kostaki, et al. (+11)
76 [GO] 2023―Nov―27 2364. Predictive Ability of mRNA COVID-19 Vaccines Against COVID-19 Disease Severity Ashley Lew, Ashley Tippett, Luis W Salazar, Laila Hussaini, Chris Choi, Khalel De Castro, et al. (+15)
77 [GO] 2023―Nov―27 2213. History of Infection and Worry about COVID-19 Drive Antibiotic Use for “Flu- or COVID-like” Symptoms in the United States and Mexico during the Pandemic Jose Luis Camarena, Brooke Hawkes, Edward Bedrick, Katherine Ellingson
78 [GO] 2023―Nov―27 2524. Safety and Pharmacokinetics of PA-001, a New Potential COVID-19 Drug That Targets the S2 Subunit of SARS-CoV-2 Spike Protein, in Healthy Subjects Haruaki Kurasaki, Masaki Ohuchi, Katsuma Matsui, Masatoshi Matsumoto, Kazutaka Nagatomo, Naoki Kawamura, et al. (+8)
79 [GO] 2023―Nov―27 526. Treatment Inconsistencies of Patients Hospitalized with COVID-19 during Four Waves in Almaty, Kazakhstan, 2020-2021 Saya Gazezova, Roberta Horth, Manar Smagul, Lena Kasabekova, Shokhruh Usmanov, S A N A M ZIKRIYAROVA, Dilyara Nabirova
80 [GO] 2023―Nov―27 533. Use of Different Communication Types for Telehealth for COVID-19 During Implementation of a State Telehealth Test to Treat Program in Minnesota Sarah Lim, Paige Dubelko, Walter James, Erin McLachlan, David Tsay, Ruth Lynfield
81 [GO] 2023―Nov―27 518. Comparable Outcomes of Remdesivir and Sotrovimab among High-risk Patients with Mild to Moderate COVID-19 During the Omicron BA.1 Surge Supavit Chesdachai, Christina G Rivera (O'Connor), Kristin Mara, Hiliary R Teaford, Maria Gonzalez Suarez, Jennifer J Larsen, et al. (+3)
82 [GO] 2023―Nov―27 522. Real-World, Retrospective Descriptive Study of COVID-19 Outpatient Therapeutic Uptake in High-Risk Patients Subsequently Hospitalized for COVID-19 During the Omicron Period in the US Amie Scott, Laura A Puzniak, Michael V Murphy, Darrin W Benjumea, Andrew Rava, Michael Benigno, et al. (+7)
83 [GO] 2023―Nov―27 432. Predictors for oxygen requirements in patients hospitalized with COVID-19 during the Omicron surge, January 2022 Jonathan K Pinsky, Mary Anderson, Ines M Casey, Jason M Pinsky
84 [GO] 2023―Nov―27 361. Evaluation of Resistance to Nirmatrelvir/ritonavir in Evaluation of Protease Inhibition for COVID-19 (EPIC) High-Risk and Standard-Risk Clinical Trials Mary Lynn Baniecki, Shunjie Guan, Zhenyu Wang, Yan Chen, Weihang Bao, Wen He, et al. (+8)
85 [GO] 2023―Nov―27 2633. Nasal Colonization Status of Respiratory Viruses in Patients During the COVID-19 Epidemic Period at a Tertiary Hospital in Japan Tomohiro Katsuta, Ryo Niiya, Yukitsugu Nakamura, Naoki Shimizu
86 [GO] 2023―Nov―27 2626. Natural History of RSV Infection in Outpatient Episodes Among Adults in the United States using an EHR Data Source by COVID-19 Era Diana Garofalo, Joshua T Swan, Emily Webber, Sally R Omidvar, Margaret Tawadrous, Glenn Pixton, et al. (+6)
87 [GO] 2023―Nov―27 2627. Natural History of RSV Infection in Outpatient Episodes Among Children in the United States using Two EHR Data Sources by COVID-19 Era Diana Garofalo, Sima Toussi, Joshua T Swan, Maria Kudela, Padmalatha Reddy, Emily Webber, et al. (+7)
88 [GO] 2023―Nov―27 2292. Measuring Effectiveness against a Shifting Variant Landscape: COVID-19 Example in the Department of Veterans Affairs Scott L DuVall, Julie A Lynch, Patrick R Alba, Michael E Matheny, Marc A Suchard, Amanda R Shields, et al. (+6)
89 [GO] 2023―Nov―27 1767. Ventilation in Non-Healthcare Congregate Settings: Capacity-Building Assessments to Reduce COVID-19 Exposure Risks, California 2022 - 2023 Jared G Wiegand, Kyle T Peerless, Robert Stepp, Elon Ullman, Taria Greenberg, Cameron R Stainken, et al. (+3)
90 [GO] 2023―Nov―27 1176. Assessing the Impact of Collaborative Antimicrobial Stewardship Guidelines on the Use of Antibiotics in Hospitalized Veterans with COVID-19 from Five Veterans Health Administration (VHA) Hospitals Neena Thomas-Gosain, Kelly W Davis, Sage Hendrickson, Todd Hulgan, Parmida Parvaz, Caroline Powers, et al. (+3)
91 [GO] 2023―Nov―27 391. Patients Hospitalized for Acute Coronary Syndrome with Concomitant COVID-19 have Worse Clinical Outcomes Deepali Boothankad Sharath, Leonid Khokhlov, Usha Thapa, Amr Aboelnasr, Leanne Pereira, Jose Improvola, Anar Patel
92 [GO] 2023―Nov―27 1444. Candida auris Outbreak in a COVID-19 Hospital: Detection and Containment Victor Baylon-Valdez, Gloria Mayela Aguirre-García, Claudia E Guajardo-Lara, Mary C Aleman-Bocanegra, Michel F Martínez-Reséndez
93 [GO] 2023―Nov―27 1095. Increased Risk of COVID-19 Hospitalization and Death in Vaccinated Patients with End-Stage Renal Disease (ESRD) and Dialysis: Initial Results from INFORM, a Retrospective Health Database Observational Study in England Sabada Dube, Yi Lu, Richard McNulty, Sophie Graham, Sofie Arnetorp, Nahila Justo, et al. (+7)
94 [GO] 2023―Nov―27 498. Covid-19 Hospitalization Rates in Kidney Transplant Patients Treated with Tixagevimab/Cilgavimab Katherine Dugan, Jillian Casale, Heather DeSanto, Colleen Dowling, Steven Smoke
95 [GO] 2023―Nov―27 461. COVID-19 Hospitalizations among Vaccinated and Unvaccinated Immunocompromised Children, 23 States, December 2022 - April 2023 Angela P Campbell, Laura D Zambrano, Margaret M Newhams, Michael J Wu, Regina Simeone, Amber Orzel, et al. (+3)
96 [GO] 2023―Nov―27 430. Clinical Features and Outcomes of COVID-19 Hospitalized Adults by Variant Maria A Perez, Ashley Tippett, Ludy R Carmola, Laila Hussaini, Luis W Salazar, Olivia Reese, et al. (+17)
97 [GO] 2023―Nov―27 2648. Taming the Cytokine Storm: Baricitinib versus Tocilizumab for COVID-19 Hyperinflammation Skyler Radziszewski, Siddharth Swamy, Ruchi Jain, Keri Bicking, Themba Nyirenda
98 [GO] 2023―Nov―27 2314. Association Between Behavior and Risk of COVID-19 in a Cohort of Healthcare Personnel Holly Shoemaker, Haojia Li, Yue Zhang, Jeanmarie Mayer, Michael Rubin, Morgan M Millar, et al. (+6)
99 [GO] 2023―Nov―27 2341. Response to Vaccination Against COVID-19 in a Community Oncology Practice: a Rational for Antibody Testing Goar Egoryan, Guillermo Rodriguez-Nava
100 [GO] 2023―Nov―27 2392. Impact of Vaccination Against SARS-CoV-2 on Severity and Mortality in Hospitalized Patients with COVID-19 in a Referral Hospital in Nicaragua N O R V I N G VEGA-JARQUIN, Guillermo D Porras-Cortés
101 [GO] 2023―Nov―27 446. Post-Acute Sequelae of COVID-19 in a Rural Wisconsin Community Prospective Cohort Maria Sundaram, Oluwakemi Alonge, Joshua Petrie, Leora R Feldstein, Melissa A Rolfes, Yoshihiro Kawaoka, et al. (+3)
102 [GO] 2023―Nov―27 523. Efficacy and Safety of Nirmatrelvir/Ritonavir for COVID-19 in Adolescents Kiriam Escobar Lee, Philip J Lee, Brenda I Anosike
103 [GO] 2023―Nov―27 903. Prevalence of Underlying Conditions Associated With Higher Risk for Severe RSV, Influenza, or COVID-19 in Adults in the United States, 2017-2018 Parinaz Ghaswalla, Abby Hitchens, Sean D Candrilli, Justin Carrico, Katherine A Hicks, Eleanor Wilson, et al. (+2)
104 [GO] 2023―Nov―27 1859. Median Income by Location of Residence and Clinical Outcomes of Hospitalized Persons with COVID-19 in an Urban Veterans Affairs Medical Center Matthew Tuck, Heather Rivasplata, Steven Towers, Angelike P Liappis, Cherinne Arundel, Anca Dinescu, et al. (+7)
105 [GO] 2023―Nov―27 485. Improved Outcome of COVID-19 in CAR T Cell Treated Patients; results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group Per Ljungman, Anne M Spanjaart, Gloria Tridello, Nina Knelange, Rafael de la Camara, Marie Jose Kersten, Stephan Mielke
106 [GO] 2023―Nov―27 438. Predicting Severe and Critical COVID-19 in Fully Vaccinated Individuals: a Single Center Retrospective Cohort Study Charles Kevin L Rivera, Mark B Carascal, Ma Cristina Perez, Raul V Destura, Karl Evans R Henson
107 [GO] 2023―Nov―27 1355. The SARS-CoV-2 Monoclonal Antibody AZD3152 Potently Neutralizes Historical and Emerging Variants and is Being Developed for the Prevention and Treatment of COVID-19 in High-risk Individuals Joseph R Francica, Yingyun Cai, Seme Diallo, Kim Rosenthal, Kuishu Ren, Daniel J Flores, et al. (+17)
108 [GO] 2023―Nov―27 447. Clinical Features, Risk Factors, and Outcomes of COVID-19 in Immunocompromised Adults Hospitalized with Acute Respiratory Infection Elizabeth G Taylor, Ashley Tippett, Luis W Salazar, Laila Hussaini, Chris Choi, Khalel De Castro, et al. (+15)
109 [GO] 2023―Nov―27 528. Matched Retrospective Study, Comparing Molnupiravir to Nirmatrelvir-Ritonavir (Paxlovid) in the Treatment of Mild-Moderate COVID-19 in Immunocompromised Cancer Patients Andrea Haddad, Mohammad Moussa, Ray Y Hachem, Ying Jiang, Hiba Dagher, Patrick Chaftari, et al. (+2)
110 [GO] 2023―Nov―27 2300. Incidence of COVID-19 in Irish Healthcare Workers: Preliminary Results from PRECISE-5 Claire Kenny, Jonathan McGrath, Gavin Kelly, Shane Walsh, Conor Moran, Lee Flynn, et al. (+8)
111 [GO] 2023―Nov―27 537. Safety and Effectiveness of Ensitrelvir for the Treatment of COVID-19 in Japanese Clinical Practice: A Post-marketing Surveillance (Interim Analysis) Eriko Ogura, Noriko Nakagawa, Noriko Hayashi, Eri Tsukimura, Satoru Takashima
112 [GO] 2023―Nov―27 520. Polymerized type I collagen as a treatment for COVID-19 in Mexico Luis Del Carpio-Orantes, Sergio García-Mendez, Jesús Salvador Sánchez-Díaz, Andrés Aguilar-Silva, Manuel Martínez-Rojas, Oscar Rodrigo Jiménez-Flores, et al. (+14)
113 [GO] 2023―Nov―27 1503. Impact of Sars-Cov-2 (Covid-19) in Patients Living with HIV from United States National Inpatient Sample Database Premalkumar M Patel, Daniel Acosta, Esha Vallabhaneni, Fernando Poli De Frias, Yavani Singh, Christopher Lopez, Claudio Tuda
114 [GO] 2023―Nov―27 2625. Characteristics and Outcomes of COVID-19 in Patients with a Left Ventricular Assist Device Jorge Fleites, Yoichiro Natori, Jacques Simkins, Hoda Butrous, Jospeh Bauerlein, Anita Phancao, et al. (+3)
115 [GO] 2023―Nov―27 1509. Clinical Features and Outcomes of COVID-19 in People Living with HIV in South Korea: a Nationwide Population-based Cohort Study Young Kyung Yoon, Jeong Yeon Kim, Yujin Jeong, Hyong Gin Ahn, Jin Woong Suh, Sun Bean Kim, Jang Wook Sohn
116 [GO] 2023―Nov―27 2365. Effectiveness of COVID-19 Vaccines Against Medically Attended COVID-19 in Pregnant Persons Within the VISION Network, December 2021 - April 2023 Allison Avrich Ciesla, Ruth Link-Gelles, Katherine E Fleming-Dutra, Victoria Lazariu, Kristin K Dascomb, Shaun J Grannis, et al. (+9)
117 [GO] 2023―Nov―27 414. Sex differences in clinical presentation and outcomes amongst hospitalized patients with COVID-19 in Singapore Matthew C Y Koh, Jinghao Nicholas Ngiam, Srishti Chhabra, Wilson Goh, Meng Ying Sim, Nicholas W S Chew, et al. (+3)
118 [GO] 2023―Nov―27 465. Use of Monoclonal Antibodies for COVID-19 in Solid Organ Transplant Recipients: A Single-Center Experience Keven Gomez, Jonathan T Arcobello, Sandy Chang
119 [GO] 2023―Nov―27 404. Impact of cross-coronavirus humoral immunity in post-acute sequelae of COVID-19 in systemic autoimmune rheumatic diseases patients Jonathan Herman, Caroline Atyeo, Yonatan Zur, Claire Cook, Naomi Patel, Kathleen Vanni, et al. (+11)
120 [GO] 2023―Nov―27 403. Demographics, Characteristics and Health Outcomes of US Individuals Diagnosed With COVID-19 in the Outpatient Setting Rikisha Gupta, Valentina Shvachko, Amos Lichtman, Mark Berry, Florentin Scarlat, Anand Chokkalingam
121 [GO] 2023―Nov―27 550. Effectiveness of Remdesivir for Treatment of COVID-19 in the Outpatient Setting Vinny P Vo, Shu Lu, Madiha Shah, Hien Nguyen
122 [GO] 2023―Nov―27 534. Healthcare Resource Utilization and Costs among Patients with COVID-19 in the United States Gui Liu, Nicolae Done, Yan Song, Hardik Goswami, Travis Wang, Hesen Li, et al. (+3)
123 [GO] 2023―Nov―27 406. Incidence and Risk Factors for Hospital-Acquired Blood Stream Infections in Patients Hospitalized with COVID-19 in the University Medical Centre, Lithuania Ieva Kubiliute, Jurgita Urboniene, Fausta Majauskaite, Birute Zablockiene, Ligita Jancoriene
124 [GO] 2023―Nov―27 1428. The proportion of excess hospital-onset antibiotic-resistant infections attributable to patients diagnosed with COVID-19 in U.S. hospitals, 2019-2021 Hannah Wolford, Natalie McCarthy, James Baggs, Sujan Reddy
125 [GO] 2023―Nov―27 548. Combined Results of the Phase 2a/2b/3 Randomized Controlled Trials of Ensitrelvir for the Treatment of COVID-19 Infection Yuko Tsuge, Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Masaya Yamato, Takumi Imamura, et al. (+3)
126 [GO] 2023―Nov―27 413. Living with Long COVID: A Study on Persistent Symptoms and Vaccination Outcomes Two Years After COVID-19 Infection Yoonjung Kim, Shin-Woo Kim, Sohyun Bae, Hyun-Ha Chang
127 [GO] 2023―Nov―27 2620. Normalization of eosinophil count is predictive of reduced oxygen requirement during Covid-19 infection Benjamin Davido, Karim Jaffal, Isabelle Vaugier, Stephane Bourlet, Pierre De Truchis, Djillali Annane
128 [GO] 2023―Nov―27 542. Evaluation of Remdesivir to the Outcomes of Hospitalized Patients with COVID-19 Infection in a Tertiary Care Hospital in Southern India Jomel Raju, Maria Tom
129 [GO] 2023―Nov―27 181. COVID-19 Infection is a Key Factor in Mortality for Staphylococcus aureus and Candida sp. Bloodstream Infections: an Evaluation of Outcomes before and during the COVID-19 Pandemic Reese Cosimi, Florian Daragjati, Subhangi Ghosh, Ana Cristina Perez Moreno, Collin Miller, Karl Saake, Mohamad G Fakih
130 [GO] 2023―Nov―27 399. Recent COVID-19 infection is associated with high risk of mortality among patients with Staphylococcus aureus bacteremia Emily Eichenberger, Allison Pall, Stepy Thomas, Susan M Ray
131 [GO] 2023―Nov―27 549. Ensitrelvir for the Treatment of COVID-19 Infection: Evaluation of Taste Disorder and Smell Disorder in the Phase 3 Part of the Phase 2/3 SCORPIO-SR Randomized Controlled Trial Yuko Tsuge, Takuhiro Sonoyama, Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Masaya Yamato, et al. (+2)
132 [GO] 2023―Nov―27 2331. Characteristics Associated with Hospital-Acquired COVID-19 Infections in Los Angeles County Heidi D Sato, Kelsey OYong, Zachary Rubin
133 [GO] 2023―Nov―27 388. Evaluating Rates of Co- and Secondary Infections in Pediatric Patients with COVID-19 Infections in Relation to Antibiotic Prescribing: An Observational Study Brian S Allen, Sarah E Firmani, Bonnie C Prokesch
134 [GO] 2023―Nov―27 2377. The Influence of the COVID-19 Infodemic on Vaccine Hesitancy: A Prospective Survey-Based Study Cameron Quon, Macey Walker, Lisa Graves
135 [GO] 2023―Nov―27 508. Nirmatrelvir/ritonavir use among patients with cancer and COVID-19 is associated with improved clinical outcomes: Single-institution case-control study Panos Arvanitis, Kendra Vieira, Jeremy L Warner, Dimitrios Farmakiotis
136 [GO] 2023―Nov―27 2324. COVID-19 Knowledge, Attitudes, and Practices Among People Living with HIV in Sub-Saharan Africa Brennan R Cebula, Allahna Esber, Nicole Dear, Valentine Sing’oei, Jonah Maswai, Michael Iroezindu, et al. (+5)
137 [GO] 2023―Nov―27 478. COVID-19 maternal antibody concentrations in twin infants: impact of multiple pregnancy on transplacental antibody transfer during pregnancy Alisa B Kachikis, Mindy Pike, Linda Eckert, Alexis L Baranoff, Hye Cho, Jennifer E Stolarczuk, et al. (+3)
138 [GO] 2023―Nov―27 546. COVID-19 Monoclonal Antibody Use at a Stand Alone Children’s Hospital Grant T Stimes, Brittany Rodriguez, Amanda Gillispie, Tanya J Hilliard, Flor M Munoz, Lisa Forbes Satter
139 [GO] 2023―Nov―27 492. Risk Factors for COVID-19 Mortality in ≥90 year old Inpatients: Retrospective Case Series Raphaela Martina C Pineda, Monica Castro, Gerald Kristoffer E Boy, Sushil Pant
140 [GO] 2023―Nov―27 1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022 Anna R Yousaf, Josephine Mak, Lisa Gwynn, Robin Bloodworth, Ramona Rai, Zuha Jeddy, et al. (+13)
141 [GO] 2023―Nov―27 2081. COVID-19 mRNA Vaccine Effectiveness against Hospitalizations among U.S. Children and Adolescents During Omicron Variant Predominance Laura D Zambrano, Margaret M Newhams, Michael J Wu, Regina Simeone, Amber Orzel, Natasha B Halasa, et al. (+3)
142 [GO] 2023―Nov―27 1888. The Impact of COVID-19 on Adherence to Directly Observed Therapy Among a Tuberculosis Treatment Cohort Victoria Overbeck, Samantha Malatesta, Tara Carney, Bronwyn Myers, Charles Parry, C Robert Horsburgh, et al. (+5)
143 [GO] 2023―Nov―27 387. Understanding the Impact of COVID-19 on Cognitive Function Using a Scalable, App-based, Self-administered Tool in the Military Liana Andronescu, Stephanie A Richard, Emily Hone, Ann Scher, David Lindholm, Katrin Mende, et al. (+23)
144 [GO] 2023―Nov―27 1436. Effect of Personal Protective Equipment Conservation Due to COVID-19 on Multidrug Resistant Organisms in a Hospital Group Josephine Fox, Carole Leone, Heather Gasama, Lydia J Grimes- Jenkins, Munigala Satish, Helen Wood, et al. (+3)
145 [GO] 2023―Nov―27 444. The disruptive effects of COVID-19 on the incidence of hospital acquired staphylococcus aureus bacteremia (HA-SAB) and its associated factors with mortality in a tertiary teaching hospital in an upper-middle income country Sasheela Sri La Sri Ponnampalavanar, Sheron Sir Loon Goh, Arulvani Rajandra, Nur Alwani Suhaimi, Siti Norintan Zainon, Sazali Basri, et al. (+3)
146 [GO] 2023―Nov―27 1771. A Novel Approach to Distributing COVID-19 Oral Antivirals During a Public Health Emergency Using a Pharmacy Home Delivery Model in New York City, 2022 Mary M K Foote, Elizabeth Diago Navarro, Matthew Silverstein, Niroshan Shanmugarajah, Meredith Eddy, Ramona Lall, et al. (+4)
147 [GO] 2023―Nov―27 580. Changes in Serotype Distribution of Invasive Pneumococcal Infections in South Korea Before and After the COVID-19 Outbreak Da Yun Kang, Ye Eun Kim, Ki Wook Yun, Eun Hwa Choi
148 [GO] 2023―Nov―27 654. Changing trends of molecular characteristics and antimicrobial susceptibility of hypervirulent Klebsiella pneumoniae in community-acquired liver abscess before and after COVID-19 outbreak in South Korea Miri Hyun, Ji Yeon Lee, Hyun ah Kim
149 [GO] 2023―Nov―27 2303. Detection of COVID-19 Outbreaks in Hospitals Using Built Environment Testing for SARS-CoV-2 Lucas Castellani, Derek MacFadden, Jason Moggridge, Bryan Feenstra, Makenna Wiebe, Sawith Abey, et al. (+8)
150 [GO] 2023―Nov―27 2359. Relative effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines in adults at higher risk for severe COVID-19 outcomes Van Hung Nguyen, Catherine Boileau, Alina Bogdanov, Ni Zeng, Mac Bonafede, Thierry Ducruet, et al. (+6)
151 [GO] 2023―Nov―27 398. Increased Risk of Severe COVID-19 Outcomes Across all Groups of Individuals with Hematological Malignancies, Solid Tumors, and Solid Organ Transplants Compared with the General Population: Initial Results from INFORM, a Retrospective Health Database Observational Study in England Richard McNulty, Sabada Dube, Yi Lu, Sophie Graham, Sofie Arnetorp, Nahila Justo, et al. (+7)
152 [GO] 2023―Nov―27 2654. International Multi-Center Study Comparing the Effect of Obinutuzumab or Rituximab Treatment in Hematological Patients on COVID-19 Outcomes During the Omicron Surge Tal Shafat, Daniel Grupel, Tzvika Porges, Ana Belkin, Ofir Deri, Yonatan Oster, et al. (+20)
153 [GO] 2023―Nov―27 1096. Fully Vaccinated Individuals with Immunocompromised Conditions (IC) are Still at Increased Risk of Severe COVID-19 Outcomes From the Omicron Variant: Initial Results From INFORM, a Retrospective Health Database Observational Study in England Sabada Dube, Yi Lu, Richard McNulty, Sophie Graham, Sofie Arnetorp, Nahila Justo, et al. (+7)
154 [GO] 2023―Nov―27 1347. Do Class 3 Semaphorins Play a Role in COVID-19 Outcomes in Patients with Non-alcoholic Fatty Liver Disease? Martina Vargovic, Branimir Gjurasin, Lara Samadan, Adriana Vince, Neven Papic
155 [GO] 2023―Nov―27 2733. Evusheld (AZD7442) Uptake and COVID-19 Outcomes in Solid Organ Transplant Recipients: A Secondary Analysis Haya Hayek, Tess Stopczynski, Asim Khanfar, Yasmeen Z Qwaider, Justin Z Amarin, Madge I Stuhlreyer, et al. (+11)
156 [GO] 2023―Nov―27 1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves Dean Follmann, Xiaowei Wang, Peter Gilbert, Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al. (+9)
157 [GO] 2023―Nov―27 660. Pediatric Rotavirus Hospitalization Rates in the Military Health System Before and During the COVID-19 Pandemic Matthew Penfold, Sarah Prabhakar, Apryl Susi, Michael Rajnik, Cade M Nylund, Matthew Eberly
158 [GO] 2023―Nov―27 980. Risk Factors for Central Line Associated Bloodstream Infection Prior to and During the COVID-19 Pandemic Jennifer Priem, Mindy Sampson, Shelley Kester, Werner Bischoff, Catherine Passaretti, Casey Stephens
159 [GO] 2023―Nov―27 1622. Increase in Congenital Toxoplasmosis and Acute Toxoplasmosis Among Pregnant Women in the US during the COVID-19 pandemic Despina Contopoulos-Ioannidis, Valerie Bonetti, Jose G Montoya
160 [GO] 2023―Nov―27 2175. Emergence of Dual-Carbapenemase Producing Enterobacterales in Chile After the COVID-19 Pandemic Aura Villamil, Paula I Rodas, Ana M Quesille-Villalobos, Jose R W Martinez, Manuel Alcalde-Rico, Valeria E Quiroz, et al. (+7)
161 [GO] 2023―Nov―27 1556. Increase in New HIV Diagnoses Following Decrease in Use of Pre-Exposure Prophylaxis (PrEP) During the COVID-19 Pandemic Li Tao, J Carlo Hojilla, Valentina Shvachko, Juan Yang, Christoph C Carter, Moupali Das, Melanie de Boer
162 [GO] 2023―Nov―27 2259. Reversal of antimicrobial consumption: long-term impact of COVID-19 pandemic Ryuji Koizumi, Shinya Tsuzuki, Yusuke Asai, Norio Ohmagari
163 [GO] 2023―Nov―27 1649. Tracking and reporting antibiotic use: Rising antibiotic prescriptions for URI illness in children during the COVID-19 pandemic. Emily Clemons, Matthew Whiteman, Lisa Garavaglia, Shipra Gupta
164 [GO] 2023―Nov―27 2194. Implementation of the CDC’s Core Elements of Antibiotic Stewardship: A Survey of Long-Term Care Facilities During the COVID-19 Pandemic Catherine (Cathy) Cichon, Jenna Preusker, Mounica Soma, Danny Schroeder, Trevor C Van Schooneveld, Scott J Bergman, Muhammad Salman Ashraf
165 [GO] 2023―Nov―27 394. Consistency of AZD7442 (Cilgavimab/Tixagevimab) Pharmacokinetics Across Prophylaxis and Treatment and Adult and Pediatric Participants: Application of Population Pharmacokinetics to Enable Rapid Decision-Making During the COVID-19 Pandemic Lindsay E Clegg, Oleg Stepanov, Henning Schmidt, Ventakesh Pilla Reddy, Weifeng Tang, Michael Gibbs, et al. (+8)
166 [GO] 2023―Nov―27 2415. Health Outcome Disparities in Device-Associated Healthcare Infections Before and During the COVID-19 Pandemic Werner Bischoff, Joni Evans, Catherine Passaretti, Andrea Fernandez
167 [GO] 2023―Nov―27 2319. Trends in Health Services Utilization among Veterans with HIV Before and During the COVID-19 Pandemic Ruth O Adekunle, Ahmed Mohamed, Charlene Pope, Mulugeta Gebregziabher, Robert Axon
168 [GO] 2023―Nov―27 2274. Trends in Empiric Antibiotic Utilization for Patients Hospitalized with Community-Onset SARS-CoV-2 Infections and Viral Sepsis During the COVID-19 Pandemic Claire N Shappell, Michael Klompas, Sanjat Kanjilal, Christina Chan, Caroline S McKenna, Chanu Rhee
169 [GO] 2023―Nov―27 2483. Rise in inpatient Candida auris cases at a tertiary hospital in Washington, DC during the COVID-19 pandemic Daniel Seeger, Matthew Spence, Marc O Siegel, Tara Palmore, Gizachew Demessie, Irvin Ibarra Flores, et al. (+5)
170 [GO] 2023―Nov―27 2375. Contemporary Patterns and Predictors of Influenza and COVID-19 Vaccination Among US Adults During the COVID-19 Pandemic Christopher Bush, Katherine E Mues, Shaina Desai, Brent Arakaki, Priyadarshani Dharia, Parinaz Ghaswalla, Yoonyoung Park
171 [GO] 2023―Nov―27 1256. Changes in Antimicrobial Stewardship (AS) Core Element Implementation among Oregon Hospitals following the COVID-19 Pandemic Jessina C McGregor, Lisa Iguchi, Elizabeth Breitenstein
172 [GO] 2023―Nov―27 230. Risk factors for bacteremia in patients receiving extracorporeal membrane oxygenation (ECMO) during the COVID-19 pandemic Curtis Hendrix, Christopher Radcliffe, Hossam Tantawy, Scott C Roberts
173 [GO] 2023―Nov―27 1734. Influenza, SARS-CoV-2, and routine childhood vaccines - trends in vaccine hesitancy in hospitalized children before and during the COVID-19 pandemic Marisa Orbea, Anurag Panjabi, Michelle Lopez, Rachel Cunningham, Julie A Boom, C Mary Healy, Claire Bocchini
174 [GO] 2023―Nov―27 1683. Severe Group A Streptococcus Infections Amongst Pediatric Patients in the Lehigh Valley, Pennsylvania Following the COVID-19 Pandemic Stormie Gough, Jonathan Berback, Tibisay Villalobos
175 [GO] 2023―Nov―27 2244. What Happened? Antibiotic Resistance During the First Two Years of the SARS-CoV-2 (COVID-19) Pandemic Matthew P Crotty, Joel Henderson, Jacqueline Hohulin, Jennifer Wright, Mingyang Cui, Julie Alexander, et al. (+3)
176 [GO] 2023―Nov―27 2322. Challenges Faced by Perinatally-Infected Young People Living with HIV in Kenya During the COVID-19 Pandemic Manjot Singh, Winstone Nyandiko, Allison DeLong, Celestine Ashimosi, Dennis Munyoro, Janet Lidweye, et al. (+10)
177 [GO] 2023―Nov―27 1235. A Retrospective Review of Antimicrobial Stewardship Audit and Feedback: Assessing Acceptance of Stewardship Recommendations During the COVID-19 Pandemic Melissa A Colaluca, Michelle Korson, Dora E Wiskirchen, Jessica Abrantes-Figueiredo
178 [GO] 2023―Nov―27 1748. Viral and Bacterial Etiology of Acute Gastroenteritis in Children < 5 Years Old at a Major Pediatric Referral Center Before and During the COVID-19 Pandemic Olla Hamdan, Tess Stopczynski, Justin Z Amarin, Yasmeen Z Qwaider, Haya Hayek, Laura S Stewart, et al. (+6)
179 [GO] 2023―Nov―27 2495. Inpatient Hepatitis C Virus Testing Increased During the COVID-19 Pandemic Brendan J Fitzgerald, Mamta K Jain, A L exander P Radunsky, Lauren N Cooper, Laura Hansen
180 [GO] 2023―Nov―27 1036. Reporting of SARS-CoV-2 testing results among PEPFAR and non-PEPFAR countries in Sub-Saharan Africa during the first year of the COVID-19 pandemic Benjamin C Johnson, Charles B Holmes
181 [GO] 2023―Nov―27 185. Pseudomonas aeruginosa (PA) Bacteremia and Patient Outcome during COVID-19 Pandemic Renuga Vivekanandan, Kelsey Witherspoon, Christopher J Destache
182 [GO] 2023―Nov―27 333. How the COVID-19 Pandemic Accelerated Development of our Complex Outpatient Oral Antimicrobial Therapy (COpAT) Program Joy J Juskowich, Jesse M Thompson, Arif R Sarwari
183 [GO] 2023―Nov―27 883. The Current State of Access: Inequitable Access to Infectious Disease Physicians in the Time of the COVID-19 Pandemic and Declining Fellowship Match Rates Benjamin P Fuller, Andrew Strumpf, Kathleen A McManus
184 [GO] 2023―Nov―27 1832. Rise in Deaths from Firearm Injury and Drug Overdose During COVID-19 Pandemic and its Impact on Organ Donation in the United States Roshan Dhand, Abhay Dhand, Seigo Nishida, Kenji Okumura
185 [GO] 2023―Nov―27 1817. Skin and Soft Tissue Infection Incidence Before and During the COVID-19 Pandemic at A Large Safety Net Healthcare System Prudencio Merino, Deborah Kupferwasser, Evelyn A Flores, Donna Phan Tran, Abisay Ortega, Loren G Miller
186 [GO] 2023―Nov―27 2242. Leveraging the McGeer criteria to Determine the Frequency of Potentially Inappropriate Antibiotic Prescribing for Urinary and Respiratory Tract Infections Prior to and During the COVID-19 pandemic at a Skilled Nursing Facility Paulina M Colombo, Ferris A Ramadan, Dilsharan Kaur, Katherine Ellingson
187 [GO] 2023―Nov―27 157. Implementation of multidisciplinary diagnostic stewardship for Clostridioides difficile infection during the COVID-19 pandemic at a small Japanese hospital Yasuhiro Sasaki, Masataka Yano, Ayumi Umehara, Yasuaki Tagashira
188 [GO] 2023―Nov―27 1343. Drug Education Needs of HCPs and Patients During the COVID-19 Pandemic Based on Over 60,000 Unsolicited Medical Information Requests Globally Over 3 Years (2020-2022) Sonia K Sandhu, Linda Chen
189 [GO] 2023―Nov―27 2258. "Identification of Respiratory Viral Pathogens Using Real-Time PCR Was Not Associated with Reduced Antibiotic Use During the COVID-19 Pandemic, but Displayed Viral-Viral Interactions" Asif Khan, Daynha P Marti Ojeda, Richard A Murphy, Joel Elzweig, Victoria W Lacasse, Suzette Rovelsky
190 [GO] 2023―Nov―27 1894. Delay in TB care before and during the COVID-19 pandemic, Dushanbe, Tajikistan, 2022 Rajabali Sharifov, Dilyara Nabirova, Zulfiya Haybullo Tilloeva, Sanam Zikriyarova, Salomudin Yusufi, Navruz Jafarov, Roberta Horth
191 [GO] 2023―Nov―27 805. Did Mask Mandates have an Affect on Pulmonary Mycoses? Trends of Coccidioidomycosis Incidence during COVID-19 Pandemic Era in California and Texas Nirusha Abeydeera, Linda Pham, Andrew Hwang, Napatkamon Ayutyanont
192 [GO] 2023―Nov―27 2466. The Evolution of Candidemia during the COVID-19 Pandemic in Connecticut Johanna Gleason-Vergados, Maria Correa, James Meek, David Banach
193 [GO] 2023―Nov―27 442. Unveiling Factors Associated with Mortality in Mucormycosis Patients: Insights from Second and Third Waves of COVID-19 Pandemic in India Vagisha Sharma, Kushal Kriplani, Isha Preet Tuli
194 [GO] 2023―Nov―27 2658. Mortality among children hospitalized with suspected pneumonia during the COVID-19 pandemic in India (PREVAIL study) Yangyupei Yang, Maria D Knoll, Anurag Agarwal, Vikas Manchanda, Melissa Higdon, Rajeshwar Dayal, et al. (+11)
195 [GO] 2023―Nov―27 2321. Prevalence and determinants of depression among healthcare workers during the COVID-19 pandemic in Khujand, Tajikistan, 2022 Jamila Silemonshoeva, Roberta Horth, Zulfiya Haybullo Tilloeva, Navruz Jafarov, S A N A M ZIKRIYAROVA, Dilyara Nabirova
196 [GO] 2023―Nov―27 1338. Changes in Volume and Diagnoses in a Pediatric Emergency Department during the COVID-19 Pandemic in Northeast Mexico Paulina Blanco Murillo, Oscar Tamez-Rivera, Rommy E Pineda-Magaña, Lucia Escobedo-Berumen, Ricardo J Estrada-Mendizabal, Katheryne P Madrazo-Aguirre, et al. (+2)
197 [GO] 2023―Nov―27 2277. Variability in Changes in Physician Outpatient Antibiotic Prescribing from 2019 to 2021 during the COVID-19 Pandemic in Ontario, Canada Pranav Tandon, Kevin Brown, Nick Daneman, Bradley J Langford, Valerie Leung, Lindsay Friedman, Kevin Schwartz
198 [GO] 2023―Nov―27 832. Epidemiology, Clinical Characteristics, Treatment and Outcome of Mucormycosis during COVID-19 Pandemic in the VA Health System Nirmal Muthukumarasamy, Hiroyuki Suzuki
199 [GO] 2023―Nov―27 694. Impact of COVID-19 Pandemic on Clostridioides difficile Infection Rates and Risk Factors in Maryland Kaytlynn Marceaux-Galli, Rebecca Perlmutter, David Blythe, Lucy Wilson
200 [GO] 2023―Nov―27 1508. The effects of the COVID-19 pandemic on depression severity and viral load non-suppression among people with HIV accessing care in an urban infectious disease clinic in Baltimore, MD Tarfa Verinumbe, Catherine Lesko, Richard Moore, Anthony Fojo, Jeanne Keruly, LaQuita N Snow, et al. (+2)
201 [GO] 2023―Nov―27 2462. The impact of the COVID-19 pandemic on hospital-acquired infections and multidrug-resistant organisms, and comparison with seasonal influenza Halima Dabaja-Younis, Zmira Silman, Jalal Tarabeia, Khetam Hussein
202 [GO] 2023―Nov―27 1365. Self-Reported Impacts of COVID-19 Pandemic on Patients with Bronchiectasis and Nontuberculous Mycobacterium Pulmonary Infections: Healthcare Avoidance and Other Impacts Across Delta and Omicron Waves Haley Miller, Jeremy Hawkins, Sarah A R Siegel, Arielle G Hernandez, Emily Henkle, Kevin L Winthrop
203 [GO] 2023―Nov―27 1671. Impact of COVID-19 Pandemic on Rates of Positive Blood Cultures and Contaminations in Children Hiroyuki Aiba, Masaki Yamada, Toshihiro Matsui, chikara Ogimi
204 [GO] 2023―Nov―27 2631. The impact of the COVID-19 pandemic on seasonal respiratory virus circulation in Korean children Kyo Jin Jo, Yoon Ha Hwang, Yechan Kyung, Ju-Suk Lee, Su Eun Park
205 [GO] 2023―Nov―27 2479. Impact of the COVID-19 pandemic on the hospital acquisition of multidrug-resistant organism in two Greek hospitals Polyxeni Karakosta, Elisavet Kousouli, Sophia Vourli, Panagiota Christina Georgiou, Vasiliki Mamali, Olympia Zarkotou, Spyros Pournaras
206 [GO] 2023―Nov―27 1440. Hand Hygiene in Nursing Homes During And After The Covid-19 Pandemic Outbreak Ida H Sandbekken, Borghild Løyland, Åsmund Hermansen, Inger Utne, Ellen Karine Grov
207 [GO] 2023―Nov―27 2297. Trends in Respiratory Pathogens Detected by Using a Multiplex PCR Panel during the Different COVID-19 Pandemic Phases in Taiwan Yu-Lung Hsu, Yan-Yi Low, Chiung-Tzu Hsiao, Yu-Chang Chang, Hong-Mo Shih, Hsiao-Chuan Lin, et al. (+2)
208 [GO] 2023―Nov―27 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic-CDC National Surveillance, February 2020-December 2022 Anna R Yousaf, Katherine N Lindsey, Ami B Shah, Allison D Miller, Michael J Wu, Michael Melgar, et al. (+2)
209 [GO] 2023―Nov―27 2228. Knowledge, Attitudes, and Practices Regarding Antibiotic Use during the COVID-19 Pandemic: A Comparison of United States (US) Survey Respondents Living in the US-Mexico Border Region with those Living in Non-border Regions Maja Subelj, Jose Luis Camarena, Brooke A Hawkes, Katherine Ellingson
210 [GO] 2023―Nov―27 1870. Changes of Tuberculosis Incidence and Mortality after COVID-19 Pandemic: A Interrupted Time-series Analysis Jungju Lee, Byung Chul Chun
211 [GO] 2023―Nov―27 2257. Cost-Benefit Analysis of Fidaxomicin (FDX) as First Line Treatment for Initial Episode of Clostridioides difficile Infection (CDI) during the COVID-19 Pandemic: A Quality Control/Improvement (QC/QI) Project at a Tertiary Care Veterans Affairs Medical Center (VAMC) over a 4-year period Sumaiya F Khaja, Ryan Kuhn, Sajjad Ali, Suganthini Krishnan Natesan
212 [GO] 2023―Nov―27 426. The diagnosis and treatment of COVID Associated Pulmonary Aspergillosis in patients requiring Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) in the Republic of Ireland during the COVID-19 pandemic: A Retrospective Review Rhea O’Regan, Gillian Crowe, Maureen Lynch, Eavan Muldoon, Jennifer Hastings
213 [GO] 2023―Nov―27 2434. Healthcare-associated Infections in the Era of COVID-19 Pandemic: An Experience from a Tertiary Care Hospital in Long Island, New York Monirul I Sajib, Tamasin Adams, Susan V Donelan, Roderick Go, Miguel A Saldivar
214 [GO] 2023―Nov―27 1709. Shifting Infection Spectrum in Febrile Neutropenic Pediatric Cancer Patients During the COVID-19 Pandemic: An Impact Assessment Aditya Dabas, Vagisha Sharma, Amitabh Singh, Kushal Kriplani, Rajni Gaind, Rani Gera
215 [GO] 2023―Nov―27 1457. Carbapenem-resistant Acinetobacter baumannii in an Intensive Care Unit during the COVID-19 pandemic: An Outbreak Investigation Utilizing Whole Genome Sequencing Samantha Williams, Rochelle T Thompson Kolawole, Bhagyashri Navalkele, Melinda Grubb, Sheila Fletcher, Daphne Ware, Ashley Robinson
216 [GO] 2023―Nov―27 149. Stewardship Efforts during the COVID-19 Pandemic: Impact on Antibiotic Prescribing Practices of Ambulatory Care Providers for Common (non-COVID-19) Viral Respiratory Syndromes Melinda Mackey, Reese Cosimi, Florian Daragjati, Erin Rice, Collin Miller, Aaron Shoemaker, Mohamad G Fakih
217 [GO] 2023―Nov―27 2471. Comparison of Dialysis Infection Events in Outpatient End Stage Renal Facilities Pre- and During the COVID-19 Pandemic: Louisiana, 2018-2021 Grace Lee, Erica Washington, Ashlyn Pinkins
218 [GO] 2023―Nov―27 2323. Pediatric Infectious Diseases Outpatient Telehealth Services During the COVID-19 Pandemic: Single Center Experience Celisse Zabalo, Athanasios Tsalatsanis, Ambuj Kumar, Claudia M Espinosa, Amol Purandare, Carina A Rodriguez, Claudia Gaviria-Agudelo
219 [GO] 2023―Nov―27 1763. Attendance and Learning Outcomes of Statewide Infection Prevention and Control Education and Support Webinars Initiative During the COVID-19 Pandemic: The Nebraska Experience Rebecca Martinez, Mounica Soma, Josette McConville, Laura "Kate" Tyner, Matthew Donahue, Muhammad Salman Ashraf, Daniel M Brailita
220 [GO] 2023―Nov―27 417. Impact of Post-acute Sequelae of COVID-19 (PASC) on Healthcare Workers (HCW) in NYC Public Hospital in the South Bronx Chee Yao Lim, Jorge Gutierrez, Alberto Romero Garcia, Pinal Patel, Kenneth Johan, Israel Duran, et al. (+9)
221 [GO] 2023―Nov―27 695. Incidence and Risk Factors for Clostridioides difficile Infections in Non-COVID and COVID-19 Patients Therese Mathew, Rhema Maria Punnoose
222 [GO] 2023―Nov―27 1212. Impact of Infectious Diseases Fellow Collaboration in the Medical Intensive Care Unit and Medical Intermediate Unit on Antimicrobial Utilization in COVID-19 Patients Smit Rajput, Franklin Mikell, Aaron Kipp, Jennifer Emberger
223 [GO] 2023―Nov―27 428. Risk Stratification and Clinical Outcomes in a Mixed Vaccination Cohort of COVID-19 Patients Admitted in a Tertiary Hospital Using ISARIC 4C Scores May Anne S Pascual, John Robinson L Reyes
224 [GO] 2023―Nov―27 525. Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years Kohei Fujita, Osamu Kanai, Hiroaki Hata, Takao Odagaki, Tadashi Mio
225 [GO] 2023―Nov―27 2632. Duration of viable SARS-CoV-2 shedding in immunocompromised COVID-19 patients during the widespread vaccination era Osamu Kanai, Kohei Fujita, Hiroaki Hata, Takao Odagaki, Tadashi Mio
226 [GO] 2023―Nov―27 1367. COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalizations Across the Four SARS-CoV-2 Pandemic Waves in Florida Ian Motie, John Sia, Joseph Seaman, Karen Hamad, Wilhelmine Wiese-Rometsch, Robert A Smith, Manuel E Gordillo
227 [GO] 2023―Nov―27 2269. Inpatient Antibiotic Prescribing for Symptomatic COVID-19 Patients in a Large US Sample, 2020-2022 Michael Pulia, Meggie Griffin, Daniel J Hekman, Rebecca Schwei, Aurora E Pop-Vicas, Lucas Schulz, et al. (+3)
228 [GO] 2023―Nov―27 427. Bloodstream infections among adult COVID-19 patients in Colombian hospitals between 2020-2021 Christian Pallares, María Virginia Villegas, Jessica Porras, Karen Melissa Ordoñez, Elsa Yasmín Vente, Erika Vanessa Patiño, Sandra Milena Gómez
229 [GO] 2023―Nov―27 1341. Clinico-demographic Features and Mortality of COVID-19 Patients in Southwest Michigan Alana Pinheiro Alves, Alec Johnson, Benjamin I Bizer, Matthew Belardo, Kathryn Garber, Mujahed Abbas
230 [GO] 2023―Nov―27 2289. Accuracy of the National Early Warning Score 2 (NEWS2) in predicting Mortality and ICU Admission among COVID-19 patients in the Emergency Department of a Tertiary Private Hospital in the Philippines Bernice Ong-dela Cruz, Darlene Mae E Cledera
231 [GO] 2023―Nov―27 416. Poor clinical outcomes of COVID-19 patients receiving rituximab during the Omicron era Chan Mi Lee, Chang Kyung Kang, Hyeon Jae Jo, Pyoeng Gyun Choe, Nam Joong Kim, Wan Beom Park, Myoung-don Oh
232 [GO] 2023―Nov―27 449. Elevated Lactate Dehydrogenase in Convalescent Severe COVID-19 Patients Reflects Delayed Clinical Recovery and Activated Th1 and Th17 Responses Jinyoung Yang, Ho Cheol Jang, Min Seo Kang, Keon Young Lee, Young Ho Lee, Kyungmin Huh, et al. (+6)
233 [GO] 2023―Nov―27 540. A Dose-Comparison Study of Methylprednisolone on Mortality in COVID-19 Patients Require Oxygen in A Tertiary Hospital in Thailand Pattraporn Piyapan, Viranpat Masamhisak
234 [GO] 2023―Nov―27 1345. Clinical Characteristics and Outcomes of Mild to Moderate COVID-19 Patients with Abnormal Chest Radiologic Findings Treated in the Hospitels in Thailand Naruemit Sayabovorn, Pochamana Phisalprapa, Weerachai Srivanichakorn, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Tullaya Sitasuwan, et al. (+10)
235 [GO] 2023―Nov―27 483. Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with Hemodialysis Xin Li, Huajian Ying, Feng Sun, Yaxin Fan, Yi Li, Xiaofen Liu, et al. (+5)
236 [GO] 2023―Nov―27 423. Development and Validation of a Predictive Model of New-Onset Deep Vein Thrombosis/Pulmonary Embolism Among Hospitalized COVID-19 Patients: A Retrospective Cohort Study Qingqing Meng, Guillermo Rodriguez-Nava, Goar Egoryan, Armen Kishmiryan
237 [GO] 2023―Nov―27 515. The Impact of Prolonged Steroid Use on Critically Ill COVID-19 Patients: A Retrospective Cohort Study Jaijun Han, Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Ho Choi, et al. (+4)
238 [GO] 2023―Nov―27 87. The safety and efficacy advantage of blocking C5a vs C5 in critically ill, COVID-19 patients: Results from PANAMO, a Phase 3 randomized controlled trial Bruce P Burnett, Endry H T Lim, Alexander Vlaar, Sanne De Bruin, Matthijs Brouwer, Maria Habel, et al. (+8)
239 [GO] 2023―Nov―27 2389. Surveillance evaluation of COVID-19 pharmacovigilance-Karakalpakstan, Uzbekistan, 2022 Yunis Tursinov, Botirjon Kurbanov, Alfiya Denebayeva, Roberta Horth, Dilyara Nabirova
240 [GO] 2023―Nov―27 543. Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol Adriana Rauseo, Tatyana Der, Radica Alicic, Bindu Balani, Caryn Morse, Pearl Zakroysky, et al. (+3)
241 [GO] 2023―Nov―27 551. Efficacy of adjusting steroids dose in non-ICU COVID-19 pneumonia patients with chest radiology deterioration Qingqing Wang, Bijie Hu
242 [GO] 2023―Nov―27 451. Pre- and Post-implementation Comparison of the Impact of Emergency Department (ED)-Based COVID-19 Point-of-Care Testing on ED Patient Metrics Katherine Z J Fenstermacher, Eili Klein, Jeanne Mumford, Barbara Maliszewski, Gai Cole, Mustapha O Saheed, Richard E Rothman
243 [GO] 2023―Nov―27 1886. Prevalence Of Latent TB Infection Among Critically Ill COVID-19 Population In a Tertiary Teaching Hospital In Mexico Santiago Montiel, Benjamin Valente-Acosta
244 [GO] 2023―Nov―27 493. ENDURANCE - EffectiveNess of Evusheld for COVID-19 Pre-exposUre PRophylAxis iN ImmunoCompromised PatiEnts - A Pilot Study James Polega, Heather Brooks, Rebecca Emery, Joshua D Donkin, Kevin Fitzgerald, G O R D A N A SIMEUNOVIC
245 [GO] 2023―Nov―27 494. Real-world effectiveness of tixagevimab/cilgavimab for COVID-19 pre-exposure prophylaxis in solid organ transplant recipients during the Omicron variant period Gun Rojanakit, Sasisopin Kiertiburanakul, Sarinya Boongird, Napan Sutharattanapong, Teerapat Yingchoncharoen, Abhasnee Sobhonslidsuk, Jackrapong Bruminhent
246 [GO] 2023―Nov―27 2230. Consumption of Quinolones, Macrolides, and Beta-Lactam Antibiotics at a Tertiary Care Veterans Affairs Medical Center (VAMC) during COVID-19 Pre-pandemic and Pandemic periods: A 4-year Analysis and Implications for Antimicrobial Stewardship Sajjad Ali, Ryan Kuhn, Sumaiya F Khaja, Suganthini Krishnan Natesan
247 [GO] 2023―Nov―27 1363. Preliminary Safety Results from a Phase 1 First in Human Study of VYD222: an Extended Half-Life Monoclonal Antibody (mAb) in Development for COVID-19 Prevention Kathryn Mahoney, Deepali Gupta, Yong Li, Natalia Betancourt, Aanika Das, Ed Campanaro, Pete Schmidt
248 [GO] 2023―Nov―27 2332. COVID-19 Primary Series and Booster Vaccination and Potential for Immune Imprinting Hiam Chemaitelly, Houssein H Ayoub, Laith J Abu-Raddad
249 [GO] 2023―Nov―27 2387. Assessment of COVID-19 primary series vaccination and factors associated with early and late uptake among Servicemembers in the Military Health System Laveta Stewart, Megan Clare Craig-Kuhn, Erica Sercy, Caryn Stern, Brock Graham, Amber Michel, et al. (+6)
250 [GO] 2023―Nov―27 397. The Three COVID-19 Prognostic Tools (CALL, 4Cs, NLR): Head-to-Head Comparison George Doumat, Hady Yazbeck, Hassan Itani, Rayyan Wazzi-Mkahal, Mario Badr, Elie Moussa, et al. (+3)
251 [GO] 2023―Nov―27 1098. COVID-19 Reinfections in Older Adults: Risk Factors for Poor Outcomes Elizabeth Lando-King, Keeley Morris, Scott Seys, Zachary Zirnhelt, Elle Talsma, Haley Wienkes, et al. (+2)
252 [GO] 2023―Nov―27 429. Risk of COVID-19 Related Deaths for SARS-CoV-2 Omicron (B.1.1.529) Compared With Delta (B.1.617.2): A Retrospective Cohort Study Shon Paulson, Jomel Raju
253 [GO] 2023―Nov―27 552. Effect of Lactococcus lactis strain plasma (LC- Plasma) on immune response and symptoms in patients with mild COVID-19. Result of the multicenter, double- blinded, randomized controlled trial (PLATEAU study) Kazuko Yamamoto, Tsuyoshi Inoue, Kenta Jounai, Ryohei Tsuji, Daisuke Fujiwara, Naoki Iwanaga, et al. (+10)
254 [GO] 2023―Nov―27 2312. COVID-19 risk factors before and after the vaccines among hospital workers: Have they changed? Fernando Rosso, David E Rebellon-Sanchez, Julio Llanos-Torres, Eric Tafurt
255 [GO] 2023―Nov―27 2311. Predictive cut-off values for anti-N and anti-S antibodies for COVID-19 risk identification David E Rebellón Sánchez, Julio Llanos-Torres, Eric Tafurt, Fernando Rosso
256 [GO] 2023―Nov―27 524. Hepatic Safety of Remdesivir Across Phase 3 Placebo-controlled COVID-19 Studies Lindsey Force, Chris Blair, Joshua Duckworth, Mazin Abdelghany, Ngoc-Quyen Nguyen, Robert H Hyland, et al. (+4)
257 [GO] 2023―Nov―27 392. The Impact of Therapeutic Interventions on Post-Acute Sequelae of SARS-CoV-2 (PASC) in COVID-19 Survivors: A Retrospective Analysis Andrea S Calderon, Kristin Englund
258 [GO] 2023―Nov―27 930. COVID-19 symptom and viral load rebound among individuals reporting nirmatrelvir/ritonavir use compared to propensity score matched individuals not taking COVID-19 treatment Sarah E Smith-Jeffcoat, Jessica E Biddle, H Keipp Talbot, Vanessa Olivo, Ellen Sano, Sara H Goodman, et al. (+31)
259 [GO] 2023―Nov―27 2315. Hidden in Plain Sight: Latent Class Analysis of Respiratory Infection Symptoms based on COVID-19 Testing and Vaccination History Xiaowu Sun, Laura L Lupton, Coetzer Henriette, Jonathan DeShazo, Alexandra Berk, Laura Anatale-Tardiff
260 [GO] 2023―Nov―27 468. Associations of Socioeconomic Status and Care Access Measures with COVID-19 Testing in Patients with Breast Cancer Jincong Q Freeman, Xinyi Li, Yong Gun Lee, Ted O Akhiwu
261 [GO] 2023―Nov―27 475. "The Outcomes and Adverse Effects of COVID-19 Therapies in High-Risk Children" Johanna Holschier, Alison Boast, Christine Plover, Suzanne Boyce, Sarah McNab, Nigel Curtis, Amanda Gwee
262 [GO] 2023―Nov―27 2294. Severity and characteristics of patients hospitalized during Delta and Omicron-predominant COVID-19 time periods in Los Angeles County Carmon Greene, Heidi D Sato, Kelsey OYong, Elizabeth Traub, Zachary Rubin
263 [GO] 2023―Nov―27 2293. Examining social vulnerability and its effect on COVID-19 transmission in households Sara H Goodman, Alexandra Mellis, Carlos G Grijalva, H Keipp Talbot, Melissa Stockwell, Son H McLaren, et al. (+15)
264 [GO] 2023―Nov―27 1366. Temporal changes in Demographics, Characteristics and Treatments for Patients enrolled in the Canadian Treatments for COVID-19 Trial Samiha Mohsen, Srinivas Murthy, Ruxandra Pinto, Robert Fowler
265 [GO] 2023―Nov―27 856. CT-proET-1 and sFlt-1 as Predictors of Clinical Outcomes in a COVID-19 US Cohort Johnny Atallah, Natalie Atallah, Vahe Panossian, Hailey Warren, Damian Inlall, Andrej Schwabe, et al. (+3)
266 [GO] 2023―Nov―27 2393. Factors Associated with Time to COVID-19 Vaccination among People with HIV Aasith Villavicencio Paz, Alex P Sanchez-Covarrubias, Fatemeh Ghadimi, Hervette Nkwihoreze, Raymond Zelada, Helen Koenig, Florence Momplaisir
267 [GO] 2023―Nov―27 2388. Factors Associated with COVID-19 Vaccination Among Racial/Ethnic Minority Populations with HIV, Miami-Dade County, Florida, 2022 Mary Jo Trepka, Daisy Ramirez-Ortiz, Michele Jean-Gilles, Robert Ladner, Tan Li, Diana Sheehan
268 [GO] 2023―Nov―27 2376. Trends in COVID-19 vaccination among reproductive-aged in Jamaica: a comparison of two time periods Jodian Pinkney, Laura Bogart, Kamali Carroll, Lenroy Bryan, Givana Witter, Dina Ashour, et al. (+5)
269 [GO] 2023―Nov―27 462. Infant antibody titers at birth following maternal COVID-19 vaccination and protection against infection in the first 6 months of life Cristina Cardemil, Flor M Munoz, Yi Cao, Fei Gao, Christine M Posavad, Martina L Badell, et al. (+16)
270 [GO] 2023―Nov―27 2080. Reduced risk of SARS-CoV-2 infection among household contacts with hybrid immunity from recent COVID-19 vaccination and SARS-CoV-2 infection Melissa A Rolfes, H Keipp Talbot, Kerry Grace Morrissey, Melissa Stockwell, Yvonne A Maldonado, Huong McLean, et al. (+31)
271 [GO] 2023―Nov―27 2361. Prevalence of Zoster Infection Post mRNA COVID-19 Vaccination Compared to Influenza Vaccination Mark S Lazbin, David C Kaelber
272 [GO] 2023―Nov―27 1836. Disparities in COVID-19 Vaccination Coverage Among a Large Patient Population in a Network of Community-Based Healthcare Organizations Holly C Groom, Frances Biel, Bradley Crane, Evelyn Sun, Joanna Georgescu, Eric Weintraub, et al. (+5)
273 [GO] 2023―Nov―27 2335. Up-to-date COVID-19 vaccination coverage among healthcare personnel in nursing homes -National Healthcare Safety Network Sushmitha Ananth, Hannah E Reses, Heather Dubendris, Kira A Barbre, Emily Wong, Meng Lu, Jeneita Bell
274 [GO] 2023―Nov―27 499. Level of Cord Blood Anti-SARs-CoV-2 Antibodies in Infants Born During 2021-2023 to The Mothers Who Had Received COVID-19 Vaccination During Pregnancy Nophathai Sojisirikul, Keswadee Lapphra, Kulkanya Chokephaibulkit
275 [GO] 2023―Nov―27 1144. Dissociative Neurological Symptom Reactions Following COVID-19 Vaccination in Adolescents in Japan Yuho Horikoshi, Takayuki Yamanaka, Yuta Aizawa, Yukitsugu Nakamura, Takayo Shoji, Toshihiko Okumura, Yoshiaki Cho
276 [GO] 2023―Nov―27 2339. COVID-19 Vaccination in Adults and Children. Cross-Sectional Study of Adults', Pediatricians' and Parents' perceptions and Acceptance of COVID-19 Vaccine in Colombia Margarita Cortés, Andrea Puentes, Mónica Arenas, Carlos Arango, José Brea, Claudia Beltran, Roberto Debbag
277 [GO] 2023―Nov―27 1726. Characterization of humoral immune responses to COVID-19 vaccination in children in Canada: interim analysis from the Severe acute respiratory syndrome-related coronavirus 2 PRevalence In children and youNG adults in British Columbia (SPRING) Study Gabrielle N Gaultier, Mandy Lo, Brynn McMillan, Amy Lee, Bing Cai, Tony Harn, et al. (+9)
278 [GO] 2023―Nov―27 2351. Concordance Between Sources of COVID-19 Vaccination Information Among Children Aged 5-18 years, May 2021-March 2023 Sarah Hamid, Laura D Zambrano, Regina Simeone, Margaret M Newhams, Natasha B Halasa, Katherine E Fleming-Dutra, et al. (+4)
279 [GO] 2023―Nov―27 2345. Factors associated with COVID-19 vaccination refusal among U.S. Immigration and Customs Enforcement detainees Carlo Foppiano Palacios, Mark Travassos
280 [GO] 2023―Nov―27 747. Employer requirements of COVID-19 vaccination reported by healthcare personnel, April 2022 Marie de Perio, Anup Srivastav, Anthony Laney, Carla Black, Hilda Razzaghi
281 [GO] 2023―Nov―27 2348. Identifying Barriers Against COVID-19 Vaccination: A Prospective Study Gabriela S Generette, William Graft, Kayeromi Gomez, Basil Muhan, Jeana Kim, Kovas Polikaitis, et al. (+3)
282 [GO] 2023―Nov―27 1727. Household Vaccination Status and Attitudes towards Pediatric COVID-19 Vaccination: A survey at four New Jersey clinic-based pediatric practices Bozena J Katic, Jessica L Alvitres, Uzma Hasan, Aspasia Katragkou, Stephen M Friedman, Joseph V Schwab, et al. (+14)
283 [GO] 2023―Nov―27 1780. COVID-19 Vaccine Accessibility and Uptake among U.S. Children Aged 6 Months-4 Years and 5 Years-11 Years by Domains of Social Vulnerability Rohan Khazanchi, Benjamin Rader, Jonathan Cantor, Dena M Bravata, Kathleen A McManus, Christopher Whaley, et al. (+2)
284 [GO] 2023―Nov―27 2344. Clinical Profile and Immunologic Response from COVID-19 Vaccine Among People Living with HIV Enrolled in a Treatment Hub in the Philippines Mark John Festin, Regina Berba, Christine P Ramos, Jodor Lim
285 [GO] 2023―Nov―27 2358. Safety Profiles of Three Major Types of COVID-19 Vaccine among Two Cohorts of People Living with HIV Thana Khawcharoenporn, Sirashat Hanvivattanakul
286 [GO] 2023―Nov―27 2369. kinetics of total and neutralizing SARS-CoV-2 spike antibodies after the 2nd and 3rd dose of the BNT162b2 covid-19 vaccine and association with epidemiological characteristics and breakthrough infection Athanasios Michos, Elizabeth-Barbara Tatsi, Filippos Filippatos, Charilaos Dellis, Vasiliki Syriopoulou
287 [GO] 2023―Nov―27 479. Optimizing maternal COVID-19 vaccine antibodies in low birthweight infants: is timing everything? Alisa B Kachikis, Mindy Pike, Linda Eckert, Alexis L Baranoff, Hye Cho, Amber L Young, et al. (+3)
288 [GO] 2023―Nov―27 1938. CoviLiv™, a Novel Intranasal Live-Attenuated COVID-19 Vaccine Candidate, Induces Robust Humoral and Cellular Immunity in First-In-Human Clinical Trial CDX-CoV-001 Johanna K Kaufmann, Keri Wyllie, Yiwen Zhao, Lasmy Tea, Sybil Tasker, Leena R Yeolekar, et al. (+2)
289 [GO] 2023―Nov―27 496. Maternal Participation in Enrollment Interview and Risk of Bias in a Multicenter Pediatric Network Evaluating COVID-19 Vaccine Effectiveness in Infants Regina Simeone, Laura D Zambrano, Margaret M Newhams, Natasha B Halasa, Katherine E Fleming-Dutra, Amber Orzel, et al. (+3)
290 [GO] 2023―Nov―27 1158. Immunogenicity of COVID-19 vaccine four-dose series in healthy community dwelling adults 50 years and above: interim analysis from the ‘PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines’ (PREVENT-COVID) study Gabrielle N Gaultier, Brynn McMillan, Mandy Lo, Bing Cai, Jean Zheng, Hennady Shulha, et al. (+9)
291 [GO] 2023―Nov―27 385. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2 Grant C Paulsen, Lawrence Sher, Charu Sabharwal, Nicholas Kitchin, Sungeen Hill, Emily Wasserman, et al. (+18)
292 [GO] 2023―Nov―27 362. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to Toddlers and Children 6 Months to < 5 Years of Age Who Previously Received Original BNT162b2 as a 3-Dose Primary Series Lawrence Sher, Charu Sabharwal, Nicholas Kitchin, Justice Kofi Boakya-Appiah, Xia Xu, Emmanuel Walter, et al. (+17)
293 [GO] 2023―Nov―27 2395. An Interim Report of the Safety, Reactogenicity, and Immunogenicity of a Self-amplifying mRNA (samRNA) COVID-19 Vaccine GRT-R910 as a Booster in Healthy Adults Jennifer Whitaker, Paulina Rebolledo, Nadine Rouphael, Getahun Abate, Tara M Babu, Anna Wald, et al. (+16)
294 [GO] 2023―Nov―27 2340. COVID-19 Vaccine Hesitancy among Faculty Members, College Students and Health Care Workers in Lebanon George Doumat, Mohamad Ali Tfaily, Rayyan Wazzi-Mkahal, Zeina Kanafani
295 [GO] 2023―Nov―27 490. Identifying and Evaluating the Drivers of COVID-19 Vaccine Hesitancy Among Individuals with HIV in New Jersey Jessica Occhiogrosso, Leena Rijhwani, Divya Rijhwani, Aravind Rajagopalan, Theresa C Fox, Roseann Marone, et al. (+3)
296 [GO] 2023―Nov―27 2390. Factors Affecting Parental COVID-19 Vaccine Hesitancy in Cancer Parents with Minor Children Kazue Umetsu, Kazuhiro Kosugi, Tomoko Takahashi, Daisuke Fujisawa, Takashi Kawaguchi, Emi Kubo, et al. (+11)
297 [GO] 2023―Nov―27 2384. Exploring COVID-19 Vaccine Hesitancy in Unvaccinated Adults within a Semi-Urban Population of South India: A Qualitative Investigation Dipu T Sathyapalan, Sivapriya Nair, Vrinda Nampoothiri, Merlin Moni
298 [GO] 2023―Nov―27 2336. General Safety Profile of mRNA-1273 (Moderna COVID-19 Vaccine) in the Elderly Population Kate Anteyi, Veronica Urdaneta, Priyadarshani Dharia, Magalie Emile-Backer, Vaishali Khamamkar, Daina Esposito, Walter Straus
299 [GO] 2023―Nov―27 2385. Factors associated with delay of completion of a two-dose COVID-19 vaccine primary series among servicemembers in the Military Health System Erica Sercy, Laveta Stewart, Megan Clare Craig-Kuhn, Caryn Stern, Brock Graham, Amber Michel, et al. (+6)
300 [GO] 2023―Nov―27 2370. Characterizing Predictors of COVID-19 Vaccine Refusal in an Urban Southern California Jail Nazia Qureshi, Loren G Miller, Stephen Judge, Ngoc Dung Tran, Sean O Henderson
301 [GO] 2023―Nov―27 2357. Descriptive Analyses of mRNA-1273 (Moderna COVID-19 vaccine) Spontaneous Reports by Geographic Regions Magalie Emile-Backer, Vaishali Khamamkar, Priyadarshani Dharia, Samantha St Laurent, Cindy Ke Zhou, Daina Esposito, et al. (+2)
302 [GO] 2023―Nov―27 2382. Sociodemographic and Occupational Characteristics Associated with Delayed and Low COVID-19 Vaccine Uptake Among Healthcare Personnel: Monroe County, NY Savanah Russ, Christopher J Myers, Erin Licherdell, Acacia Bowden, Ellen Chinchili, Runda Dahhan, et al. (+3)
303 [GO] 2023―Nov―27 2360. Factors Affecting COVID-19 Vaccine Uptake in People Living with HIV Victoria N Kunkel, Nathan A Summers, Nupur Singh
304 [GO] 2023―Nov―27 2386. Examining Ways to Increase COVID-19 Vaccine Uptake through Motivational Interviewing Summer M Reyes, Sydney A Reyes, Tyler Walsh, Jamee T SHELLEY, Humza Agha, Ana V Torres, et al. (+6)
305 [GO] 2023―Nov―27 2367. Six-month Humoral Response Following Two Or Three Doses Of Covid-19 Vaccines As Primary Vaccination Followed Or Not By a Booster Dose In Specific Populations - ANRS0001S COV-POPART Cohort Study Paul LOUBET, Camille Gilbert, David Laplaud, Martine Laville, Bruno Laviolle, Jean-Daniel Lelièvre, et al. (+10)
306 [GO] 2023―Nov―27 2371. A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin ) Debdeep Mitra, Neerja Saraswat
307 [GO] 2023―Nov―27 1371. Results From the COVID-19 Vaccines Discrete Choice Experiment Pre-Test Qualitative Interviews in Canada, Germany, the UK, and US General Population Sumitra Sri Bhashyam, L G Shane, Hannah B Lewis, Marie de la Cruz, Jayne Galinsky, Keeva Demchuk, et al. (+3)
308 [GO] 2023―Nov―27 1720. Immunogenicity of COVID-19 Vaccines in Youth with Inflammatory Bowel Disease Blake T Cirks, Emily Parsons, Emily Samuels, Eric D Laing, Michael Rajnik, Allison M Malloy
309 [GO] 2023―Nov―27 408. Clinical Spectrum of Pediatric Long COVID and Impact of COVID-19 Vaccines on the Clinical Course Dina Kamel, Jeffrey Bender, David Warburton, John C Wood, Sindhu Mohandas
310 [GO] 2023―Nov―27 507. Impact of COVID-19 variant prevalence on hospitalization rate among individuals receiving monoclonal antibodies within a community health-system Gretchen S Arnoczy, Andrew Kessell, Felicia M Vielbaum, Brenda Brock, Rebecca Carter, Jan M Scholl
311 [GO] 2023―Nov―27 459. Characteristics and Presentations of Hospitalized Children due to three predominate COVID-19 variants within a healthcare network Sejal M Bhavsar, Katharine N Clouser, Hailey Connolly, Jasmine Gadhavi, Ranbir Kaur, Tara Lozy, et al. (+7)
312 [GO] 2023―Nov―27 2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein Tatsuro Kawamura, Masaki Ohuchi, Takayuki Nagasawa, Hirofumi Ohashi, Naoko Iwata-Yoshikawa, Nozomi Shiwa-Sudo, et al. (+13)
313 [GO] 2023―Nov―27 88. Fostamatinib for the Treatment of Hospitalized Patients With COVID-19 Who Required Oxygen Supplementation: Results of a Phase 3 Trial Deepa B Gotur, Anuj Malik, Vadim Markovtsov, Lucy Yan, Wolfgang Dummer, Ziad Mallat
314 [GO] 2023―Nov―27 512. Interim Results of a Prospective Cohort Study to Monitor the Emergence of Resistance in Immunocompromised Non-Hospitalized Patients With COVID-19 Who Were Treated with Sotrovimab in Great Britain: LUNAR Study  Judith Breuer, Myriam Drysdale, Jill Walker, Jennifer Han, Magdalena Gorczycka, Alicia Aylott, et al. (+4)
315 [GO] 2023―Nov―27 2308. Exploring the Seasonality of COVID-19 with Machine Learning: A Distinct Bimodal Pattern? Guillermo Rodriguez-Nava, Lucy S Tompkins, Karen McIntyre, Bryan Bohman, Jorge Salinas
316 [GO] 2023―Nov―27 1861. Prevalence of COVID-19 within Predominantly Black Church Congregations in Ontario, Canada Nicole Wisener, Alice Litosh, Walter Byrne, Matthew Hwang, Kimberly Thompson, Upton D Allen
317 [GO] 2023―Nov―27 740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020 Kelly A Jackson, Sydney Resler, Joelle Nadle, Susan Petit, Kimberly Yousey-Hindes, Susan M Ray, et al. (+11)
318 [GO] 2023―Nov―27 2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023 Jennifer DeCuir, Yuwei Zhu, Manjusha Gaglani, Adit A Ginde, Nicholas Mohr, Kevin Gibbs, et al. (+24)
319 [GO] 2023―Nov―27 516. A Systematic Literature Review Evaluating Real-World Use of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Death Ashley S Cha-Silva, Meghan B Gavaghan, Jennifer L Nguyen, Ronika Alexander-Parrish, Jingyan Yang, Jaymin Patel, et al. (+3)
320 [GO] 2023―Nov―27 1354. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of COVID-19: 15-Month Final Analysis of the PROVENT Phase 3 Study Myron J Levin, Andrew Ustianowski, Stéphane De Wit, Rohini Beavon, Jesse Thissen, Seth Seegobin, et al. (+3)
321 [GO] 2023―Nov―27 529. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Phase 3 Study F D Richard Hobbs, Hugh Montgomery, Francisco Padilla, Jesus Abraham Simón Campos, Douglas Arbetter, Seth Seegobin, et al. (+5)
322 [GO] 2023―Nov―27 2234. Ambulatory Prescribing Trends of Azithromycin and Systemic Glucocorticoids in Patients Diagnosed with COVID-19: A Large Healthcare Network Analysis in Massachusetts Shamsuddin Anwar, Maureen Campion, Kap Sum Foong, Shira Doron, Gabriela Andujar Vazquez
323 [GO] 2023―Nov―27 474. Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting Jun Hirai, Nobuaki Mori, Daisuke Sakanashi, Nobuhiro Asai, Mao Hagihara, Hiroshige Mikamo
324 [GO] 2023―Nov―27 491. Risk Factors for Severe Pediatric COVID-19: A Systematic Review Carlos R Oliveira, Zachary I Willis, Gabriela Maron, Paul K Sue, Brenda I Anosike, Laura Bio, et al. (+5)
325 [GO] 2023―Nov―27 510. Real-world Effectiveness of Sotrovimab for COVID-19: Evidence from United States (US) Administrative Claims Data Christopher F Bell, Tasneem Lokhandwala, Daniel C Gibbons, Myriam Drysdale, Jane Wang, Emily Lloyd
326 [GO] 2023―Nov―27 1353. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of COVID-19: Final Analysis of the STORM CHASER Phase 3 Study Myron J Levin, Andrew Ustianowski, Jesse Thissen, Seth Seegobin, Rohini Beavon, Kanika Dey, et al. (+5)
327 [GO] 2023―Nov―27 2643. Seasonality of infant respiratory syncytial virus associated bronchiolitis around the US since the onset of COVID-19: Results from four US health systems 2016-2023 Adam Blatt, Mina Suh, Zachary Wolf, Emory Waddell, Christopher B Nelson
328 [GO] 2023―Nov―27 530. Population Pharmacokinetic Analysis of Ensitrelvir, an Inhibitor of 3C-like (3CL) Protease of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for patients with SARS-Cov-2 Infection Toru Ishibashi, Luna Nomura, Ryosuke Shimizu, Ryuji Kubota
329 [GO] 2023―Nov―27 482. Long-Term Outcomes of Coronavirus disease 2019 and Risk Factors for Prolonged SARS-CoV-2 Infection in Lymphoma Patients: Multicenter, Retrospective Cohort Study Jung Ah Lee, Min Han, Sangmin Ahn, Yongseop Lee, Joon-sup Yeom, Jun Yong Choi, et al. (+8)
330 [GO] 2023―Nov―27 1479. Analysis of Depression in People Living with Human Immunodeficiency Virus (HIV) During the Coronavirus Disease 2019 Pandemic in 4 African Countries Paul Adjei, Nicole Dear, Allahna Esber, Hannah Kibuuka, Jonah Maswai, John Owuoth, et al. (+4)
331 [GO] 2023―Nov―27 2355. Incidence of Omicron Variant Reinfection and Reduction of Reinfection Risk After Coronavirus Disease 2019 Vaccination in Children Tatsuki Ikuse, Yuta Aizawa, Satoshi Hasegawa, Masashi Takahashi, Takanori Hayashi, Miyako Kon, et al. (+3)
332 [GO] 2023―Nov―27 1337. Detection of SARS-CoV-2 using an electrostatic precipitator air sampler in hospital patient rooms of coronavirus disease-2019 and public areas Hiroaki Baba, Kyohei Fukuda, Mie Yoshida, Kouichi Kitabayashi, Shinjirou Katsushima, Hiroki Sonehara, et al. (+5)
333 [GO] 2023―Nov―27 531. Clinical efficacy of inhaled corticosteroids in patients with coronavirus disease-2019: an updated systematic review and meta-analysis Su Jin Jeong
334 [GO] 2023―Nov―27 1752. Seasonal Human Coronavirus in Pediatric Patients enrolled by the New Vaccine Surveillance Network, 2016-2020 Samar Musa, Xueyan Zhang, G K Balasubramani, Natasha B Halasa, Laura S Stewart, Jennifer E Schuster, et al. (+13)
335 [GO] 2023―Nov―27 1103. Endemic Coronavirus Infections in a US Cohort of Children from Birth to 4 Years Daniel C Payne, Ardythe L Morrow, Shannon C Conrey, Meredith L McMorrow, Monica McNeal, Liang Niu, et al. (+10)
336 [GO] 2023―Nov―27 304. Immunoproteasome Inhibition Augments Endoplasmic Reticulum Stress and Enhances Disease During Coronavirus Respiratory Infection Jacob C Steigmann, Lauren Suttenberg, Xiaofeng Zhou, Jason Weinberg
337 [GO] 2023―Nov―27 918. Identification of novel druggable host targets for Middle East respiratory syndrome coronavirus using a quantitative phosphoproteomics approach Jasper F W Chan, Bingjie Hu, Kenn K H Chik, Shuofeng Yuan, Hin Chu
338 [GO] 2023―Nov―27 367. Safety and Immunogenicity of a 50-μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Adolescents Amparo Figueroa, Kashif Ali, Gary Berman, Honghong Zhou, Weiping Deng, Monali Patel, et al. (+6)
339 [GO] 2023―Nov―27 880. Diagnostic Testing Sample-Type Preferences: Results From An International Survey On SARS-CoV-2 Sumaira Akbarzada, Nithya Narayanan, Leah Salzano, Emily R Tobik, Sarah Megiel, Craig Duni, et al. (+3)
340 [GO] 2023―Nov―27 450. Performance Evaluation of PMMV as an internal control for the wastewater surveillance of SARS-CoV-2 Hosoon Choi, John David Coppin, Piyali Chatterjee, Emma Brackens, Lynn Mayo, Munok Hwang, et al. (+3)
341 [GO] 2023―Nov―27 634. Head-to Head Comparison of the Performance of BIOFIRE® SPOTFIRE® Respiratory/Sore throat Panel, Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV and Cobas® SARS-CoV-2 & Influenza A/B Assay for Detection of Respiratory Viruses Dithi Banerjee, Anjana Sasidharan, Stephanie Gummersheimer, Sydnie Petty, Amanda M Hayes, Minati Dhar, Rangaraj Selvarangan
342 [GO] 2023―Nov―27 473. Trends among hospitalized pregnant patients with laboratory-confirmed SARS-CoV-2 - COVID-NET, 14 U.S. States, January 2021-January 2023 Fiona P Havers, Michael Whitaker, Jennifer Milucky, Monica E Patton, Bhoomija Chatwani, Shua Chai, et al. (+15)
343 [GO] 2023―Nov―27 2298. Penetration of SARS-CoV-2 Alpha, Delta, and Omicron Variants in the USA Hosoon Choi, Munok Hwang, John David Coppin, Piyali Chatterjee, Chetan Jinadatha
344 [GO] 2023―Nov―27 390. Corticosteroid Treatment in Severe Patients with SARS-CoV-2 and Chronic HBV Co-infection: A Retrospective Multicenter Study Sanju Biju, Shon Paulson, Jomel Raju
345 [GO] 2023―Nov―27 2651. Successful Sequencing and Genotyping of SARS-CoV-2 and Influenza Viruses from Self-Collected Nasal Swabs for SARS-CoV-2 Rapid Antigen Testing Kat Schmidt, Stephanie A Richard, Emily Hone, Simon Pollett, Rezalina Tant, Michele Wayman, et al. (+8)
346 [GO] 2023―Nov―27 539. Efficacy in Multiple SARS-CoV-2 Animal Models Supports Phase 3 Dose Selection for Obeldesivir Jared Pitts, Darius Babusis, Rita Humeniuk, David Martinez, Robert M Cox, Alexandra Schäfer, et al. (+18)
347 [GO] 2023―Nov―27 1165. Longitudinal Evaluation of SARS-CoV-2 Antibody Response Using Dried Blood Spot Samples Following Vaccination with Three and Four Doses of mRNA-1273, BNT162b2 and/or ChAdOx1-S in Adults Aged 50 and Above: Interim Analysis from the PREVENT-COVID Study Brynn McMillan, Gabrielle N Gaultier, Ana Citlali Marquez, Tahereh Valadbeigy, Bonny So, Sydney Schwartz, et al. (+13)
348 [GO] 2023―Nov―27 2305. The effect of SARS-CoV-2 antibody testing on the results of admission screening Kenji Ota, Tomohiro Yamakawa, Daisuke Sasaki, Fujiko Mitsumoto-Kaseida, Norihito Kaku, Kosuke Kosai, et al. (+5)
349 [GO] 2023―Nov―27 1796. Use of SARS-CoV-2 Antibody Tests by U.S. Infectious Disease Physicians: Qualitative Results of an Emerging Infections Network Survey, March 2022 Scott S Santibanez, Adi Gundlapalli, Susan E Beekmann, Timothy M Uyeki, Panayampalli Satheshkumar, Ian D Plumb, et al. (+4)
350 [GO] 2023―Nov―27 454. How Useful is SARS-CoV-2 Antigen Detection in Individuals Admitted to the Hospital With no Respiratory Symptoms? Monique A Prince, Wajeeha Aiman, Modupeoluwa Owolabi, Alaa Muhanna, Evans Martin, Joe Hessell, Jihad Slim
351 [GO] 2023―Nov―27 639. Are SARS-CoV-2 antigenemia measurements still relevant? Comparison of Omicron era to early pandemic plasma nucleocapsid levels Gregory L Damhorst, Hans Verkerke, Sydney E Martin, Eli Wilber, Wilbur A Lam
352 [GO] 2023―Nov―27 452. Ongoing Surveillance of SARS-CoV-2 for In Silico Analysis to Monitor the Performance of SARS-CoV-2 Assays in BIOFIRE® Panels Eleanor K Horrocks, Toma Todorov, Alexandra Debernardi, Usha Spaulding, Tanner Robinson, Jeremiah Antosch, et al. (+3)
353 [GO] 2023―Nov―27 434. Characteristics and long-term outcomes of SARS-CoV-2 associated myocarditis cases in the Military Health System Simon Pollett, Stephanie A Richard, Catherine Berjohn, Josh Chenoweth, Paul Blair, Clifton Dalgard, et al. (+18)
354 [GO] 2023―Nov―27 377. Phase I trial of two novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as 4th dose boosters Terry Nolan, Georgia Deliyannis, Sabine Braat, Lilith Allen, Jennifer Audsley, Marcin Ciula, et al. (+32)
355 [GO] 2023―Nov―27 2396. In Nursing Home Residents, SARS-CoV-2 Boosters Reduced Sex Disparity in Vaccine Response Observed in Primary Series Brigid Wilson, Stefan Gravenstein, Sabra L Klein, Carson Smith, Anna Yin, Patrick Shea, et al. (+3)
356 [GO] 2023―Nov―27 467. Maternal Antibody and Placental Transfer Increases with Hybrid Immunity Against SARS-CoV-2 but Transferred Antibody is Qualitatively Different Ketrah Dekanich, Kristen Smith, Eric D Laing, Wei Wang, Carol D Weiss, Emily C Samuels, et al. (+23)
357 [GO] 2023―Nov―27 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study Alexandra Mellis, Sarah E Smith-Jeffcoat, Joshua Petrie, H Keipp Talbot, Kerry Grace Morrissey, Melissa Stockwell, et al. (+30)
358 [GO] 2023―Nov―27 441. Prior SARS-CoV-2 Diagnosis is a Risk Factor for Herpes Zoster in Younger Adults: A Nested Case-control Study in the EPICC Cohort Kat Schmidt, Stephanie A Richard, Catherine Berjohn, Tahaniyat Lalani, Alfred Smith, Rupal Mody, et al. (+24)
359 [GO] 2023―Nov―27 2079. Maternal hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant antibody responses compared to natural infection alone Sylvia M LaCourse, Erica A Wetzler, Morgan C Aurelio, Jaclyn N Escudero, Stacy Selke, Alex L Greninger, et al. (+7)
360 [GO] 2023―Nov―27 1336. Presence of Antibodies to non-SARS-CoV-2 Associates With Generation of Neutralizing Antibodies to SARS-CoV-2 Following mRNA Vaccination Roukaya Al Hammoud, Gabriela P Del Bianco, Anoma Somasunderam, Stacy Gomez Hernandez, Kaleigh Riggs, Syed Hashmi, et al. (+2)
361 [GO] 2023―Nov―27 1792. SARS-CoV-2 Genomic Surveillance System Development as a Model for Other Emerging Pathogens in Texas Saroj Rai, Rania Milleron, Rachel Lee, Blake M Hanson, Marlisa Hardy, Eric Boerwinkle, et al. (+3)
362 [GO] 2023―Nov―27 500. Durability of antibody response after booster vaccination against SARS-CoV-2 in kidney transplant recipients with or without prior infection Thornthun Ueaphongsukkit, Athiphat Banjongjit, Yingyos Avihingsanon, Suwasin Udomkarnjananun, Natavudh Townamchai, Kamonwan Jutivorakool, Jakapat Vanichanan
363 [GO] 2023―Nov―27 2299. Genomic Epidemiology of SARS-CoV-2 in Metropolitan Detroit Jagjeet Kaur, Katherine Gurdziel, Benjamin Wasinski, Nivisa Vakeesan, Sayed Hassan Raza, Wanqing Liu, et al. (+2)
364 [GO] 2023―Nov―27 464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding Eui Jin Chang, Jungmin Lee, Sung-Woon Kang, So Yun Lim, Ji Yeun Kim, Choi-Young Jang, et al. (+2)
365 [GO] 2023―Nov―27 497. Safety and tolerability of 2000mg intravenous sotrovimab dose in immunocompromised participants uninfected with SARS-CoV-2 in the PROTECT-V trial Davinder Dosanjh, Wendi Qian, Francis Dowling, Louise Crowley, Michael Chen-Xu, Rona M Smith
366 [GO] 2023―Nov―27 2372. Preliminary evidence of durable immune responses induced by self-amplifying mRNA (samRNA) vaccine candidates against SARS-CoV-2 in vaccine-naive South African population A Koen, E Mitha, J Allagappen, A Nagare, M Dhar, M Marrali, et al. (+13)
367 [GO] 2023―Nov―27 477. Characteristics and Long-Term Outcomes of Cardiac Complications of SARS-CoV-2 in Youth: Results from the EPICC YES C3 Prospective Longitudinal Cohort Module Milissa U Jones, Stephanie A Richard, Allison M Malloy, Kirk N Liesemer, Rebecca Sainato, Joseph May, et al. (+20)
368 [GO] 2023―Nov―27 411. Comparison of clinical outcomes between early and delayed transplantation after SARS-CoV-2 infection A Reum Kim, Eui Jin Chang, SeongMan Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, et al. (+4)
369 [GO] 2023―Nov―27 2082. Effectiveness of Bivalent mRNA Vaccines in Preventing SARS-CoV-2 Infection Among Children Aged 5-17 years: an Evaluation of Multicenter Prospective Cohorts, United States, September 2022 - January 2023 Leora R Feldstein, Amadea Britton, Lauren Beacham, Ryan E Wiegand, Jasmine Ruffin, Melissa Briggs-Hagen, et al. (+22)
370 [GO] 2023―Nov―27 288. Analysis of serum antibody response as correlates of protection against SARS-CoV-2 infection and the effects of BA.4/5 bivalent booster vaccination So Yun Lim, Jineui Kim, Ji-Soo Kwon, Sung-Woon Kang, Eui Jin Chang, Seongman Bae, et al. (+6)
371 [GO] 2023―Nov―27 2656. Longitudinal Trends in Attributable Causes of Death Among US Veteran Patients with Documented SARS-CoV-2 Infection between January 2021 and March 2023 Caitlin A Trottier, Jennifer La, Lucy Li, Nathanael Fillmore, Paul Monach, Westyn Branch-Elliman, Shira Doron
372 [GO] 2023―Nov―27 2306. A serosurvey of healthcare workers caring for, or handling specimens from, individuals exposed to, or diagnosed with, SARS-CoV-2 infection (COVID-HEROES) Alyssa Pradhan, Dominic E Dwyer, Linda Hueston, Will Asquith, Ravindra Dotel, Ralph Nanan, et al. (+13)
373 [GO] 2023―Nov―27 1624. SARS-CoV-2 Maternal Vaccination Induces More Efficient Placental Antibody Transfer to Newborns than SARS-CoV-2 Infection During Pregnancy Leire Pérez Latorre, Shira H Cohen, Paula Rodriguez-Molino, Hannah Kim, Mariah Eisner, Traci Pifer, et al. (+16)
374 [GO] 2023―Nov―27 1364. Association Between Tixagevimab/Cilgavimab Administration and Self-Reported SARS-CoV-2 Infection During the Omicron Surge Daniya S Mathew, Patricia Saunders-Hao, Sumeet Jain, Trever Ball, Amparo Abel-Bey, Keisha Bowman, et al. (+3)
375 [GO] 2023―Nov―27 400. Predictors of Post-COVID Conditions after SARS-CoV-2 Infection in Adults Enrolled in a Multistate Household Transmission Study Michelle Floris-Moore, Melissa Stockwell, Carlos G Grijalva, H Keipp Talbot, Alexandra Mellis, Sarah E Smith-Jeffcoat, et al. (+20)
376 [GO] 2023―Nov―27 484. Clinical Description of SARS-CoV-2 Infection in Patients with Primary Antibody Deficiency Who Received Tixagevimab/Cilgavimab Prophylaxis Sung Min Lim, Je Hee Shin, Jee Yeon Baek, Ji Young Lee, Ji-Man Kang, Jong Gyun Ahn
377 [GO] 2023―Nov―27 536. Development of post acute sequelae of SARS-Cov-2 infection (long Covid) in outpatient receiving monoclonal antibodies Amelia Neto, Vivek Kak
378 [GO] 2023―Nov―27 421. Impact of SARS-CoV-2 Infection on Physical Fitness in Air Force Basic Trainees Elena M Crouch, Joseph Marcus, Heather Yun, Theresa Casey, John Kieffer, Erin Winkler, et al. (+2)
379 [GO] 2023―Nov―27 456. Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment Sangmin Ahn, Yongseop Lee, Min Han, Jung Ah Lee, Jung Ho Kim, Su Jin Jeong, et al. (+4)
380 [GO] 2023―Nov―27 489. Spatial transcriptomic analysis of placental tissue demonstrates differential gene expression in pregnancies with SARS-CoV-2 infection, SARS-CoV-2 placentitis, and controls Leena B Mithal, Ramon Lorenzo-Redondo, Ashwin Sunderraj, Elisheva D Shanes, Jeffrey A Goldstein
381 [GO] 2023―Nov―27 2296. Trends in reasons for hospital admission among adults ≥18 years hospitalized with laboratory-confirmed SARS-CoV-2 infection-COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), 14 U.S. States, June 2020 - January 2023 Fiona P Havers, Michael Whitaker, Monica E Patton, Michael Melgar, Art Reingold, Nisha B Alden, et al. (+14)
382 [GO] 2023―Nov―27 460. SARS-CoV-2 Infection-Induced Antibody Seroprevalence in Previously Infected Persons with Immunocompromising Conditions - United States, 2020-2022 Anna Bratcher, Jefferson M Jones, Aaron Harris, Kristie E N Clarke
383 [GO] 2023―Nov―27 1351. Predictors of Loss of Infectivity Among Healthcare Workers with Primary and Recurrent SARS-CoV-2 infection: An Observational Cohort Study Stefka Dzieciolowska, Yves Longtin, Hugues Charest, Tonya Roy, Judith Fafard, Ines Levade, et al. (+6)
384 [GO] 2023―Nov―27 2301. Viral Kinetics of Sequential SARS-CoV-2 Infections Stephen Kissler, James Hay, Joseph Fauver, Christina Mack, Caroline Tai, Deverick Anderson, et al. (+3)
385 [GO] 2023―Nov―27 503. Post-vaccination SARS-CoV-2 Infections and Immune Response in People with Immune Disorders Mackenzie Zendt, Fausto Bustos Carrillo, Rahul Subramanian, Viviane Callier, Ana Ortega-Villa, Emily Ricotta
386 [GO] 2023―Nov―27 2307. Respiratory Virus Testing Strategy on Admission to Hospital in a Season where SARS-CoV-2 is Co-circulating with Seasonal Respiratory Viruses Paige Reason, Victoria R Williams, Lorraine Maze Dit Mieusement, Heather Candon, Xena Li, Robert Kozak, Jerome A Leis
387 [GO] 2023―Nov―27 1344. Stakeholders’ Perspectives of the Establishment of SARS-CoV-2 Monoclonal Antibody Infusion Centers in Rural Southwestern Virginia: A Qualitative Analysis with Realist Interview Approach Hyun Sue Kim, Anthony Baffoe-Bonnie
388 [GO] 2023―Nov―27 2368. SARS-CoV-2 mRNA vaccination induces B cell immunity in the tonsils and adenoids of children Qin Xu, Pamela Mudd, Hengameh Behzadpour, Lorenza Bellusci, Gabrielle Grubbs, Sara Pourhashemi, et al. (+11)
389 [GO] 2023―Nov―27 2352. The Dynamic Change in Humeral Immunity Against SARS-CoV-2 Omicron Subvariants in Patients with Breakthrough Infection: The Prospective Cohort Study Monprach Harnphadungkit, Opass Putcharoen, Supaporn Wacharapluesadee
390 [GO] 2023―Nov―27 480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients K O H E I KAMEGAI, Noriko Iwamoto, Naoya Itoh, Masahiro Ishikane, Yusuke Asai, Nana Akazawa, et al. (+14)
391 [GO] 2023―Nov―27 453. Distribution of cycle threshold values and the associated factors of SARS-CoV-2 omicron variant in a community setting in Japan Yoshikazu Mutoh, Takumi Umemura, Toshihiko Ichihara
392 [GO] 2023―Nov―27 545. Remdesivir And Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants Lauren Rodriguez, Jiani Li, Dong Han, Ross Martin, Jasmine Moshiri, Nadine Peinovich, et al. (+3)
393 [GO] 2023―Nov―27 2362. SARS-CoV-2 Omicron Variants Associated with Less Severe Disease in Hospitalized Patients Irrespective of Baseline Risk Factors and Immunity Austin Lee, Eric Kawaguchi, Christina Vu, Brianna Ray, Joy Suh, Vanya Vojvodic, et al. (+7)
394 [GO] 2023―Nov―27 2363. Three-Month Safety and Immunogenicity of Bivalent SARS-CoV-2 Omicron-Containing Booster Vaccines: Interim Results From a Phase 3, Randomized, Observer-Blind, Active-Controlled Trial Ivan T Lee, Catherine A Cosgrove, Patrick Moore, Marcin Bula, Philip Kalra, Paul Dargan, et al. (+22)
395 [GO] 2023―Nov―27 2330. Ventilation Strategies Based on an Aerodynamic Analysis During a Large-Scale SARS-CoV-2 Outbreak in an Acute-Care Hospital Se Yoon Park, Jungyeon Yu, Jin Su Song, Shin Young Lee, Jin Hwa Kim, Yeon Su Jeong, et al. (+4)
396 [GO] 2023―Nov―27 1340. Towards better understanding of the epidemiology of SARS-CoV-2 PCR conversion in hospitalized patients: a case-control study Farrin A Manian, Chaitanya A Karlapalem
397 [GO] 2023―Nov―27 2326. SARS-CoV-2 PCR Cycle Threshold Trends in Immunocompromised Patients and Implications for Isolation Precautions Courtney E Harris, Vineeta Vaidya, Michael Klompas, Chanu Rhee, Lindsey R Baden, Meghan Baker
398 [GO] 2023―Nov―27 2458. Carbapenem-resistant Acinetobacter baumannii complex infections and SARS-CoV-2 positivity in 9 U.S. sites, 2020-2022 Sandra N Bulens, Amanda Hall, Jesse T Jacob, Gillian Smith, Lucy E Wilson, Elisabeth Vaeth, et al. (+16)
399 [GO] 2023―Nov―27 1356. "Correlates of protection against SARS-CoV-2 post-vaccine infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study" Emilie Goguet, Cara Olsen, William A Meyer, Sara Ansari, Tonia Conner, John H Powers, et al. (+42)
400 [GO] 2023―Nov―27 1348. Identification of GB-0669, a Novel S-2 Targeted Spike Monoclonal Antibody in Development for SARS-CoV-2 Prophylaxis Francesco Borriello, Grace Marden, Hongru Li, Eric Carlin, Geetika Sharma, Monica Menzenski, et al. (+13)
401 [GO] 2023―Nov―27 419. Viral SARS-CoV-2 rebound rates in linked commercial pharmacy-based SARS-CoV-2 RT-qPCR testing and healthcare claims Shishi Luo, Lisa M McEwen, Scott P Kelly, Magnus Isaksson, Sarah Murphy, Simon White, et al. (+9)
402 [GO] 2023―Nov―27 2337. Immunogenicity and Safety of a Heterologous Booster Dose of Omicron Subvariant (BA.1 and BA.5) and Bivalent SARS-CoV-2 Recombinant Spike Protein Vaccines: A Phase 3, Randomized, Clinical Trial Chijioke Bennett, Wayne Woo, Alex Marcheschi, Raburn M Mallory
403 [GO] 2023―Nov―27 2318. Utility of Routine Asymptomatic Post-Admission SARS-CoV-2 Screening in a Rehabilitation Facility Victoria R Williams, Larry Robinson, Morty Eisenberg, Robert Kozak, Kuldeep Virdi, Heather Candon, Jerome A Leis
404 [GO] 2023―Nov―27 436. SARS-CoV-2 Seropositivity and Association with Dengue Severity in Adults Megha Priyadarshi, Manish Soneja, Saurav Sekhar Paul, Ayush Agarwal, Praveen Kumar Tirlangi, Shilpa Sachan, et al. (+2)
405 [GO] 2023―Nov―27 1097. A Prospective Evaluation of SARS-CoV-2 Shedding and Evolution in Immunocompromised Hosts During the Omicron Period - IVY Network, 5 U.S. States, April 11, 2022 - February 1, 2023 Zoe M Raglow, Diya Surie, James Chappell, Yuwei Zhu, Emily T Martin, Jennie H Kwon, et al. (+20)
406 [GO] 2023―Nov―27 1361. The association between antibody responses and prolonged viable SARS-CoV-2 shedding in immunocompromised patients: a prospective cohort study So Yun Lim, Jun-Won Kim, Ji Yeun Kim, Sung-Woon Kang, Choi-Young Jang, Eui Jin Chang, et al. (+8)
407 [GO] 2023―Nov―27 2343. SARS-CoV-2 Spike Conformation Essentially Influences Vaccine Immunogenicity - Results from Two Clinical Phase I Trials of the Vector Vaccine Candidates MVA-SARS-2-S and MVA-SARS-2-ST Anahita Fathi, Christine Dahlke, Svenja Hardtke, Sibylle C Mellinghoff, Leonie Mayer, Leonie M Weskamm, et al. (+9)
408 [GO] 2023―Nov―27 455. Changing epidemiology of SARS-CoV-2 testing, positivity rates, and variant distribution in children and adults over multiple pandemic waves in New York City Priya Velu, Charlene Thomas, Sophie Rand, Melissa Cushing, Zachary Grinspan, Erika Abramson, et al. (+5)
409 [GO] 2023―Nov―27 2285. Using Genomic Sequencing to Describe SARS-CoV-2 Transmission Dynamics in U.S. Major League Soccer Clubs Joseline Velasquez-Reyes, Ludy R Carmola, Jacquelyn Turcinovic, Isaac Schneider, Margot Putukian, Kyle Sherry, et al. (+13)
410 [GO] 2023―Nov―27 2295. Documented SARS-CoV-2 Transmission Events Between Patients and Hospital Staff Alison Han, Heike Bailin, Jennifer Kwan, Michael Bell, Brooke K Decker, Tara Palmore
411 [GO] 2023―Nov―27 2284. SARS-CoV-2 Transmission in Utah Nursing Homes Julia Bohman, Karim Khader, Alun Thomas, Jeffrey Ferraro, Matthew H Samore
412 [GO] 2023―Nov―27 463. Immunogenicity and Safety of mRNA-based SARS-CoV-2 vaccination in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review Jorge Luis Cardenas-Alvarez, Abel Triana, Juan Uribe, Dan Morgenstern-Kaplan, John M Reynolds, Mohammed Raja, Yoichiro Natori
413 [GO] 2023―Nov―27 2346. Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with mRNA or AZD1222 primary series Alison Uriel, Pedro Garbes, A Nagare, J C Kuan, Christine Palmer, K Bae, et al. (+16)
414 [GO] 2023―Nov―27 2636. Discovery of Spike Identification (SpiID) Nanobody Panel for SARS-CoV-2 Vaccine Development Qi Li, Jennifer Doering, Zepei Ma, Nicholas Mantis, Lisa Cavacini, Yang Wang
415 [GO] 2023―Nov―27 2342. Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model Ross N England, Elizabeth Drapeau, Reihaneh Hosseinzadeh, Drew Weissman, Scott Hensley
416 [GO] 2023―Nov―27 466. Immunogenicity of 2nd, 3rd, 4th SARS-CoV-2 Vaccines in Renal Patient Populations Michael Chen-Xu, Daniel Cooper, Rainer Döffinger, Rachel Jones, Rona M Smith
417 [GO] 2023―Nov―27 2304. Surveillance strategies for the detection of new SARS-CoV-2 variants across epidemiological contexts Kirstin Oliveira Roster, Stephen M Kissler, Enoma Omoregie, Jade Wang, Helly Amin, Steve Di Lonardo, et al. (+2)
418 [GO] 2023―Nov―27 2287. Goal! Goal! Goal! Detection of SARS-CoV-2 Variants in Travelers During the FIFA World Cup, Qatar 2022 - CDC Traveler-Based Genomic Surveillance Program, November 2022-January 2023 Katrina M Byrd, Stephen Bart, Teresa C Smith, Samantha M Loh, Sarah Anne J Guagliardo, Benjamin Rome, et al. (+6)
419 [GO] 2023―Nov―27 2291. SARS-CoV-2 Viral Kinetics Among Immunologically Naïve Adults: Comparison by Variant and Reinfection Status Margaret K Doll, Brianna Levenson Shakoor, Louise E Kimball, Jeffery Crukley, Nina Ozbek, Rachel L Blazevic, et al. (+14)
420 [GO] 2023―Nov―27 2286. A comparison of SARS-CoV-2 wastewater-based surveillance in a sentinel community versus a large metropolitan sewershed in Massachusetts, 2020-2023 Tyler Brown, Sowmya R Rao, Daniel Begemann, Flor Amaya, Barry Keppard, Amir Mohareb, et al. (+6)
421 [GO] 2023―Nov―27 2325. Five-day quarantine of patients exposed to SARS-CoV-2 within hospitals in the Omicron variant era Eun Ju Choo
422 [GO] 2023―Nov―27 2313. Population-based Incidence of SARS-CoV-2-associated Hospitalizations across the Age Spectrum in New York City, 2020-2021 Lisa Saiman, Edward E Walsh, Angela R Branche, Angela Barrett, Luis R Alba, Sonia Gollerkeri, et al. (+3)
423 [GO] 2023―Nov―27 481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022 Diane Lee, Robyn Mitchell, Linda Pelude, Charles Frenette, Bonita Lee, Marie-Astrid Lefebvre, et al. (+3)
424 [GO] 2023―Nov―27 2646. Characterization of Respiratory Infections Before and After the Emergence of SARS-CoV-2: Beyond the “Tripledemic” Michaela Powell, Jay Jones
425 [GO] 2023―Nov―27 2624. The Usual Suspects: A Retrospective Analysis of Pediatric Respiratory Viral Testing During the Pandemic Iris Cazali, Diego Erdmenger, Karin roldan
426 [GO] 2023―Nov―27 1755. Hospitalizations for Respiratory Viruses among Children 5-17 Years of Age in the Pre-COVID-19 Pandemic Era, the New Vaccine Surveillance Network, 2016-2020 Leila C Sahni, Justin Z Amarin, Tess Stopczynski, Andrew J Spieker, Laura S Stewart, Mary A Staat, et al. (+16)
427 [GO] 2023―Nov―27 1320. Pneumococcal Meningitis Before and During Covid - 19 Pandemic in Uruguay, South America (2017 - 2022). Marcos Delfino, Ana P Méndez, Monica Pujadas Ferrer, María Catalina Pírez
428 [GO] 2023―Nov―27 2514. Single Ascending Dose Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intramuscular CD388, a Novel Long-acting Drug-Fc Conjugate for Universal Prevention of Seasonal and Pandemic Influenza Shawn Flanagan, Voon Ong, Tristan Baguet, Roxana E Rojas, Sy-Shi Wang, Ozlem Equils
429 [GO] 2023―Nov―27 912. Influence of a Global Pandemic on Bronchiolitis at a Bronx Hospital Michael Rosenberg, Karen Schaeffer, Alexandra J Boni, Christiaan Strydom
430 [GO] 2023―Nov―27 896. Epidemiology and effect of pandemic on regional coxsackie viral testing Ramesh Kordi, Arthur Chang, Mark D Hicar
431 [GO] 2023―Nov―15 Decreased self-reported physical fitness following SARS-CoV-2 infection and the impact of vaccine boosters in a cohort study Stephanie A Richard, Ann I Scher, Jennifer Rusiecki, Celia Byrne, Catherine M Berjohn, Anthony C Fries, et al. (+198)
432 [GO] 2023―Nov―14 Effect of inhaled ciclesonide in non-critically ill hospitalized patients with COVID-19: a multicenter observational study in Japan Jun Suzuki, Shiro Endo, Takayuki Suzuki, Teppei Sasahara, Shuji Hatakeyama, Yuji Morisawa, et al. (+7)
433 [GO] 2023―Nov―07 Efficacy of mRNA-1273 against SARS-CoV-2 acquisition in young adults from March-December 2021 Kathryn E Stephenson, Jasmine R Marcelin, Audrey E Pettifor, Holly Janes, Elizabeth Brown, Moni Neradilek, et al. (+23)
434 [GO] 2023―Nov―07 Antibody response after the third SARS-CoV-2 vaccine in solid organ transplant recipients and people living with HIV (COVERALL-2) Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, Patrizia Amico, Marcel P Stoeckle, Anna L Eichenberger, et al. (+159)
435 [GO] 2023―Nov―06 Hepatic steatosis and weight gain during COVID-19 pandemic among people living with HIV: impact of therapy with tenofovir alafenamide M Santos, A Corma-Gómez, J Martín Carmona, M Pérez-García, C Martín-Sierra, P Rincón-Mayo, et al. (+4)
436 [GO] 2023―Oct―25 Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial Scott R Goldsmith, Fahrettin Covut, Mark Fiala, Zhifu Xiang, Zahid Iqbal, Nathan Moore, et al. (+13)
437 [GO] 2023―Oct―18 Effect of swine glyco-humanized polyclonal neutralizing antibody on survival and respiratory failure in patients hospitalized with severe COVID-19: A Randomized, placebo-controlled Trial Benjamin Gaborit, Bernard Vanhove, Karine Lacombe, Thomas Guimard, Laurent Hocqueloux, Ludivine Perrier, et al. (+313)
438 [GO] 2023―Oct―07 Antibiotic use among hospitalized patients with COVID-19 in the United States, March 2020-June 2022 Christine Kim, Hannah Wolford, James Baggs, Sujan Reddy, Lauri A Hicks, Melinda Neuhauser, Sarah Kabbani
439 [GO] 2023―Oct―06 Fever and Leukocytosis are Poor Predictors of Bacterial Coinfection in Patients with COVID-19 and Influenza Receiving Extracorporeal Membrane Oxygenation Luke B Jackson, Michal J Sobieszczyk, James K Aden, Joseph E Marcus
440 [GO] 2023―Oct―02 Risk of new-onset Long Covid following reinfection with SARS-CoV-2: community-based cohort study Matthew L Bosworth, Boran Shenhuy, A Sarah Walker, Vahé Nafilyan, Nisreen A Alwan, Margaret E O’Hara, Daniel Ayoubkhani
441 [GO] 2023―Sep―20 Remdesivir is associated with reduced mortality in COVID-19 patients requiring supplemental oxygen including invasive mechanical ventilation across SARS-CoV-2 variants Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Stephanie H Read, EunYoung Lee, et al. (+5)
442 [GO] 2023―Sep―08 Effectiveness of an mRNA vaccine booster dose against COVID-19 among U.S. healthcare personnel, October 2021-July 2022 Ian D Plumb, Nicholas M Mohr, Melissa Hagen, Ryan Wiegand, Ghinwa Dumyati, Karisa K Harland, et al. (+31)
443 [GO] 2023―Sep―06 Protection of Covid-19 vaccination against hospitalisation during the era of Omicron BA.4 and BA.5 predominance: a nationwide case-control study based on the French National Health Data System Laura Semenzato, Jérémie Botton, Stéphane Le Vu, Marie-Joëlle Jabagi, François Cuenot, Jérôme Drouin, et al. (+3)
444 [GO] 2023―Aug―31 Proteomic profiling of urine from hospitalised patients with severe pneumonia due to SARS-CoV-2 versus other causes: a preliminary report Lindsay Wilson, Ju-Wei Chang, Stuart Meier, Tariq Ganief, Naadir Ganief, Suzette Oelofse, et al. (+5)
445 [GO] 2023―Aug―22 Correction to: Performance of Blood-Based Nucleocapsid Antigen Tests for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Infectious Viral Shedding: A Systematic Review
446 [GO] 2023―Aug―10 Humoral Immune Response to mRNA COVID-19 Vaccination Among Children 5-11 in a Multisite Prospective Cohort study, September 2021-September 2022 Zoe L Lyski, Cynthia Porter, Jennifer L Uhrlaub, Katherine D Ellingson, Zuha Jeddy, Lisa Gwynn, et al. (+20)
447 [GO] 2023―Aug―10 Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients-A Prospective Longitudinal Study May Y Liew, Josh I Mathews, Amy Li, Rohan Singh, Salvador A Jaramillo, Zoe F Weiss, et al. (+12)
448 [GO] 2023―Aug―09 Predicting the public health impact of bivalent vaccines and nirmatrelvir-ritonavir against COVID-19 Hailey J Park, Sophia T Tan, Tomás M León, Seema Jain, Robert Schechter, Nathan C Lo
449 [GO] 2023―Aug―09 Comparison of Tocilizumab versus Baricitinib in Clinical Outcomes Among Hospitalized Patients with COVID-19: Experience from a Public Hospital System in New York City Subin Sunny, Ami Tran, Jennifer Lee, Marie Abdallah, Nimra Chaudhry, John Quale
450 [GO] 2023―Aug―08 The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a model for rapid evidence review and dynamic practice recommendations during a public health emergency George L Anesi, Kathleen Degnan, Lauren Dutcher, Stephen Saw, Christina Maguire, Amanda Binkley, et al. (+20)
451 [GO] 2023―Aug―07 The STOP COVID 2 study: Fluvoxamine vs placebo for outpatients with symptomatic COVID-19, a fully-remote randomized controlled trial Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, David R Boulware, Todd C Lee, Rachel Hess, et al. (+18)
452 [GO] 2023―Jul―26 Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis Marta Colaneri, Emanuele Maria Giusti, Camilla Genovese, Lucia Galli, Andrea Lombardi, Andrea Gori
453 [GO] 2023―Jul―26 Sexual behaviour and STI incidence in sexually active MSM living with HIV in times of COVID-19 Catrina Mugglin, Kalongo Hamusonde, Luisa Salazar-Vizcaya, Katharina Kuseijko, Dunja Nicca, David Haerry, et al. (+64)
454 [GO] 2023―Jul―24 Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People with Human Immunodeficiency Virus: Cohort Study John J Hanna, Liyu B Geresu, Marlon I Diaz, Milan Ho, Julia A Casazza, Madison A Pickering, et al. (+11)
455 [GO] 2023―Jul―21 A brief peer-led intervention to increase COVID-19 vaccine uptake among people who inject drugs in San Diego County: Results from a pilot randomized controlled trial Steffanie A Strathdee, Daniela Abramovitz, Alicia Harvey-Vera, Tara Stamos-Buesig, Carlos F Vera, Irina Artamonova, et al. (+4)
456 [GO] 2023―Jul―21 Viral determinants of acute COVID-19 symptoms in a non-hospitalized adult population in the pre-Omicron era Sarah A Goldberg, Scott Lu, Miguel Garcia-Knight, Michelle C Davidson, Michel Tassetto, Khamal Anglin, et al. (+15)
457 [GO] 2023―Jul―20 Cross-Sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals Marilyn Whelan, Yannick Galipeau, Nicole White-Al Habeeb, Danijela Konforte, Mohamed Abou El Hassan, Ronald A Booth, et al. (+3)
458 [GO] 2023―Jul―20 Decreased Pneumococcal Carriage Among Older Adults in Denmark During the COVID-19 Lockdown Michaela Tinggaard, Hans-Christian Slotved, Randi Føns Petersen, Nichlas Hovmand, Thomas Benfield
459 [GO] 2023―Jul―13 Post COVID-19 syndrome 2 years following the first wave: the role of humoral response, vaccination and reinfection Maddalena Peghin, Maria De Martino, Alvisa Palese, Stefania Chiappinotto, Federico Fonda, Valentina Gerussi, et al. (+5)
460 [GO] 2023―Jul―12 Intramuscular Versus Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Non-inferiority Clinical Trial Adrienne E Shapiro, Elias Sarkis, Jude Acloque, Almena Free, Yaneicy Gonzalez-Rojas, R몺 Hussain, et al. (+22)
461 [GO] 2023―Jul―11 Humoral and cellular immune responses of patients living with HIV (PLWH) after 3 doses of m-RNA BNT162b2 SARS-CoV-2 vaccine: a prospective cohort study Luba Tau, David Hagin, Tal Freund, Tamar Halperin, Amos Adler, Rotem Marom, et al. (+7)
462 [GO] 2023―Jul―10 A Descriptive Cohort Study of Drug Utilization Patterns among Patients Hospitalized with COVID-19 in the United States, January 2021- February 2022 Sarah E Vititoe, Priya Govil, Aidan Baglivo, Elisha Beebe, Elizabeth M Garry, Nicolle M Gatto, et al. (+9)
463 [GO] 2023―Jul―10 SARS-CoV-2 Vaccine-Induced Immune Responses among Hematopoietic Stem Cell Transplant Recipients Afoke Kokogho, Trevor A Crowell, Muneerah Aleissa, Ana-Mihaela Lupan, Sonya Davey, Jun Bai Park Chang, et al. (+3)
464 [GO] 2023―Jul―07 Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Hospitalized Participants With COVID-19 Philip Robinson, Sima S Toussi, Sudeepta Aggarwal, Arthur Bergman, Tong Zhu, Frances Hackman, et al. (+17)
465 [GO] 2023―Jul―07 Safety, Virology, Pharmacokinetics, and Clinical Experience of High-dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-label Clinical Trial Jaynier Moya, Marisol Temech, Sergio Parra, Erick Juarez, Reinaldo Hernandez-Loy, Juan C Moises Gutierrez, et al. (+11)
466 [GO] 2023―Jul―03 Carbapenem-Resistant Acinetobacter spp. Infection in Critically Ill Patients with Limited Treatment Options: a Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic Maddalena Giannella, Stefano Verardi, Andreas Karas, Hasania Abdel Hadi, Hervé Dupont, Alex Soriano, et al. (+3)
467 [GO] 2023―Jun―30 Sero-Epidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France Alix de Thoisy, Tom Woudenberg, Stéphane Pelleau, Françoise Donnadieu, Laura Garcia, Laurie Pinaud, et al. (+8)
468 [GO] 2023―Jun―27 Geographic targeting of COVID-19 testing to maximize detection in Los Angeles County Katherine M Jia, Rebecca Kahn, Rebecca Fisher, Sharon Balter, Marc Lipsitch
469 [GO] 2023―Jun―24 Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient Veterans Jennifer M Ross, Jonathan D Sugimoto, Andrew Timmons, Jonathan Adams, Katrina Deardoff, Anna Korpak, et al. (+43)
470 [GO] 2023―Jun―17 Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru Rifat S Rahman, Marco A Tovar, Jesús Peinado, J Santiago Palomino, Claudio Ramirez, Fernando Llanos-Zavalaga, et al. (+10)
471 [GO] 2023―Jun―10 Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE) Michael G Ison, Debra F Weinstein, Marta Dobryanska, Anna Holmes, Anne-Marie Phelan, Yong Li, et al. (+9)
472 [GO] 2023―Jun―09 Successful Treatment of Persistent Symptomatic Coronavirus Disease 19 Infection With Extended-Duration Nirmatrelvir-Ritonavir Among Outpatients With Hematologic Cancer Catherine Liu, Leah H Yoke, Pooja Bhattacharyya, Ryan D Cassaday, Guang-Shing Cheng, Zahra Kassamali Escobar, et al. (+7)
473 [GO] 2023―Jun―08 Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients with COVID-19 Using Nationwide Real-World Data: An Observational Matched Cohort Study from The Japan COVID-19 Task Force Hiromu Tanaka, Shotaro Chubachi, Ho Namkoong, Yasunori Sato, Takanori Asakura, Ho Lee, et al. (+54)
474 [GO] 2023―Jun―02 Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward Allyson L Russell, Lee M Hampton, Antara Sinha, Francisco J Luquero, Jalaa’ Abdelwahab
475 [GO] 2023―May―27 Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive COVID-19 Treatment Trial (ACTT) as a Test Case Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, et al. (+36)
476 [GO] 2023―May―25 Correction to: Effectiveness of COVID-19 mRNA Vaccines in Preventing COVID-19-Associated Outpatient Visits and Hospitalizations Among American Indian and Alaska Native Persons, January-November 2021: A Test-Negative Case-Control Analysis Using Surveillance Data
477 [GO] 2023―May―25 Relative effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines and homologous boosting in preventing COVID-19 in adults in the US Van Hung Nguyen, Catherine Boileau, Alina Bogdanov, Meg Sredl, Mac Bonafede, Thierry Ducruet, et al. (+7)
478 [GO] 2023―May―24 A Prospective Study of Key Correlates for Household Transmission of SARS-CoV-2 Elizabeth R Brown, Meagan P O’Brien, Brian Snow, Flonza Isa, Eduardo Forleo-Neto, Kuo-Chen Chan, et al. (+4)
479 [GO] 2023―May―24 Association between SARS-CoV-2 variants and frequency of acute symptoms: Analysis of a multi-institutional prospective cohort study - December 20, 2020 - June 20, 2022 Ralph C Wang, Michael Gottlieb, Juan Carlos Montoy, Robert Rodriguez, Huihui Yu, Erica S Spatz, et al. (+103)
480 [GO] 2023―May―24 Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate COVID-19: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron Michael G Ison, Myra Popejoy, Nikolay Evgeniev, Maria Tzekova, Kathryn Mahoney, Natalia Betancourt, et al. (+54)
481 [GO] 2023―May―22 Association between Cycle Threshold value and Vaccination Status among SARS-CoV-2 Omicron variant cases in Ontario in December, 2021 Saranyah Ravindran, Jonathan B Gubbay, Kirby Cronin, Ashleigh Sullivan, Austin Zygmunt, Karen Johnson, et al. (+2)
482 [GO] 2023―May―21 Understanding the Relationship Between Antiviral Prescription Data and COVID-19 Incidence in New York City: A Retrospective Cohort Study Christina M Kaul, Gabriel M Cohen, Matthew Silverstein, Andrew B Wallach, Elizabeth Diago-Navarro, Robert S Holzman, Mary K Foote
483 [GO] 2023―May―19 Multiregional population-based cohort study for evaluation of the association between herpes zoster and mRNA vaccinations for SARS-CoV-2: the VENUS Study Chieko Ishiguro, Wataru Mimura, Yukari Uemura, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
484 [GO] 2023―May―17 Incidence rates and clinical characteristics of patients with confirmed myocarditis or pericarditis following COVID-19 mRNA vaccination: experience of the Veterans Health Administration through October 9, 2022. Jing Luo, Kwan Hur, Cedric Salone, Nina Huang, Muriel Burk, Lucy Pandey, et al. (+3)
485 [GO] 2023―May―17 Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges among Vaccinated Healthcare Workers at a Boston Hospital Maura C Dodge, Lei Ye, Elizabeth R Duffy, Manisha Cole, Susan H Gawel, Martha M Werler, et al. (+3)
486 [GO] 2023―May―17 Rapid emergence of potentially transmissible SARS-CoV-2 with resistance to combination monoclonal antibody therapy Jana L Jacobs, Ghady Haidar, Asma Naqvi, Kevin D McCormick, Michele Sobolewski, Benjamin R Treat, et al. (+16)
487 [GO] 2023―May―11 Prevalence of SARS-CoV-2 viremia in pre-symptomatic blood donors in the delta and omicron variant eras Paula Saá, Rebecca V Fink, Hina Dawar, Clara Di Germanio, Leilani Montalvo, David J Wright, et al. (+12)
488 [GO] 2023―May―11 Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
489 [GO] 2023―May―08 Association of Self-Reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE) Wendy P Bannister, Dorthe Raben, Palle Valentiner-Branth, Martin Tolstrup, Lykke Larsen, Britta Tarp, et al. (+20)
490 [GO] 2023―May―05 Genomic Epidemiology of a SARS-CoV-2 Outbreak in a U.S. Major League Soccer Club: Was it travel related? Ludy R Carmola, Jacquelyn Turcinovic, Garrison Draper, David Webner, Margot Putukian, Holly Silvers-Granelli, et al. (+11)
491 [GO] 2023―May―03 Effectiveness of BA.1- and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines against symptomatic SARS-CoV-2 infection during the BA.5-dominant period in Japan Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, et al. (+26)
492 [GO] 2023―May―02 Investigation of blood plasma viral nucleocapsid antigen as a marker of active SARS-CoV-2 Omicron variant infection Gregory L Damhorst, Nils Schoof, Phuong-Vi Nguyen, Hans Verkerke, Eli Wilber, Kaleb McLendon, et al. (+13)
493 [GO] 2023―Apr―20 Large diffusion of SARS-CoV-2 after the successive epidemiological waves, including Omicron, in Guinea and Cameroon: implications for vaccine strategies Mamadou Saliou Kalifa Diallo, Marie Amougou-Atsama, Ahidjo Ayouba, Cece Kpamou, Eric Donald Mimbe Taze, Guillaume Thaurignac, et al. (+13)
494 [GO] 2023―Apr―19 Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients with COVID-19: A Post-Hoc Analysis in a Phase 1/2/3 Double-Blind Trial Selin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, Ernesto Oviedo-Orta, Meagan P O’Brien, Veronica Mas Casullo, et al. (+11)
495 [GO] 2023―Apr―19 Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine Nabin K Shrestha, Patrick C Burke, Amy S Nowacki, James F Simon, Amanda Hagen, Steven M Gordon
496 [GO] 2023―Apr―19 Baricitinib treatment of COVID-19 is associated with a reduction of secondary infections Daniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, John H Beigel, Tatiana Beresnev, Valeria D Cantos, et al. (+24)
497 [GO] 2023―Apr―19 Neutralizing Antibody Responses to mRNA COVID-19 Vaccines versus SARS-CoV-2 Infection Among Pregnant Women and Vaccine Induced Antibody Transfer to Infants Fatimah S Dawood, Alan Tita, Melissa S Stockwell, Gabriella Newes-Adeyi, Kristina Wielgosz, Cynthia Gyamfi-Bannerman, et al. (+12)
498 [GO] 2023―Apr―19 Correction to: A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
499 [GO] 2023―Apr―18 Correction to: Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019: A Prospective Cohort Study
500 [GO] 2023―Apr―13 Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic SARS-CoV-2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods Allison Avrich Ciesla, Ryan E Wiegand, Zachary R Smith, Amadea Britton, Katherine E Fleming-Dutra, Joseph Miller, et al. (+6)
501 [GO] 2023―Apr―13 Immunogenicity, Safety, and Breakthrough SARS-CoV-2 infections after COVID-19 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study Dima Kabbani, Demitra M Yotis, Victor H Ferreira, Sarah Shalhoub, Sara Belga, Varalika Tyagi, et al. (+11)
502 [GO] 2023―Apr―13 Factors associated with COVID-19 vaccine uptake among pregnant women and nonpregnant women of reproductive-age in Jamaica Jodian A Pinkney, Laura M Bogart, Kamali N Carroll, Lenroy Bryan, Givana Witter, Dina Ashour, et al. (+6)
503 [GO] 2023―Apr―13 Host Expression Profiling from Diagnostic COVID-19 Swabs Associate Upper Respiratory Tract Immune Responses with Radiologic Lung Pathology and Clinical Severity Robert A Kozak, Elsa Salvant, Veronica Chang, Anastasia Oikonomou, Mia J Biondi, Jordan J Feld, et al. (+8)
504 [GO] 2023―Apr―12 Factors Associated with Enrollment into Inpatient COVID-19 Randomized Controlled Trials - A Cross-Sectional Analysis Matthew Kaczynski, Gregorio Benitez, Evangelia K Mylona, Quynh-Lam Tran, Eleftheria Atalla, Maria Tsikala-Vafea, et al. (+3)
505 [GO] 2023―Apr―12 Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Response to Comment Nathaniel M Lewis, Jillian Rhoads, Wesley H Self, Diya Surie
506 [GO] 2023―Apr―12 Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment Amnuay Kleebayoon, Viroj Wiwanitkit
507 [GO] 2023―Apr―06 Successful Treatment of Prolonged SARS-CoV-2 Infection in Patients with Immunodeficiency with Extended Nirmatrelvir/Ritonavir: Case Series Madison Breeden, Samuel L Aitken, Ji Hoon Baang, Misty Gravelin, Daniel R Kaul, Adam S Lauring, et al. (+2)
508 [GO] 2023―Mar―31 Antibody response after third vaccination with mRNA-1273 or BNT162b2: Extension of a randomised controlled SARS-CoV-2 non-inferiority vaccine trial in patients with different levels of immunosuppression (COVERALL-2) Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, Patrizia Amico, Marcel P Stoeckle, Anna L Eichenberger, et al. (+19)
509 [GO] 2023―Mar―28 Longitudinal Neutralizing and Functional Antibody Responses to SARS-CoV-2 Variants following mRNA COVID-19 Vaccination Xuemin Chen, Caroline Ciric, Theda Gibson, Larry J Anderson, Evan J Anderson, Christina A Rostad
510 [GO] 2023―Mar―28 SARS-CoV-2 Neutralizing Antibody Responses after Community Infections in Children and Adults Fatimah S Dawood, Alexia Couture, Xueyan Zhang, Melissa S Stockwell, Christina A Porucznik, Joseph B Stanford, et al. (+9)
511 [GO] 2023―Mar―27 Effectiveness of COVID-19 mRNA vaccines in preventing COVID-19-associated outpatient visits and hospitalizations among American Indian and Alaska Native persons, January-November 2021: a test-negative case-control analysis using surveillance data Chelsea S Lutz, Rachel M Hartman, Deionna E Vigil, Amadea Britton, Amanda B Burrage, Angela P Campbell, et al. (+21)
512 [GO] 2023―Mar―27 Hybrid immunity provides protective advantage over vaccination or prior remote COVID-19 alone Abinash Virk, Matthew G Johnson, Daniel L Roellinger, Christopher G Scott, Priya Sampathkumar, Laura E Breeher, Melanie Swift
513 [GO] 2023―Mar―21 COVID-19 Associated Pulmonary Aspergillosis: A Non-Invasive Screening Model for Additional Diagnostics Nitipong Permpalung, Teresa Po-Yu Chiang, Robin K Avery, Darin Ostrander, Kausik Datta, Dorry L Segev, et al. (+4)
514 [GO] 2023―Mar―21 Neutralizing Antibody Responses After SARS-CoV-2 BA.2 and BA.2.12.1 Infection Do Not Neutralize BA.4 and BA.5 and Can Be Blunted By Nirmatrelvir/Ritonavir (NM/r) Treatment Aaron F Carlin, Alex E Clark, Aaron F Garretson, William Bray, Magali Porrachia, AsherLev T Santos, et al. (+3)
515 [GO] 2023―Mar―18 Surveillance of SARS-CoV-2 and variants using digital droplet polymerase chain reaction at a large university and healthcare system in California Chrysovalantis Stafylis, Olivier Pernet, Cassidy Hernandez-Tamayo, Andrea Kovacs, Jane Emerson, Pamela M Ward, et al. (+25)
516 [GO] 2023―Mar―18 Analyzing An Emerging Pandemic on Twitter: Monkeypox Lauren N Cooper, Alexander P Radunsky, John J Hanna, Zachary M Most, Trish M Perl, Christoph U Lehmann, Richard J Medford
517 [GO] 2023―Mar―11 Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial Marta Trigo-Rodríguez, Sheila Cárcel, Ana Navas, Reinaldo Espíndola-Gómez, José Carlos Garrido-Gracia, María Ángeles Esteban Moreno, et al. (+18)
518 [GO] 2023―Mar―07 Community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection Kristin L Moffitt, Mari M Nakamura, Cameron C Young, Margaret M Newhams, Natasha B Halasa, J Nelson Reed, et al. (+31)
519 [GO] 2023―Mar―04 When should healthcare workers with COVID-19 return to work? An analysis of follow-up antigen test results after a positive COVID test Anthony Baffoe-Bonnie, Mandy C Swann, Hyun Sue Kim
520 [GO] 2023―Mar―04 Risk of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients Meera Shah, Kelly Reveles, Rebecca Moote, Elizabeth Hand, Dean Kellogg III, Rebecca L Attridge, et al. (+2)
521 [GO] 2023―Mar―02 Effectiveness of fourth dose of COVID-19 mRNA vaccine in elderly population during Omicron BA.2 and BA.5 circulation: nationwide cohort study in Korea (K-COVE) Seon Kyeong Park, Young June Choe, Eun Jung Jang, Ryu Kyung Kim, Do-Sang Lim, Seonju Yi, et al. (+6)
522 [GO] 2023―Feb―24 Optimal Duration of Systemic Corticosteroids in COVID-19 Treatment: A Systematic Review and Meta-analysis Paddy Ssentongo, Nyein Yu, Navya Voleti, Surya Reddy, David Ingram, Vernon M Chinchilli, Catharine I Paules
523 [GO] 2023―Feb―22 COVID-19 and Outpatient Antibiotic Prescriptions in the United States: A County-level Analysis Alisa Hamilton, Suprena Poleon, Jerald Cherian, Sara Cosgrove, Ramanan Laxminarayan, Eili Klein
524 [GO] 2023―Feb―21 Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient COVID-19 from Influenza Lauren L Luciani, Leigh M Miller, Bo Zhai, Karen Clarke, Kailey Hughes Kramer, Lucas J Schratz, et al. (+6)
525 [GO] 2023―Feb―21 Lessons From the Field: Rapid Antigen Testing Is Efficient and Practical for Mitigation of Coronavirus Disease 2019 Outbreaks in Long-Term Care Facilities David A Miller, Lael Duncan, Lindsey Termini, Lee Ann Prebil, David Witt, Stephen A McCurdy
526 [GO] 2023―Feb―18 Use of SARS-CoV-2 Antibody Tests by U.S. Infectious Disease Physicians: Results of an Emerging Infections Network Survey, March 2022 Adi V Gundlapalli, Susan Beekmann, Jefferson M Jones, Natalie Thornburg, Kristie E N Clarke, Timothy M Uyeki, et al. (+8)
527 [GO] 2023―Feb―14 Population-level effectiveness of an inactivated whole-virion COVID-19 vaccine: A test negative case-control study in the Dominican Republic Eddy Pérez-Then, Marija Miric, Han-Zhu Qian, Ying Qing Chen, Yixin Wang, Virginia Vallejo, et al. (+109)
528 [GO] 2023―Feb―13 Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial Dean Follmann, Holly E Janes, Eric Chu, Lakshmi Jayashankar, Christos J Petropoulos, Leonid Serebryannyy, et al. (+18)
529 [GO] 2023―Feb―09 Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine Francis Mwimanzi, Hope R Lapointe, Peter K Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, et al. (+17)
530 [GO] 2023―Feb―04 Association of cytomegalovirus serostatus with SARS-CoV-2 vaccine responsiveness in nursing home residents and healthcare workers Michael L Freeman, Oladayo A Oyebanji, Daniela Moisi, Michael Payne, Maegan L Sheehan, Alejandro B Balazs, et al. (+5)
531 [GO] 2023―Feb―03 SARS-CoV-2 Evolution and Escape from Combination Monoclonal Antibody Treatment in a Person Living With HIV Dara Khosravi, Hannah Soloff, Rose M Langsjoen, Andrei Bombin, Colleen F Kelley, Susan M Ray, et al. (+7)
532 [GO] 2023―Jan―28 Pneumocystis jirovecii infections among COVID-19 Patients: A Case Series and Literature Review Paul Amstutz, Nathan C Bahr, Karen Snyder, D Matthew Shoemaker
533 [GO] 2023―Jan―19 Correction to: 494. Characteristics and Outcomes of COVID-19 in Hospitalized Native American Patients: A Single-Site Retrospective Analysis
534 [GO] 2023―Jan―18 High SARS-CoV-2 antibody prevalence after the third epidemic wave (May - October 2021) in Matadi, Democratic Republic of the Congo Yannick Munyeku-Bazitama, Patient Okitale-Talunda, Patrick Mpingabo-Ilunga, Marc K Yambayamba, Paul M Tshiminyi, Aime Umba-Phuati, et al. (+12)
535 [GO] 2023―Jan―18 Correction to: Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality
536 [GO] 2023―Jan―09 Validity of COVID-19 ICD10s in the Urgent Care Setting and Impact on Antibiotic Prescribing Rates Natalia Medvedeva, Sharon Ong’uti, Adam L Hersh, Amy Chang, Emily Mui, Edward Stenehjem, et al. (+2)
537 [GO] 2023―Jan―09 Correlates of COVID-19 Inpatient Mortality at a Southern California Community Hospital with a Predominantly Hispanic/Latino Adult Population Nicole M Gatto, Debbie Freund, Pamela Ogata, Lisa Diaz, Ace Ibarrola, Mamta Desai, et al. (+2)
538 [GO] 2023―Jan―08 Laboratory Evaluation Links Some False-Positive COVID-19 Antigen Test Results Observed in a Field Study to a Specific Lot of Test Strips Alyssa M Carter, Alexander Viloria Winnett, Anna E Romano, Reid Akana, Natasha Shelby, Rustem F Ismagilov
539 [GO] 2023―Jan―08 Challenges in harnessing shared within-host SARS-CoV-2 variation for transmission inference Katharine S Walter, Eugene Kim, Renu Verma, Jonathan Altamirano, Sean Leary, Yuan J Carrington, et al. (+7)
540 [GO] 2022―Dec―31 Absolute and Relative Vaccine Effectiveness (VE) of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022 Nathaniel M Lewis, Nancy Murray, Katherine Adams, Diya Surie, Manjusha Gaglani, Adit A Ginde, et al. (+51)
541 [GO] 2022―Dec―29 Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI) Oliver Stirrup, Madhumita Shrotri, Natalie L Adams, Maria Krutikov, Hadjer Nacer-Laidi, Borscha Azmi, et al. (+9)
542 [GO] 2022―Dec―28 A longitudinal study of SARS-CoV-2 antibody response in a subset of United States blood donors Laura Tonnetti, Roger Y Dodd, Donna D Burke, Paula Saá, Bryan R Spencer, Meng Xu, et al. (+2)
543 [GO] 2022―Dec―23 Which curve are we flattening? The disproportionate impact of COVID-19 among economically marginalized communities in Ontario, Canada, was unchanged from wild-type to omicron Huiting Ma, Adrienne K Chan, Stefan D Baral, Christine Fahim, Sharon Straus, Beate Sander, Sharmistha Mishra
544 [GO] 2022―Dec―22 Persistent symptoms and sequelae after SARS-CoV-2 infection not requiring hospitalization: Results from Testing Denmark, a Danish cross-sectional survey Maarten van Wijhe, Kamille Fogh, Steen Ethelberg, Kasper Karmark Iversen, Henrik Nielsen, Lars Østergaard, et al. (+23)
545 [GO] 2022―Dec―20 Pre-Existing Population Immunity and severe acute respiratory syndrome coronavirus 2 Variant Establishment and Dominance Dynamics in the United States: An Ecological Study Pierre O Ankomah, Mark J Siedner, Roby P Bhattacharyya
546 [GO] 2022―Dec―16 Antibiotic consumptions and bacterial resistance rates in hospitalized COVID-19 patients: a retrospective study during the three first surges Karim Jaffal, Frédérique Bouchand, Christine Lawrence, Hélène Mascitti, Clara Duran, Djillali Annane, Aurélien Dinh
547 [GO] 2022―Dec―16 Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa Simiso Sokhela, Bronwyn Bosch, Andrew Hill, Bryony Simmons, Joana Woods, Hilary Johnstone, et al. (+13)
548 [GO] 2022―Dec―16 Association between population-level factors and household secondary attack rate of SARS-CoV-2: A systematic review and meta-analysis Can Wang, Xiaotong Huang, Eric H Y Lau, Benjamin J Cowling, Tim K Tsang
549 [GO] 2022―Dec―15 1911. A Pilot Study to Evaluate the Effectiveness of Nasal and Oral Povidone Iodine in Reducing the Burden of Severe Acute Respiratory Syndrome 2 RNA in Patients with COVID-19 Sarah Redmond, Lucas D Jones, Alexandria Nguyen, Hussein Ghaddara, Jennifer Cadnum, Curtis Donskey
550 [GO] 2022―Dec―15 1928. A Population-Based Propensity Score-Matched Study of COVID-19 Vaccination on Clinical Outcomes in Hospitalized Adult Patients with COVID-19 Jianli Niu, Candice Sareli, Daniel Mayer, Alvaro Visbal, Aharon E Sareli
551 [GO] 2022―Dec―15 2160. Mucosal Antiviral Cytokine Responses Are Impaired in Children and Adolescents with Severe COVID-19 Ana M Quintero, Shira H Cohen, Zhaohui Xu, Fang Ye, Sara Mertz, Kaitlyn N Massey, et al. (+6)
552 [GO] 2022―Dec―15 LB1528. Results from ACTIV-6: A Decentralized, Double-Blinded, Randomized, Placebo-Controlled Platform Trial of Repurposed Drugs for the Treatment of Mild-to-Moderate COVID-19 Matthew W McCarthy
553 [GO] 2022―Dec―15 LB750. Safety and Immunogenicity of a Bivalent Omicron-Containing Booster Vaccine against COVID-19 Spyros Chalkias, Charles Harper, Keith Vrbicky, Stephen R Walsh, Brandon Essink, Adam Brosz, et al. (+13)
554 [GO] 2022―Dec―15 1083. Clinical Features and Long-Term Follow-up of Children Evaluated for Persistent Unwellness Following Acute COVID-19 Kathryn E Weakley, Allegra Schikler, Julianne V Green, Daniel B Blatt, Shanna M Barton, Victoria A Statler, Gary S Marshall
555 [GO] 2022―Dec―15 1079. Casirivimab and Imdevimab (CAS + IMD) Antibody Combination for the Treatment of Immunocomprised Hospitalized Patients with COVID-19 Selin Somersan-Karakaya, Eleftherios Mylonakis, Ernesto Oviedo-Orta, Meagan P O’Brien, Veronica Mas Casullo, Jenni Mou, et al. (+10)
556 [GO] 2022―Dec―15 1146. Real-World Experience Highlighting Tocilizumab Use in the Treatment of COVID-19 Christina Maguire, Adrienne Terico, Hinal Patel, George L Anesi, Kathleen Degnan, Lauren Dutcher, et al. (+4)
557 [GO] 2022―Dec―15 1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19 Anil K Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, Moti Ramgopal, Almena Free, Jennifer Han, et al. (+16)
558 [GO] 2022―Dec―15 1155. Short vs. Long Symptom Duration Prior to Remdesivir for Hospitalized Patients with COVID-19 Ramy H Elshaboury, Meagan L Adamsick, Joanne Huang, Marisa Winkler, Musie Ghebremichael, Fiona Cheung, et al. (+5)
559 [GO] 2022―Dec―15 1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19 Yusuke Asai, Shinya Tsuzuki, Nobuaki Matsunaga, Norio Ohmagari
560 [GO] 2022―Dec―15 930. Weakening the waves: Impact of a syndrome-based antimicrobial stewardship intervention during COVID-19 Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Stephanie Echeverria, Mirza Ali, Rodrigo M Burgos
561 [GO] 2022―Dec―15 1114. Comparative analysis between Polymerized Type I Collagen and Baricitinib as potential treatment for COVID-19 Luis Del Carpio-Orantes, Sergio García-Mendez, Jesús Salvador Sánchez-Díaz, Andrés Aguilar-Silva, Omar García-Hernández, Raúl Enrique Salazar-Lizárraga, et al. (+6)
562 [GO] 2022―Dec―15 1113. Clinical and Virologic Outcomes with Early Adintrevimab (ADI) Monoclonal Antibody Therapy in Mild and Moderate COVID-19 Kathryn Mahoney, Kristin Narayan, Natalia Betancourt, Yong Li, Deepali Gupta, Pamela Hawn, et al. (+2)
563 [GO] 2022―Dec―15 1139. Oral Antivirals Against SARS-CoV-2: a New Valid Strategy Against COVID-19 Neva Braccialarghe, Rosario Alessandro Cavasio, Drieda Zaçe, Ilaria Spalliera, Luigi Coppola, Iannetta Marco, et al. (+2)
564 [GO] 2022―Dec―15 1140. Outcomes and Complications of Tocilizumab and Baricitinib use in Transplant Patients with COVID-19 Maria A Mendoza, Raymund R Razonable, Omar M Abu Saleh
565 [GO] 2022―Dec―15 1132. Integrated Quantitative Systems Pharmacology (QSP) Characterizing Viral Dynamics After Intramuscular (IM) Adintrevimab (ADI) Administration in Participants with Mild to Moderate Coronavirus Disease (COVID-19) Evan Tarbell, Scott A Van Wart, Myra Popejoy, Kristin Narayan, Ellie Hershberger, Xia Pu, et al. (+4)
566 [GO] 2022―Dec―15 1044. Identification and Characterization of an Unconventional NK Subset in COVID-19 Andrew Platt, Izabella Lach, Jeffrey R Strich, Gustaf Wigerblad, Ryan Curto, Shreya Singireddy, et al. (+6)
567 [GO] 2022―Dec―15 1122. Early Infectious Diseases Consultation and Procalcitonin-Guided Therapy Limits Unnecessary Antibiotic Use in COVID-19 Joel A Kammeyer, Meghan M Deutsch, Victoria R Starnes, Makoto Ibaraki, Victoria Soewarna, Basmah Khalil, et al. (+10)
568 [GO] 2022―Dec―15 1063. Female sex and SARS-CoV-2 Serostatus Predict Nasopharyngeal RNA Clearance during Early COVID-19 Carlee Moser, Jonathan Z Li, Joseph J Eron, Evgenia Aga, Eric S Daar, David A Wohl, et al. (+11)
569 [GO] 2022―Dec―15 481. Risk Factors and Clinical Outcomes of Candidemia Associated with Severe Coronavirus Disease 2019 (COVID-19) Tanaya Bhowmick, Sugeet Jagpal, Tilly Varughese, Purvi Patel, Polly Jen, Tyler Maxwell, et al. (+10)
570 [GO] 2022―Dec―15 939. Barriers and facilitators in the implementation of ASP in Mexico and the impact of COVID-19 María Alejandra Cortés-Ortíz, Anahí Dreser, Jennifer Hegewisch-Taylor, Julián Romero-Mónico, Jorge Quiroz
571 [GO] 2022―Dec―15 304. Viral resistance analysis in the COMET-PEAK study: sotrovimab treatment in participants with mild-to-moderate COVID-19 Phillip J Yates, Jennifer Moore, Jennifer Han, Andrew Skingsley, Gretja Schnell, Andrea L Cathcart, et al. (+3)
572 [GO] 2022―Dec―15 305. Clinical scoring system to predict viable viral shedding in patients with COVID-19 Sung Woon Kang, Ji Yeon Kim, Heedo Park, Sunghee Park, So Yun Lim, SeongMan Bae, et al. (+9)
573 [GO] 2022―Dec―15 274. Epidemiology and Antimicrobial Treatment Impact of Procalcitonin in Patients with COVID-19 Anna Conlon, Krishna Rao, Sandro Cinti, Zoey Chopra, Shannon E Cahalan
574 [GO] 2022―Dec―15 281. Not the sharpest of tools: Procalcitonin and bacterial co-infections in patients admitted with COVID-19 Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Stephanie Echeverria, Sorel Lira, Rodrigo M Burgos
575 [GO] 2022―Dec―15 283. Post COVID-19 syndrome and quality of life impairment in a cohort of severe COVID-19 Carla M Roman-Montes, Guillermo A Guaracha-Basañez, Yesenia C Flores-Soto, Maria Fernanda Gonzalez, Luis Alfredo Ponce-de-leon, Karla M Tamez-Torres, José Sifuentes-Osornio
576 [GO] 2022―Dec―15 881. Nasal and Plasma SARS-CoV-2 RNA Levels Predict Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19 Yijia Li, Linda J Harrison, Kara W Chew, Joseph J Eron, Eric S Daar, David A Wohl, et al. (+10)
577 [GO] 2022―Dec―15 242. Association Between Procalcitonin and Antimicrobial Usage in Patients with COVID-19 Mahmoud H Aly, Eris Cani, Lendelle Raymond, Cosmina Zeana
578 [GO] 2022―Dec―15 2358. Dementia and Cognitive Concerns are Risk Factors for Mortality in People with Human Immunodeficiency Virus and COVID-19 Shibani S Mukerji, Douglas R Wilcox, Emily A Rudmann, Elissa Ye, Ayush Noori, Colin Magdamo, et al. (+5)
579 [GO] 2022―Dec―15 251. Clinical Features and Outcomes of Pneumothorax and Pneumomediastinum in COVID-19 Sangeeta Adusumilli, Ashish Bhargava, Rene Franco
580 [GO] 2022―Dec―15 300. Trends in electrocardiographic and cardiovascular manifestations of patients hospitalized with COVID-19 Jinghao Nicholas Ngiam, Wilson Goh, Meng Ying Sim, Srishti Chhabra, Tze Sian Liong, Nicholas W S Chew, et al. (+5)
581 [GO] 2022―Dec―15 319. Clinical accuracy and utility of plasma microbial cell free DNA NGS for the diagnosis of invasive aspergillosis in patients with hematologic malignancy and COVID-19 Ki Hyun Lee, Joon-sup Yeom, Jun Yong Choi, Nam Su Ku, Su Jin Jeong, Jung Ho Kim, et al. (+9)
582 [GO] 2022―Dec―15 289. Prolonged Corticosteroid Usage, Associated Infectious Complications, and High Mortality in Adult Patients with COVID-19 Rebecca Chu, Veronica B Zafonte, Kelly L Cervellione, Andrew S Miele, Farshad Bagheri, Javeria Shakil
583 [GO] 2022―Dec―15 878. Association between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death for Non-Hospitalized Adults with Mild-to-Moderate COVID-19 Mark Giganti, Kara W Chew, Joseph J Eron, Jonathan Z Li, Mauricio Pinilla, Carlee Moser, et al. (+10)
584 [GO] 2022―Dec―15 79. Long-term Health Outcomes of Individuals who are Infected with SARS-CoV-2 and Develop COVID-19 Lilac Tene, Tobias Bergroth, Anna Eisenberg, Gabriel Chodick
585 [GO] 2022―Dec―15 785. Bacterial Co-infection and Empirical Antibiotic Therapy in Patients with COVID-19 Jiyoung Lee, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sung-Han Kim, Sang-Oh Lee, et al. (+3)
586 [GO] 2022―Dec―15 257. Coinfection Characteristics among Children with COVID-19 Itzel Villanueva García, Nancy Evelyn Aguilar Gómez, Aarón Espinosa Atri, Angela Patricia Vedia Márquez, Juan Antonio Gallegos Marin, Ana Ruth Hernández Tepach
587 [GO] 2022―Dec―15 297. Secondary Bacterial Blood Stream Infections in Patients Hospitalized with COVID-19 Fareeha Adnan, Mariam A Khan, Amna Umer, Nazia Khursheed
588 [GO] 2022―Dec―15 925. Remdesperate for Stewardship: Impact of a Remdesivir Stewardship Strategy on the Care of Patients with COVID-19 Admitted to a Community Teaching Hospital Jillian Hayes, Ahmed Ghonim, Leslie Wooten, Jenny Sippel-Tompkins, Victor Herrera, Amy L Carr
589 [GO] 2022―Dec―15 1867. Characteristics and Outcomes of Patients with SARS-CoV-2 Reinfections Requiring Treatment in a COVID-19 Ambulatory Treatment Program Kelsie Cowman, Austin Golia, Yi Guo, Terrence D McSweeney, Mei H Chang, Hongkai Bao, Priya Nori
590 [GO] 2022―Dec―15 1402. Expand accessibility of monoclonal antibody in COVID-19 among different ethnicities and races. Hina Farooq, Shivanjali Shankaran
591 [GO] 2022―Dec―15 1788. COVID-19 and Antibiotic Prescriptions in the United States: A County-level Analysis Alisa Hamilton, Suprena Poleon, Jerald Cherian, Sara E Cosgrove, Ramanan Laxminarayan, Eili Y Klein
592 [GO] 2022―Dec―15 261. COVID-19 and Diabetes Mellitus: Glycemic Control and Risk Factors for Mortality, experience from Pakistan. Asma Nasim, Sunil Kumar
593 [GO] 2022―Dec―15 293. Risk factors for COVID-19 associated pulmonary aspergillosis (CAPA) in severe COVID-19 and impact of airborne fungal contamination within negative pressure isolation room Jung Ah Lee, Sanggwon Ahn, Se Ju Lee, Jinnam Kim, Ki Hyun Lee, Chang Hyup Kim, et al. (+8)
594 [GO] 2022―Dec―15 1922. Outbreak and Management of COVID-19 and Infection Prevention Control Practices at a Community Living Center in Veterans Administration Hospital, North Texas John J Hanna, Denisse Silva-Rodriguez, Angela Christie-Smith, Andrew O Psenicka, Sherry R Reid, Ikwo K Oboho
595 [GO] 2022―Dec―15 290. Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in Children with COVID-19 and MIS-C Gulhadiye Avcu, Sema Yıldırım Arslan, Mehmet Soylu, Melis Bilen, Candan Çiçek, Zümrüt Şahbudak Bal, et al. (+2)
596 [GO] 2022―Dec―15 1039. Clinical and Economic Impact of COVID-19 and Serologic Protection among Farm Workers: Results from the Guatemala Agricultural Workers and Respiratory Illness Impact (AGRI) Study Daniel Olson, Diva M Calvimontes, Molly Lamb, Kelsey Lesteberg, Edgar Barrios, Neudy Rojop, et al. (+15)
597 [GO] 2022―Dec―15 1217. An outbreak of carbapenem-resistant Acinetobacter baumannii in an isolation ward for COVID-19 and successful outbreak control with infection control measures Ki Hyun Lee, Joon-sup Yeom, Nam Su Ku, Su Jin Jeong, Jin Young Ahn, Jung Ho Kim, et al. (+6)
598 [GO] 2022―Dec―15 1074. Surveillance of SARS-CoV-2 variants of concern (VOC) in hospital wastewater (WW) and its correlation with hospitalized cases of COVID-19 and the occurrence of outbreaks Nicole Acosta, Maria Bautista Chavarriaga, Barbara Jean M Waddell, Janine McCalder, Kristine Du, Puja Pradhan, et al. (+33)
599 [GO] 2022―Dec―15 1043. Gastrointestinal manifestations of COVID-19 and their association with disease severity and death in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Ysalda E Santana, Alicia Rodriguez, Johan Ramos, Mariel Suarez
600 [GO] 2022―Dec―15 262. COVID-19 associated fungal co-infections in Solid Organ Transplant Recipients: A single center case series Akshay M Khatri, Jacques Simkins, Neeraj Sinha, Anita Phancao, Gaetano Ciancio, Lilian M Abbo, et al. (+3)
601 [GO] 2022―Dec―15 266. Cumulative Steroid Dose in Hospitalized Patients and COVID-19 Associated Pulmonary Aspergillosis Diego Ramonfaur, Jack Salto-Quintana, Nadia Hernández-Mata, Gloria Mayela Aguirre-García, Hiram Villanueva-Lozano, Michel Martínez-Reséndez
602 [GO] 2022―Dec―15 263. COVID-19 Associated Pulmonary Aspergillosis (CAPA) at a Hospital in Nicaragua: Prevalence and Risk Factors for Mortality. Armando J López-Gaitán, Sunaya V Marenco-Avilés, Maikelyn A Castillo-Cano, Guillermo D Porras-Cortés
603 [GO] 2022―Dec―15 294. Risk factors of COVID-19 associated pulmonary aspergillosis in a high endemic setting and development of a bedside clinical risk prediction score. Merlin Moni, Teny M M John, Abdul Razak Moosa, Kiran G Kulirankal, Fabia Edathadathil, T S Dipu
604 [GO] 2022―Dec―15 264. COVID-19 Associated Pulmonary Aspergillosis in Intensive Care Patients Based on Duration of Corticosteroid Administration Meera D Shah, G Christina Gutierrez, Rebecca Moote, Kelly R Reveles, Elizabeth O Hand
605 [GO] 2022―Dec―15 1041. Association of SARS-CoV-2 Viral load in COVID-19 at the hospital representation Ashish Bhargava, Hemang Patel, Natali Salaytah, Elisa Akagi, Louis Saravolatz, Mamta Sharma
606 [GO] 2022―Dec―15 1042. Inflammatory Representation of COVID-19 at the Time of Hospitalization: An Insight into the Mild, Moderate, Severe and Critical COVID-19 Disease Ashish Bhargava, Hemang Patel, Elisa Akagi, Mamta Sharma, Claudia V Santos, Wei Zhao, et al. (+7)
607 [GO] 2022―Dec―15 282. Occurrence of adverse events and factors related to prognosis in a cohort of patients hospitalized with COVID-19 at University hospital - UNICAMP, Brazil. Maitê V Luz, Julian F Silva, Hugo D Ceccato, Paulo J Souza, Pedro M E Villar, Paulo R A Mendes, et al. (+3)
608 [GO] 2022―Dec―15 1951. Guiding COVID-19 Booster Vaccinations by COVID-19 Quantitative Spike Ig Antibody Titers Regardless of HIV Status, Immunosuppression, and Age Ricky K Hsu, Laurence Brunet, Jennifer S Fusco
609 [GO] 2022―Dec―15 788. Risk Factors for Severe COVID-19 Breakthrough Infections: A Retrospective, Nationwide Cohort Study Austin D Vo, Westyn Branch-Elliman, Jennifer La, Matthew Ronan, Mary Brophy, Julie Wu, et al. (+4)
610 [GO] 2022―Dec―15 1571. Hospital COVID-19 Burden Impact on Inpatient Antibiotic Use Rates Elizabeth Dodds Ashley, Yuliya Lokhnygina, Danielle Doughman, Katherine R Foy, Alicia D Nelson, April Dyer, et al. (+13)
611 [GO] 2022―Dec―15 1121. Does Anti-Vaccine Equal Anti-Antibody? Differing Rates of Veteran Acceptance of Monoclonal Antibody Therapies for COVID-19 By Prior Vaccination Status Martha Brennan, Amy Hirsch Shumaker, Usha Stiefel
612 [GO] 2022―Dec―15 1078. Vaccine-induced antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective observational cohort study Yong Chan Kim, Bongyoung Kim, Nak-Hoon Son, Namwoo Heo, Yoon Soo Park, Heejung Kim
613 [GO] 2022―Dec―15 1542. MR-proADM Biomarker Predicts COVID-19 Clinical Outcomes: a US-based Cohort Study Michael Mansour
614 [GO] 2022―Dec―15 1065. Patient-Reported Reasons for Non-Participation in Inpatient COVID-19 Clinical Research: Results from a Multi-Center VA Embedded Randomized Trial Samira Reyes Dassum, Ryan Ferguson, Patricia Woods, Maura Flynn, Karen Visnaw, Sara J Schiller, et al. (+3)
615 [GO] 2022―Dec―15 1942. Effect of SARS-CoV-2 Vaccination in a Frailty COVID-19 Cohort: a Real Life Experience in a Northern Italy Hospital Chiara Russo, Luca Tagliafico, Laura Labate, Marta Ponzano, Michele Mirabella, Federica Portunato, et al. (+7)
616 [GO] 2022―Dec―15 781. COVID-19 Outcomes in the Immunocompromised Population of the COVID-19 Community Research Partnership John C Williamson, Gregory B Strylewicz, Michael E DeWitt, Diane Uschner, Ashvi Soni, Morgana Mongraw-Chaffin, et al. (+11)
617 [GO] 2022―Dec―15 530. Characterization of the Proteomic Changes via SARS-CoV-2 Infection or Vaccination in the COVID-19 Community Research Partnership (CCRP) Michael E DeWitt, David M Herrington, John C Williamson, Austin L Seals, Thomas F Wierzba, Aleksandra Binek, et al. (+2)
618 [GO] 2022―Dec―15 1868. Characterization of COVID-19 Symptoms and Outcomes by Variant Period in the North Carolina COVID-19 Community Research Partnership (NC-CCRP) Michael E DeWitt, Sharon Edelstein, Ashley H Tjaden, David M Herrington, John Schieffelin, Michael A Gibbs, et al. (+2)
619 [GO] 2022―Dec―15 1049. Breakthrough SARS-CoV-2 Infections after Vaccination in the North Carolina COVID-19 Community Research Partnership (NC-CCRP) Diane Uschner, Matthew Bott, Gregory B Strylewicz, Sharon Edelstein, Kristen Miller, William H Lagarde, et al. (+13)
620 [GO] 2022―Dec―15 1523. Association between Self-reported Masking Behavior and SARS-CoV-2 Infection Wanes from Pre-Delta to Omicron-Predominant Periods - North Carolina COVID-19 Community Research Partnership (NC-CCRP) Ashley H Tjaden, Michael A Gibbs, Michael S Runyon, William Weintraub, Yhenneko Taylor, Sharon Edelstein
621 [GO] 2022―Dec―15 1913. Baltimore City Health Department COVID-19 Community-based Testing Results Shamola Dye, Isabella Agnes, Darcy Phelan-Emrick, Adena Greenbaum
622 [GO] 2022―Dec―15 249. Characteristics and outcomes of cryptococcosis among patients with COVID-19 compared to non-COVID-19 controls Daniel B Chastain, Vanessa Kung, Sahand Golpayegany, Brittany T Jackson, Carlos Franco-Paredes, George R Thompson, Andrés F Henao-Martínez
623 [GO] 2022―Dec―15 303. Viral and bacterial infections among adults hospitalized with COVID-19, Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, 14 states, March 2020-February 2022 Shah Melisa, Christopher Taylor, Kadam Patel, Jennifer Milucky, Michael Whitaker, Huong Pham, et al. (+16)
624 [GO] 2022―Dec―15 1059. The Experiences of Healthcare Workers during the Second Wave of COVID-19 Crisis in the South Indian State of Kerala Aleena Issac, Jose J Kochuparambil
625 [GO] 2022―Dec―15 1076. The Role of Bronchoalveolar Lavage in COVID-19 Diagnoses and Management Edie Zhang, Shuman Liu, Rosemary She
626 [GO] 2022―Dec―15 1885. Experience using combined antigen and RT-PCR tests for COVID-19 diagnosis at a Veterans Affairs (VA) Health Care System during the Omicron surge Siri Chirumamilla, Krista Powell, David Gutman, Andrew S Webster, Abeer Moanna, Lauren H Epstein
627 [GO] 2022―Dec―15 1097. Risk of Severe COVID-19 Disease in Individuals with Down syndrome: a Matched Cohort Study from a Large, Integrated Health Care System Jennifer H Ku, Myron J Levin, Yi Luo, Ana Florea, I Chun Lin, Yun Tian, Hung Fu Tseng
628 [GO] 2022―Dec―15 1148. Relationship Between the Duration of Symptoms Before and COVID-19 Disease Outcome After Monoclonal Antibody Therapy Michael J Hubbard, James Polega, Diana K Haggerty, Nicholas A Andersen, Gordana Simeunovic
629 [GO] 2022―Dec―15 1895. SingHealth COVID-19 Disease Registry Jin Yee Shoon, Edwin P Conceicao, Yue Yang, Shalvi Arora, Eng Hock Marcus Ong, Sze Ling Chan, et al. (+2)
630 [GO] 2022―Dec―15 1112. Evaluating the Effects of Casirivimab-Imdevimab in Mild-to-Moderate COVID-19 Disease: A Matched Cohort Study Cindy Hage, Aileen Martinez, Alexis Dunham, Nathan Mohseni, Jarelys Hernandez-Jimenez, Lyssette L Cardona
631 [GO] 2022―Dec―15 1968. SARS-CoV-2 Anti-Spike IgG Antibodies in Neonates After Maternal Vaccination Against COVID-19 During Pregnancy and Outcomes Maria C Casillas Casillas, Claudia C Lopez-Enriquez, Jimena Reyes, Jose L Ramírez Haua, Mario E Rendon Macias
632 [GO] 2022―Dec―15 1105. A Matched-Group Comparison of Interventions for COVID-19 During the First and Second Waves of the COVID-19 Pandemic in a County Hospital in Chicago. Ruben A Hernandez Acosta, Carlos Corpuz, Sriram Gonakoti, Palak Patel, Hillary Chang, Elikplim Akaho, et al. (+3)
633 [GO] 2022―Dec―15 269. Outcomes comparison of hospitalized patients with COVID-19 during the first three pandemic waves. Experience in Colombia, South America. Fernando Rosso, Sarita Rodriguez, Estefanía Beltrán, Alvaro Martinez Valencia, Virginia Zarama, Eric Tafur, Tania Guzmán
634 [GO] 2022―Dec―15 1037. Access to hospitalization for patients with severe COVID-19 during the first wave of the pandemic in Caracas, Venezuela. Jose Orejas, David Forero, Daniela Mendoza, Oscar Omana, Fhabián S Carrión-Nessi, Maria Landaeta, Alejandro Diaz
635 [GO] 2022―Dec―15 346. Aspergillosis in COVID-19 era in Dominican Republic Rita A Rojas-Fermin, Ann S Sanchez-Marmolejos, Ricardo Acra-Tolari, Anel E Guzman-Marte, Irina Suero
636 [GO] 2022―Dec―15 1972. Sources of COVID-19 Exposure Among Health Care Personnel in a Large Tertiary Care Medical Center. Jana Shaw, Heidi Steigerwald, Paul Suits, Stephen J Thomas, Margaret Formica
637 [GO] 2022―Dec―15 258. Comparison of Different COVID Waves during COVID-19 Pandemic: A Retrospective Study from a Dedicated COVID-19 Facility of Karachi Pakistan Muneeba A Sayeed
638 [GO] 2022―Dec―15 306. Development a Predictive Score for Severe Coronavirus Disease 2019 (COVID-19) from High Risk Factor of Patient Described by Thai Government Policy Preudtipong Noopetch, Rutporn Benchamanon, Samerjan Kongsuwan, Chatree Chai-adisaksopha
639 [GO] 2022―Dec―15 1965. Promoting COVID-19 Health Equity through Partnership with Community-Based Organizations and Home Vaccination Services Justin Daniels, David P Holland, Tanner Forbes, Jane Y Scott
640 [GO] 2022―Dec―15 1396. COVID-19 Hospitalization Impact of Age, Race and Ethnicity Among Medicaid and Uninsured Mamta K Jain, Yi Zhang, Mae Thamer, Michael Harms, Jillian Smartt, Stefanie Baierlipp, Kavita Bhavan
641 [GO] 2022―Dec―15 287. Procalcitonin and D-dimer levels at baseline, but not CRP, were informative of COVID-19 hospitalization outcomes Trini Mathew, Julie George, Christine N Yost, Mustafa Deebajah, Paul C Johnson, James Huang, Christopher F Carpenter
642 [GO] 2022―Dec―15 1053. Comorbidities Associated with All-Cause Readmission to the Same Hospital after Index COVID-19 Hospitalization: A Retrospective Cohort Study of 232155 Patients in the United States Gita Nadimpalli, Lyndsay M O’Hara, Lawrence Magder, J Kristie Johnson, Abdolreza Haririan, Lisa Pineles, et al. (+4)
643 [GO] 2022―Dec―15 1397. COVID-19 Hospitalizations in North Texas: Impact of Insurance Status Mamta K Jain, Yi Zhang, Mae Thamer, Michael Harms, Jillian Smartt, Stefanie Baierlipp, Kavita Bhavan
644 [GO] 2022―Dec―15 1924. Outpatient Treatment With the SARS-CoV-2-Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) for Preventing COVID-19 Hospitalizations in the Phase 3 TACKLE Trial F D Richard Hobbs, Hugh Montgomery, Francisco Padilla, Kenneth Kim, Jesus Abraham Simón Campos, Douglas Arbetter, et al. (+7)
645 [GO] 2022―Dec―15 240. Antibiotic Overuse Among Children with COVID-19 Hospitalized in a Pediatric Intensive Care Unit Jessica Gillon, Kathryn Garguilo, Kerry LeBlanc, Ritu Banerjee
646 [GO] 2022―Dec―15 288. Prognostic Factors for In-hospital Mortality of Patients with Severe COVID-19 Hospitalized in the University Medical Center, Lithuania Ieva Kubiliute, Jurgita Urboniene, Akvile Rudenaite, Birute Zablockiene, Giedre Gefenaite, Ligita Jancoriene
647 [GO] 2022―Dec―15 301. Use of a multiplex PCR assay for detection of respiratory co-infections in COVID-19 hospitalized non-ICU patients: an ace up a clinician’s sleeve Christina Louka, Lemonia Velentza, Nektaria Rekleiti, Anastasia Apanomeritaki, Vasiliki Mamali, Alexandra Stamati, et al. (+6)
648 [GO] 2022―Dec―15 1159. Treatment experience of regdanvimab for mild to moderate COVID-19 hospitalized patients in the Delta variant-predominant period in Korea Yee Gyung Kwak, Je Eun Song, Myung Jin Lee, Baek-Nam Kim
649 [GO] 2022―Dec―15 789. Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir Kanal Singh, Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin L Dewar, et al. (+14)
650 [GO] 2022―Dec―15 1111. Baricitinib versus Tocilizumab for Hospitalized Adults with Severe COVID-19 in a Community Health System: A Retrospective Cohort Alexandra Gonzalez, Aileen Martinez, Lyssette L Cardona, Jarelys Hernandez-Jimenez
651 [GO] 2022―Dec―15 1086. COVID-19 in a Comprehensive Cancer Center: 2020-2022 Patricia Mulanovich, Roy F Chemaly, Bruno Granwehr, Kelly McConn, Physician Assistant, Nina Patel, et al. (+3)
652 [GO] 2022―Dec―15 1871. Clinical epidemiological characterization of patients affected by COVID-19 in a General Hospital of Veracruz, Mexico Luis Del Carpio-Orantes, Sergio García-Mendez, Daniel Márquez-Uscanga, Jesús Salvador Sánchez-Díaz, Omar García-Hernández, Andrés Aguilar-Silva, et al. (+7)
653 [GO] 2022―Dec―15 1062. Examining the impact of type 2 diabetes status and severity on in-hospital outcomes amongst patients hospitalized with COVID-19 in a southwest Virginia healthcare system Jesse Bendetson, Anthony Baffoe-Bonnie
654 [GO] 2022―Dec―15 1894. Sensitivity of Symptom-Based Screening for COVID-19 in Active Duty Service Members Zachary Matthews, Daniel Cybulski, Dianne Frankel, John Kieffer, Theresa Casey, Angela Osuna, Joseph E Marcus
655 [GO] 2022―Dec―15 1160. Treatment-Emergent Viral Variants in the Phase 3 TACKLE Trial Investigating Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for the Treatment of Mild to Moderate COVID-19 in Adults Gustavo H Kijak, Bahar Ahani, Douglas Arbetter, Tyler Brady, Fernando Chuecos, Vancheswaran Gopalakrishnan, et al. (+7)
656 [GO] 2022―Dec―15 784. Real-world effectiveness of the mRNA-12733-dose primary series against COVID-19 in an immunocompromised population Interim results from a prospective observational cohort study Jennifer H Ku, Lina S Sy, Lei Qian, Bradley Ackerson, Yi Luo, Julia Tubert, et al. (+7)
657 [GO] 2022―Dec―15 2159. Monoclonal Antibody Treatment for COVID-19 in Children: Experience of a Pediatric Tertiary Care Center Osama Ibrahim, Kristen Ferlisi, Winston McCormick, Cristina E Alcorta, Michael Koster
658 [GO] 2022―Dec―15 933. Antibiotic Prescribing Changes in Adults During COVID-19 in Outpatient Patient-Centered Medical Homes (PCMH) in Arkansas Jill Johnson, Cheng Peng, Ryan K Dare, Jacob T Painter, Holly Maples, Jeremy Thomas, et al. (+3)
659 [GO] 2022―Dec―15 1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial Claudia M Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, et al. (+43)
660 [GO] 2022―Dec―15 2298. Clinical and Demographic Characteristics of COVID-19 in Pediatric Patients in the United States Milan Ho, Zachary M Most, Marlon Diaz, Julia A Casazza, Bhaskar Thakur, Sameh Saleh, et al. (+5)
661 [GO] 2022―Dec―15 1087. COVID-19 in Solid Organ Transplant Recipients: A Single Transplant Center Experience Suhel A Sabunwala, Tuhina Cornelius, Sadaf Aslam, Sally Alrabaa
662 [GO] 2022―Dec―15 2116. Long-term (2-year) outcomes and complications of COVID-19 in solid organ transplant (SOT) recipients Daniel Burack, Marcus R Pereira, Elizabeth Verna
663 [GO] 2022―Dec―15 1104. A comparison of remdesivir versus remdesivir plus tocilizumab for patients with severe COVID-19 in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Liz De la Nuez, Ana Hernando, Cesar Jimenez, et al. (+2)
664 [GO] 2022―Dec―15 LB1577. Outcomes of Pregnant Women Exposed to Sotrovimab for the Treatment of COVID-19 in the Omicron Predominant Era (PRESTO) Jessica Tuan, Manas Sharma, Jehanzeb Kayani, Matthew W Davis, Dayna McManus, Jeffrey E Topal, Onyema Ogbuagu
665 [GO] 2022―Dec―15 LB1528C. Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial Susanna Naggie
666 [GO] 2022―Dec―15 1077. Understanding the Psychosocial Burden Associated with Hospitalization Among Adults Diagnosed with COVID-19 in the United States Wajeeha Ansari, Florin Draica, Joanna Atkinson, Kathy Annunziata, Martine C Maculaitis, Amie Scott
667 [GO] 2022―Dec―15 1145. Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 in the US Mindy M Cheng, Daniel C Gibbons, Helen Birch, Vishal Patel, Christopher F Bell, Myriam Drysdale, et al. (+2)
668 [GO] 2022―Dec―15 1923. Outcomes of the adsorbed Sinovac CoronaVac COVID-19 inactivated vaccine among the employee recipients in St. Luke’s Medical Center Quezon City: an observational cohort study Almira V Uy, Medical Doctor, Ryan Llorin, Medical Doctor
669 [GO] 2022―Dec―15 1901. Utilizing Antiviral Prescription Data as a Predictor of Increasing COVID-19 Incidence: A Retrospective Study of Citywide Data Christina Kaul, Gabriel M Cohen, Matthew Silverstein, Andrew B Wallach, Elizabeth Diago-Navarro, Mary K Foote
670 [GO] 2022―Dec―15 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection Salman Bangash, Adriana Betancourth, Ayesha Khan, Chiu-Bin Hsiao, Cassandra Oehler, Charmaine Clarisse D Abalos
671 [GO] 2022―Dec―15 1088. Evaluating the Effect of Donepezil on Mortality Among Alzheimer’s Disease Patients With and Without COVID-19 Infection Taissa A Bej, Elizabeth Edmiston, Brigid Wilson, Joy Phillips, Robin L Jump
672 [GO] 2022―Dec―15 2357. Risk Factors for COVID-19 Infection and Outcomes in People Living with HIV John J Hanna, Liyu B Geresu, Marlon Diaz, Madison Pickering, Julia A Casazza, Milan Ho, et al. (+9)
673 [GO] 2022―Dec―15 1889. Knowledge, beliefs and practices about COVID-19 infection and vaccination in healthcare personnel at non-acute care facilities Armaghan-e-Rehman Mansoor, Caroline A ONeil, David McDonald, Victoria J Fraser, Hilary Babcock, Jennie H Kwon
674 [GO] 2022―Dec―15 354. Invasive fungal disease in patients with severe COVID-19 infection at a midwestern academic medical center Stephen M Maurer, Kathleen A Linder, Marisa H Miceli
675 [GO] 2022―Dec―15 1092. Management of Transplant Graft and Role of Immunosuppression in the Outcome of Covid-19 Infection in Solid Organ Transplant Recipients Suhel A Sabunwala, Tuhina Cornelius, Sadaf Aslam, Sally Alrabaa, Ambuj Kumar
676 [GO] 2022―Dec―15 1161. Vaccination During Acute COVID-19 Infection Protects Against 30 Day Adverse Outcomes Julia A Casazza, Robert W Turer, Sameh N Saleh, Madison Pickering, Marlon Diaz, Milan Ho, et al. (+5)
677 [GO] 2022―Dec―15 1126. Effect of Remdesivir on Recovery, Quality of Life, and Long-COVID Symptoms One Year after Hospitalization for COVID-19 Infection: A Randomized Controlled SOLIDARITY Finland Trial Olli P O Nevalainen, Saana Horstia, Sanna Laakkonen, Jarno Rutanen, Jussi Mustonen, Ilkka Kalliala, et al. (+15)
678 [GO] 2022―Dec―15 265. Cryptococcal disease in Covid-19 infection: Case series from South Texas Sumbal Babar, Marcos I Restrepo, Delvina Ford, Jose Cadena-Zuluaga
679 [GO] 2022―Dec―15 239. Acute Thromboembolism in Non-ICU Hospitalized Patients with COVID-19 infection: Examining the Impact of Prior COVID Vaccination James McKinnell, Felix Pham, Volha Yarashenka, John Kunesh, Lisa Hughes, Kyle Fu, et al. (+3)
680 [GO] 2022―Dec―15 1116. Comparative Efficacy of Tocilizumab and Baricitinib in Treatment of Severe COVID-19 Infections Phylicia Pellot, Nikunj M Vyas, Cindy Hou, Michael Rosati
681 [GO] 2022―Dec―15 1934. Association between Receipt of COVID-19, Influenza, and Pneumococcal Vaccination Chris Choi, Ashley Tippett, Luis W Salazar, Laila Hussaini, Olivia D Reese, Khalel De Castro, et al. (+11)
682 [GO] 2022―Dec―15 1130. Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure - Results from the placebo-controlled EMPATHY trial Luis Abrishamian, Marc Bonten, Richa Chandra, Damodaran Solai Elango, Pierre Fustier, Kinfemichael Gedif, et al. (+19)
683 [GO] 2022―Dec―15 2058. Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda Preethiya Sekar, Elizabeth Nalintya, Paul Kavuma, Joanita Kigozi, Martin Ssuna, Paul Kirumira, et al. (+7)
684 [GO] 2022―Dec―15 1119. Covid-19 Mab Use in High-Risk Pediatric Patients Hannah Bahakel, Catherine R Murphy, Robert W Frenck, Michael Grimley, Christine Phillips, Grant Schulert, et al. (+4)
685 [GO] 2022―Dec―15 1117. COVID-19 Monoclonal Antibodies: A Single Center Real World Experience Sara Brenner, Alexander Knee, Douglas Salvador, Erica Housman, Gladys Fernandez, Armando Paez
686 [GO] 2022―Dec―15 316. The Value of Monocyte-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Predicting COVID-19 Mortality: A Single-Center Retrospective Study Denise Marie J Nanas, Marjorie A Nolasco, Divina Cristy R Samin
687 [GO] 2022―Dec―15 255. Clinical, echocardiographic and electrocardiographic manifestations of COVID-19 multisystem inflammatory syndrome in children in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Kelvin Espinal, Franzory Peralta, Hilario Maria
688 [GO] 2022―Dec―15 1909. Steak with a Side of Omicron? Efficacy of Coordinated Outbreak Response during an early COVID-19 Omicron Outbreak amongst Restaurant Workers in Riverside County, CA Shunling Tsang, Wendy Hetherington, Wendy Hetherington, Juan Landeros-Tavera, Jennifer Chevinsky, Marshare Penny
689 [GO] 2022―Dec―15 736. Impact of COVID-19 on Mortality Associated with Pseudomonas aeruginosa Bloodstream Infection in the Veterans Health Administration System Leila S Hojat, Brigid Wilson, Federico Perez, Robert A Bonomo
690 [GO] 2022―Dec―15 LB1532. The Impact of COVID-19 on nursing home residents’ clinical, functional, and psychosocial outcomes Lori Popejoy, Amy Vogelsmeier, Gregory Petroski, Daivd Mehr, Marilyn Rantz, Steven Miller, et al. (+3)
691 [GO] 2022―Dec―15 1020. The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) at an Academic Medical Center Ravitej Goteti, Lea M Monday, Allison J Weinmann
692 [GO] 2022―Dec―15 LB1530. Clinical Benefit of Oral sabizabulin for Hospitalized Adults with CoVID-19 on Supplemental Oxygen Tara L Gonzales, Paula Skarda, Thomas G Bird, Michael Schnaus, Mitchell Steiner, Alan Skolnick, et al. (+7)
693 [GO] 2022―Dec―15 2199. Herpesviridae lung reactivation and infection in patients with severe Covid-19 or influenza virus pneumonia: a comparative study Charles-Edouard Luyt, Sonia Burrel, Vincent Guiraud, Alain Combes, David Boutolleau
694 [GO] 2022―Dec―15 1093. Multiparametric Investigation Of Spike-Protein Specific T-cell Cytokine Expression Profile In Children With Symptomatic COVID-19 Or Multisystem Inflammatory Syndrome Filippos Filippatos, Marianna Tzanoudaki, Elizabeth-Barbara Tatsi, Vasiliki Efthymiou, Manolis Liatsis, Vasiliki Syriopoulou, Athanasios Michos
695 [GO] 2022―Dec―15 1883. Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS) Priscilla Rupali, Malathi Murugesan, Venkata Raghava Mohan, Padmanaban Venkatesan, Senthil Kumar, Premkumar Thangavelu, et al. (+2)
696 [GO] 2022―Dec―15 1879. Detection of COVID-19 Outbreaks in Long-Term Care Homes Using Built Environment Testing for SARS-CoV-2: A Multicentre Prospective Study Michael Fralick, Jason Moggridge, Lucas Castellani, Sylva Donaldson, David S Guttman, Aaron Hinz, et al. (+11)
697 [GO] 2022―Dec―15 2213. Increased Early Syphilis Detection and Treatment in an Urban Emergency Department During the COVID-19 Pandemic Ashley Lipps, Carlos Malvestutto, Susan L Koletar, Michael Dick, Sommer E Lindsey, Jose A Bazan
698 [GO] 2022―Dec―15 2214. National Testing Assessment of Select Bacterial STIs During the COVID-19 Pandemic Giuiseppe A Fonseca, Marissa Maier, Shimrit Keddem, Joleen Borgerding, Elliott Lowy, Lorenzo McFarland, et al. (+6)
699 [GO] 2022―Dec―15 2017. Comparison of California Acute Care Hospital Central Line-Associated Bloodstream Infection Incidence by Hospital Location Before and During the COVID-19 Pandemic Lizette Brenes, Monise Magro, Tisha Mitsunaga, Erin Epson
700 [GO] 2022―Dec―15 1919. Implementation of Hydrogen Peroxide Vapor (HPV) Decontamination of N95 Respirators for Reuse During COVID-19 Pandemic Nancy L Havill, Richard A Martinello, Patrick Kenney, Cherie Bragg, Jacqueline Epright, Margaret Cintron, et al. (+2)
701 [GO] 2022―Dec―15 1921. Leveraging Bluetooth Low-Energy Technology to Improve Contact Tracing in Healthcare Settings during the COVID-19 Pandemic M Cristina Vazquez Guillamet, Ashraf Rjob, Jingwen Zhang, Reshad Hamauon, Ruixuan Dai, Ruiqi Wang, et al. (+5)
702 [GO] 2022―Dec―15 2205. Potential Causative Association between Respiratory Viruses and Pneumococcus-Associated Disease in Young Children in Israel: Lessons from the COVID-19 Pandemic Ron Dagan, Bert Adriaan van der Beek, David Greenberg, Yonat Shemer Avni, Shalom Ben-Shimol, Daniel M Weinberger
703 [GO] 2022―Dec―15 2203. Involvement of Respiratory Viruses in Community-Acquired Alveolar Pneumonia (CAAP) in Children < 5 Years in Southern Israel, Before and During the COVID-19 Pandemic Dana Danino, Bert Adriaan van der Beek, Shalom Ben-Shimol, Yonat Shemer Avni, David Greenberg, Ron Dagan
704 [GO] 2022―Dec―15 1912. Addressing Uncertainty: An Evidence-Based, Data-Driven, Decision Matrix for Healthcare Operations During The COVID-19 Pandemic Valerie Ausborn, Luis Ostrosky-Zeichner, Misti G Ellsworth, Tawanna A McInnis-Cole, Kristine Aleman Verrill, Shannon Lutz, et al. (+2)
705 [GO] 2022―Dec―15 1907. Initiation of Comfort Measures Only Care in the Medical Intensive Care Unit during the COVID-19 Pandemic Max Jacobs, Helene Rovnan, Deeksha Ramanujam, Amina Hamza, Stephen Caucci, Tariq Cheema
706 [GO] 2022―Dec―15 1765. Antibiotic Consumption in a Healthcare System in Bolivia During the First Wave of COVID-19 Pandemic Rodolfo E Quiros, Elvio D Escobar, Juan Carlos Tapia, Valeria Fabre
707 [GO] 2022―Dec―15 1400. Emergency Department (ED) Use among Persons With HIV (PWH) before and during the COVID-19 Pandemic Deana Agil, Lindsay Browne, Thibaut Davy-Mendez, Amy Durr, Heather Henderson, Kuo-Ping Li, et al. (+3)
708 [GO] 2022―Dec―15 1425. Changes in Clinical Presentation of TB due to the COVID-19 pandemic Nazia Khan, Surksha Sirichand, Xianhong Xie, Jacqueline M Achkar
709 [GO] 2022―Dec―15 1321. Increased Prevalence of Group A Streptococcus (GAS) High Level Macrolide Resistance During the COVID-19 Pandemic Ami B Patel, Judith A Guzman-Cottrill, Katherine E Fleming-Dutra, Sopio Chochua, Bernard Beall, Preeti Jaggi, et al. (+6)
710 [GO] 2022―Dec―15 1215. Variation in Hand Hygiene Improvement After Implementation of an Electronic Hand Hygiene System During the COVID-19 Pandemic James P Steinberg, Elizabeth Overton, Nancye Feistritzer, Kari L Love, Jill Holdsworth, Margaret Whitson`, et al. (+4)
711 [GO] 2022―Dec―15 1329. Pediatric Group A Streptococcus (GAS) Pharyngitis Incidence has Decreased During the COVID-19 Pandemic Ami B Patel, Matthew McHugh, Stanford Shulman, Robert R Tanz
712 [GO] 2022―Dec―15 961. Pandemic Hits: Evaluation of an Antimicrobial Stewardship Program Website for Hospital Communication During the COVID-19 Pandemic Reinaldo Perez, Michael E Yarrington, Rebekah Wrenn, Connor R Deri, Martha B Adams, Richard H Drew, et al. (+3)
713 [GO] 2022―Dec―15 580. Influenza, SARS-CoV-2, and routine childhood vaccines - trends in vaccine hesitancy in hospitalized children before and during the COVID-19 pandemic Marisa Orbea, Rachel Cunningham, C Mary Healy, Julie A Boom, Claire Bocchini
714 [GO] 2022―Dec―15 1007. Impact of an Interdisciplinary Outpatient Parenteral Antimicrobial Therapy (OPAT) Clinic During the COVID-19 Pandemic Amir Zaki, Teena H Xu, Parisa Khan, Amna Ahmed, Katharine Breaux
715 [GO] 2022―Dec―15 944. Development & Implementation of a Biomarker-based Remotely-delivered Antimicrobial Stewardship (AMS) Strategy during the COVID-19 Pandemic Divya Deodhar, Jane Miracline, Hanna Alexander, Naveena gracelin princy Zacchaeus, Premkumar Thangavelu, Priscilla Rupali
716 [GO] 2022―Dec―15 1107. A Survey on Remdesivir Use and Antimicrobial Stewardship Restrictions Throughout the COVID-19 Pandemic Alfredo J Mena Lora, Fischer Herald, Rodrigo M Burgos, Scott Borgetti, Brenna Lindsey, Lelia H Chaisson, Susan C Bleasdale
717 [GO] 2022―Dec―15 268. Dengue - SARS-CoV-2 co-infection: Experience in hospitalized patients during COVID-19 pandemic Fernando Rosso, Isabel L Zapata-Vasquez, Sarita Rodriguez, Diana M Martinez, Olga Agudelo, Sebastián Robles-Castillo, Alejandro Tejada
718 [GO] 2022―Dec―15 105. Expanding and Sustaining Influenza Vaccination Acceptance amongst Adults with HIV in Delaware during the COVID-19 Pandemic Deborah A Kahal, Christopher James, Brian Wharton
719 [GO] 2022―Dec―15 355. Outcome of patients with non-COVID-19 related Aspergillosis during the COVID-19 pandemic Carla M Roman-Montes, Adriana Guzman-Pérez, Medical Student, Rosa Areli Martinez-Gamboa, Maria Fernanda Gonzalez, Paulette G Díaz-Lomelí, et al. (+4)
720 [GO] 2022―Dec―15 1437. Investigation of Increased Latent Tuberculosis Infection Rates During the COVID-19 Pandemic Among International Students at a U.S. University Campus Wajih Askar, Lauri E Nandyal, RaeJean Hardig, Tina Coberley, Amanda Doner, Lisa Haglund, et al. (+4)
721 [GO] 2022―Dec―15 1905. High food insecurity during the COVID-19 pandemic among secondary school teachers - Tajikistan, 2021 Davron Akhmedov, Roberta Horth, Dilyara Nabirova
722 [GO] 2022―Dec―15 1903. Factors associated with response to a phone-administered alcohol and substance use survey during the COVID-19 pandemic among women in the MACS/WIHS Combined Cohort Study: Who are we missing? Hannah R Tierney, Yifei Ma, Peter Bacchetti, Ralph J DiClemente, Mirjam-Colette Kempf, Deborah L Jones, et al. (+10)
723 [GO] 2022―Dec―15 2014. Central Line - Associated Bloodstream Infections and Their Increase With the COVID-19 Pandemic at Veterans Affairs in San Antonio, Texas Divya Chandramohan, Delvina Ford, Erica Beck, Lauren N Garza, Kelly R Reveles, Jose Cadena
724 [GO] 2022―Dec―15 385. Impact of the COVID-19 Pandemic First Wave on Clostridioides difficile Infection Rafael Mendo-Lopez, Lauren Pacheco, Javier A Villafuerte-Galvez
725 [GO] 2022―Dec―15 248. Change in Incidence of Multisystem Inflammatory Syndrome in Children Across the COVID-19 Pandemic in Chicago - March 2020 - March 2022 Hillary Spencer, Jennifer Seo, Massimo Pacilli, Candice L Robinson, Hannah Matzke, Maria Joseph, Stephanie Gretsch
726 [GO] 2022―Dec―15 2040. Healthcare-Associated Infection Surveillance During the COVID-19 Pandemic in New Mexico Morgan Edwards-Fligner, Erin C Phipps
727 [GO] 2022―Dec―15 1393. Body Mass Index Change In People Living With HIV During The COVID-19 Pandemic In New York Kai-Ming Chang, Guillermo Ramirez, Praveen Vikraman, Lemar Nadi, Cristina Sison, Michael Oey
728 [GO] 2022―Dec―15 2209. RSV-associated Hospitalizations in Adults Aged ≥18 Years and the Impact of the COVID-19 Pandemic in the United States, October 2018 - February 2022 Fiona P Havers, Michael Whitaker, Huong Pham, Onika Anglin, Jennifer Milucky, Kadam Patel, et al. (+17)
729 [GO] 2022―Dec―15 275. Evaluating the COVID-19 Pandemic in US Veterans: Transitioning from Delta to Omicron Variants Audun J Lier, Zeena Lobo, George Psevdos
730 [GO] 2022―Dec―15 1573. Impact of the COVID-19 Pandemic on Antibiotic Use among Hospitalized Adults in Argentina, Brazil, and Chile Twisha S Patel, Olivia L McGovern, Garrett W Mahon, Icaro Boszczowski, Jose M Munita, Maria I Garzon, et al. (+18)
731 [GO] 2022―Dec―15 1917. Impact of the COVID-19 Pandemic on Antimicrobial Stewardship, Infection Prevention & Control, and Clinical Microbiology Practices in Argentina, Brazil, and Chile Hanako Osuka, Twisha S Patel, Olivia L McGovern, Icaro Boszczowski, Jose M Munita, Maria I Garzon, et al. (+11)
732 [GO] 2022―Dec―15 2019. Understanding the Impact of COVID-19 Pandemic on Central Line-Associated Bloodstream Infections (CLABSIs): Expanding Analysis to the Microbiologic Level Jay Raj Krishnan, Elizabeth Dodds Ashley, Andrea Cromer, Deverick J Anderson, Sonali D Advani, Melissa D Johnson
733 [GO] 2022―Dec―15 2042. Impact of the COVID-19 Pandemic on Healthcare-Associated Infections (HAI) by Race and Ethnicity in a Large Network of Community Hospitals: A Call to Action Erin Gettler, Ibukunoluwa Kalu, Sonali D Advani, Jessica Seidelman, Jay Raj Krishnan, Melissa Campbell, et al. (+3)
734 [GO] 2022―Dec―15 1209. The Impact of the COVID-19 Pandemic on Hospital-Acquired Infections at a Comprehensive Cancer Center Rita Wilson Dib, Amy Spallone, Fareed Khawaja, Adina Feldman, Jalen Bartek, Sherry Cantu, et al. (+8)
735 [GO] 2022―Dec―15 2200. Impact of COVID-19 Pandemic on Influenza-like Illness (ILI) Experience among Healthcare Workers in Military Treatment Facilities Ryan Liberg, Christina Schofield, Stephanie A Richard, Limone Collins, Christina Spooner, Srihari Seshadri, et al. (+13)
736 [GO] 2022―Dec―15 1223. The Impact of the COVID-19 Pandemic on the Prevalence of Multidrug-resistant Organisms in Veterans Affairs Nursing Homes Monirul I Sajib, Florence M Ford, George Psevdos
737 [GO] 2022―Dec―15 267. Delayed Pulmonary Tuberculosis (PTB) Diagnosis During the COVID-19 Pandemic: A Case Series Mikhail Khaitov, Nadim Salomon, David Perlman, Sarah Humphreys
738 [GO] 2022―Dec―15 1214. The Effects of Modified Personal Protective Equipment (PPE) Protocols on Healthcare Personnel Providing Patient Care During the COVID-19 Pandemic: A Qualitative Assessment Emily E Chasco, Jaqueline Pereira da Silva, DeShauna Jones, Kimberly Dukes, Melissa Ward, Loreen Herwaldt
739 [GO] 2022―Dec―15 929. A Nationwide Survey on the Role of Antimicrobial Stewardship Programs during the COVID-19 Pandemic: What is restricted and who decides? Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Rodrigo M Burgos, Scott Borgetti, Lelia H Chaisson, Susan C Bleasdale
740 [GO] 2022―Dec―15 485. A hypermutator strain of Pseudomonas aeruginosa in a COVID-19 patient with ventilator-associated pneumonia Sophia Nozick, Egon A Ozer, Rachel Medernach, Jori Mills, Richard Wunderink, Alan R Hauser
741 [GO] 2022―Dec―15 Reconsideration of anti-nucleocapsid IgG antibody as a marker of SARS-CoV-2 infection post-vaccination for mild COVID-19 patients Santosh Dhakal, Tong Yu, Anna Yin, Nora Pisanic, Zoe O Demko, Annukka A R Antar, et al. (+4)
742 [GO] 2022―Dec―15 1945. Effects of COVID-19 Vaccines on Outcomes Among Hospitalized COVID-19 Patients Serene Hoskins, Marcos I Restrepo, Jose Cadena
743 [GO] 2022―Dec―15 907. Impact of Antimicrobial Stewardship Prospective Audit and Feedback on Antibiotic Utilization in Hospitalized COVID-19 Patients Ashfaq Shafiq, Taylor Hori, Selena Pham
744 [GO] 2022―Dec―15 1123. EDP-235, A Potent and Once-daily Oral Antiviral, Demonstrates Excellent Penetration into Macrophages and Monocytes, with the Potential for Mitigation of Cytokine Storm in High-Risk COVID-19 Patients Yang Li, Tianzhu Indy Zang, Lisha Xu, Daniel Leonard, Khanh Hoang, Tim Greizer, et al. (+7)
745 [GO] 2022―Dec―15 1124. Effect of High-Dose versus Standard-Dose Dexamethasone on Mortality Among Mechanically Ventilated COVID-19 Patients Pramodini Kale-Pradhan, Regina Pacitto, Lauren Krumm, Anna Hejnar, Christopher Giuliano, Leonard B Johnson
746 [GO] 2022―Dec―15 276. Factors Predicting Bacterial Coinfection in Hospitalized COVID-19 Patients Yi Guo, Kelsie Cowman, Hongkai Bao, Victor Chen, Mimi Kim, Xianhong Xie, et al. (+4)
747 [GO] 2022―Dec―15 165. Biofire pneumonia panel use in severe pneumonia and antibiotic treatment in COVID-19 patients Erica J Stohs, Maureen McElligott, Hannah M Creager, Paul D Fey, Trevor C Van Schooneveld
748 [GO] 2022―Dec―15 270. Secondary bacterial infection in hospitalized COVID-19 patients. Experience in Colombia, South America Fernando Rosso, Sarita Rodriguez, Isabel L Zapata-Vasquez, Eric Tafur, Diana M Martinez, Tania Guzmán, et al. (+2)
749 [GO] 2022―Dec―15 1875. Continued demographic shifts in hospitalised COVID-19 patients from migrant workers to a vulnerable and more elderly local population at risk of severe disease Jinghao Nicholas Ngiam, Srishti Chhabra, Wilson Goh, Meng Ying Sim, Tze Sian Liong, Nicholas W S Chew, et al. (+3)
750 [GO] 2022―Dec―15 1090. Factors effecting mortality among Covid-19 patients in Renal Transplant Recipients from a single center in Pakistan Asma Nasim, Sunil Kumar
751 [GO] 2022―Dec―15 291. Retrospective Study on Bacteremia in COVID-19 Patients in the Delta and Omicron Era Sunghee Park, Tark Kim, Eun Ju Choo
752 [GO] 2022―Dec―15 1106. A Retrospective Assessment of the Effects of Baricitinib and Tocilizumab on COVID-19 Patients requiring High Flow Oxygen Kathy Tin, Annamarie Fernandes, Alexander Njoroge, Roderick Go
753 [GO] 2022―Dec―15 1067. Predicting next 7-day Discharges of Hospitalized COVID-19 Patients Using Ensemble Learning Xiangyang Ye, Mingyuan Zhang, Matthew H Samore, Jincheng Shen, Julia Bohman, Yue zhang, Jeffrey Humpherys
754 [GO] 2022―Dec―15 1071. Retrospective study evaluating the cytokine dynamics in COVID-19 patients who were treated with casirivimab/imdevimab Akiho Sugita, Masahiro Ishikane, Noriko Iwamoto, Masaya Sugiyama, Katsuji Teruya, Masayuki Hojo, et al. (+2)
755 [GO] 2022―Dec―15 1045. Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration T-lymphocyte Counts and Interferon-gamma Production Alessandra Imeneo, Grazia Alessio, Andrea Di Lorenzo, Laura Campogiani, Alessandra Lodi, Filippo Barreca, et al. (+10)
756 [GO] 2022―Dec―15 349. Characteristics and Outcomes of COVID-19 Patients with Candidemia at a Community Teaching Hospital in Chicago - One Year Follow Up. Oluwadamilola A Adeyemi, David Okoh, Gregg Gonzaga, Sean Cariño, Steve B Kalish
757 [GO] 2022―Dec―15 LB1533. Impact of Treatment of Hospitalised COVID-19 Patients With Inhaled Interferon Beta-1a (SNG001) on Long COVID Symptoms: Results From the SPRINTER trial Phillip D Monk, Rachael A Evans, Victoria J Tear, Jody L Brookes, Toby Batten, Marcin Mankowski, et al. (+4)
758 [GO] 2022―Dec―15 245. Can Inflammatory Markers be used as an Early predictor for Mechanical ventilation in COVID-19 patients with Stages IIIb-V Chronic Kidney Disease? Harinivaas Shanmugavel Geetha, Maya Gogtay, Sushmita Prabhu, Abinesh Sekar, Yuvaraj Singh, George M Abraham, Suzanne Martin
759 [GO] 2022―Dec―15 1128. Efficacy and Safety of Nelfinavir in Asymptomatic and Mild COVID-19 Patients: A Multicenter, Randomized Controlled Trial Shigeru Kohno, Taiga Miyazaki, Naoki Hosogaya, Shinpei Morimoto, Hiroshi Yamamoto, Shingo Iwami, et al. (+2)
760 [GO] 2022―Dec―15 1157. The Clinical Impact of Casirivimab-Imdevimab Monoclonal Antibody Therapy (CIMAT) in COVID-19 patients: A real-world insight from India. Jose J Kochuparambil, Aleena Issac
761 [GO] 2022―Dec―15 277. Frequency of Pneumomediastinum and Pneumothorax in COVID-19 Patients: a Retrospective Cohort Study in a Community Hospital in Evanston, Illinois Goar Egoryan, Guillermo Rodriguez Nava, Guillermo Rodriguez Nava, Armen Kishmiryan
762 [GO] 2022―Dec―15 LB1529. Randomized, Controlled Phase 3 Study of anti-C5a Vilobelimab's Effect on Mortality in Critically Ill COVID-19 Patients: A Therapy for Viral Pneumonia Bruno Mourvillier, Alexander Vlaar, Martin Witzenrath, Michael Bauer, Leo Heunks, Luis Hercilla Vasquez, et al. (+23)
763 [GO] 2022―Dec―15 1058. Development of a Steroid Stewardship Bundle to tackle the Glucocorticoid-Induced Hyperglycemia in COVID-19 patients: Results of SUPER Diabetes Study. Aleena Issac, Jose J Kochuparambil
764 [GO] 2022―Dec―15 1134. Lenzilumab Treatment in COVID-19 Pneumonia Reduces Circulating Cytokines and Markers of Systemic Inflammation Dale Chappell, Adrian Kilcoyne, Frank Cerasoli, John Lukas, Cameron Durrant, Zelalem Temesgen, et al. (+3)
765 [GO] 2022―Dec―15 1125. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalized adults with severe COVID-19 pneumonia: an open-label randomized trial. Carlos Dueñas Gutierrez, Jesica Abadia-Otero, Ivan Cusacovich, Jose Ignacio Martín-González, Alberto Muela-Molinero, Luis Corral-Gudino, et al. (+16)
766 [GO] 2022―Dec―15 LB1531. Administration of Abatacept or Infliximab Reduces Mortality in Hospitalized Patients with COVID-19 Pneumonia: Results from the ACTIV-1 IM Master Protocol Emily R Ko
767 [GO] 2022―Dec―15 272. Do Empiric Antibiotics Improve Outcomes in Clinically Stable Patients Admitted with COVID-19 Pneumonia? Retrospective Cohort Study of 221 U.S. Hospitals, March 1st, 2020-December 31st, 2020 Alexander Lawandi, Jeffrey R Strich, Xioabai Li, Christina Yek, Sarah Warner, Sameer S Kadri
768 [GO] 2022―Dec―15 1127. Effectiveness of Remdesivir as Treatment for COVID-19 Positive US Veterans Sujee Jeyapalina, Margaret Lundquist, Guo Wei, Gregory Stoddard, Jay Agarwal
769 [GO] 2022―Dec―15 591. Adintrevimab (ADI) Population Pharmacokinetics (PPK) in Phase 1 and Phase 2/3 COVID-19 Prevention and Treatment Study Participants Christopher M Rubino, Anthony P Cammarata, Paul Ambrose, Pete Schmidt, Myra Popejoy, Jean Gong, Xia Pu
770 [GO] 2022―Dec―15 1892. Rise of COVID-19 Re-infections as Omicron Variant Prevailed: Implications on Monitoring the Course of the Pandemic Kassiani Mellou, Kassiani Gkolfinopoulou, Kyriaki Tryfinopoulou, Ioannis Panagoulias, Panagiota Psallida, Gerasimos Gerolymatos, et al. (+4)
771 [GO] 2022―Dec―15 202. Vintage or Vogue? The Utility of Procalcitonin for Identifying Secondary Infections in Patients With Influenza or Covid-19 Receiving Extracorporeal Membrane Oxygenation Kajal D Patel, Michal J Sobieszczyk, Joseph E Marcus, James Aden
772 [GO] 2022―Dec―15 1152. Risk factors for 30-day all-cause mortality in hospitalized patients with COVID-19 receiving immunomodulator therapy: a retrospective cohort study Chas A Hoffmann, Adam R Patrick, David J Hutchinson, Lauren M Finoli, Tiffany L Guliano, Matthew A Moffa, et al. (+2)
773 [GO] 2022―Dec―15 1954. Immunogenicity against SARS CoV-2 ancestral strain and variants of two new COVID-19 recombinant adjuvanted vaccines compared to BNT162b2 as a third dose following two doses of BNT162b2: a single-blinded multicenter randomized controlled trial Odile Launay, Marine Cachanado, Liem Binh Luong, Laetitia Ninove, Marie Lachâtre, Inès Ben Ghezala, et al. (+26)
774 [GO] 2022―Dec―15 1878. Demographic and Clinical Characteristics of COVID-19 Reinfection Robert Hoard, Eric Coate, Elizabeth A Macias, Luke B Jackson, Alice E Barsoumian, Jason Okulicz, Elizabeth Markelz
775 [GO] 2022―Dec―15 1876. COVID-19 Reinfection and Disease Severity in the New York City Health + Hospitals System Jenny R Smolen, Thomas D Filardo, Annie George, Sakil Bhuiyan, Sowmya Kalava, Noor Shahin, et al. (+7)
776 [GO] 2022―Dec―15 2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients Marilyne Daher, Fareed Khawaja, Georgios Angelidakis, Gabriella Rondon, Amy Spallone, Jeremy Ramdial, et al. (+3)
777 [GO] 2022―Dec―15 78. Longitudinal Analysis of T cells in COVID-19 Survivors with Post-Acute Sequelae of COVID-19 Reveals Associations between Individual Symptoms and Inflammatory Indexes Stephanie LaVergne, Stephanie LaVergne, Taru Dutt, Kim McFann, Bridget Baxter, Tracy Webb, et al. (+5)
778 [GO] 2022―Dec―15 317. Use cases for rapid antigen-detecting tests for COVID-19 screening and surveillance: a systematic review Apoorva Anand, Jacob Bigio, Emily MacLean, Talya Underwood, Nitika Pant Pai, Sergio Carmona, et al. (+2)
779 [GO] 2022―Dec―15 1069. Psychometric Properties of the Symptoms of Infection with Coronavirus-19: A Patient-Reported Outcome Measure for COVID-19 Signs and Symptoms Eric K H Chan, Jeffrey Stoddard, Jerald Sadoff, Yan Liu, Ilse van Dromme, Eva G Katz, et al. (+2)
780 [GO] 2022―Dec―15 1061. Evaluation of Measures for the Assessment of Covid-19 Signs and Symptoms in Children and Adolescents Carla Romano, Margaret Mayorga, Javier Ruiz-Guiñazu, Géralyn C Trudel, Sheri Fehnel, Kelly McQuarrie, et al. (+2)
781 [GO] 2022―Dec―15 1888. Implementation of COVID-19 Surveillance Testing Procedures in Dental School Holly Shoemaker, Jeri Bullock, Kristina Stratford, Melodie L Weller, Wendy L Hobson-Rohrer, Wendy L Hobson-Rohrer, et al. (+3)
782 [GO] 2022―Dec―15 1953. Immune responses, viral shedding, and COVID-19 symptom burden from breakthrough SARS-CoV-2 infection in a 2:1 randomized, double-blind, placebo-controlled Phase 3 study of AZD1222 (ChAdOx1 nCoV-19) vaccination Magdalena E Sobieszczyk, Ann R Falsey, Anne F Luetkemeyer, Grant C Paulsen, Sharon A Riddler, Merlin L Robb, et al. (+15)
783 [GO] 2022―Dec―15 1054. Comparison of Post-Acute COVID-19 Symptoms in Infected Individuals Pre- and Post-Vaccination Dylan McDonald, Jennifer Logue, Nicholas M Franko, Megan M Kemp, Denise J McCulloch, Eric J Chow, Helen Y Chu
784 [GO] 2022―Dec―15 1918. Impact of the SARS-CoV-2-Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) on the Severity and Progression of COVID-19 Symptoms in the Phase 3 TACKLE Trial Jesus Abraham Simón Campos, Douglas Arbetter, Hugh Montgomery, F D Richard Hobbs, Francisco Padilla, Kenneth Kim, et al. (+4)
785 [GO] 2022―Dec―15 1156. Sustained Alleviation and Resolution of Targeted COVID-19 Symptoms with Nirmatrelvir/Ritonavir versus Placebo Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, Paula Abreu, Weihang Bao, Wayne Wisemandle, et al. (+6)
786 [GO] 2022―Dec―15 1401. Evaluating Barriers and Potential Solutions to Speaking Up About COVID-19 Symptoms: A Survey Among Nursing Home Workers Gabrielle M Gussin, Raveena D Singh, Thomas T Tjoa, Raheeb Saavedra, Sherrie H Kaplan, Susan S Huang
787 [GO] 2022―Dec―15 1070. Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes Giovanni Guaraldi, Jovana Milic, Sara Barbieri, Tommaso Marchio’, Agnese Caselgrandi, Federico Motta, et al. (+16)
788 [GO] 2022―Dec―15 1407. Increasing access to COVID-19 testing in underserved Black American neighborhoods Elizabeth Avery, Tamara Olinger, Sumihiro Suzuki, Yolanda Cartwright, LaDawne Jenkins, Lelia H Chaisson, et al. (+5)
789 [GO] 2022―Dec―15 1898. The Impact of Polymerase Chain Reaction Versus Antigen Based COVID-19 Testing on Subsequent Infections in Military Trainees Daniel Cybulski, Zachary Matthews, John Kieffer, Theresa Casey, Angela Osuna, Korey Kasper, et al. (+3)
790 [GO] 2022―Dec―15 903. Formulary Edits and Consistent Messaging for Unproven COVID-19 Therapeutics Tyler Stephen, Alyssa Tutino, Justin Bender, Michelle Sageer, Mona Chitre, Ted Louie
791 [GO] 2022―Dec―15 1118. COVID-19 Therapeutics: Real-World Experience in Flint, Michigan (MI) Mariam Younas, Danielle Osterholzer, Carlos Rios-Bedoya, Brandon R Flues, Ghassan Bachuwa, Ghassan Bachuwa
792 [GO] 2022―Dec―15 1109. Rise and Fall of COVID-19 Therapies Throughout Different Waves of the Pandemic: Results of a Nationwide Survey Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Scott Borgetti, Lelia H Chaisson, Rodrigo M Burgos, Susan C Bleasdale
793 [GO] 2022―Dec―15 1046. Assessing School-Based COVID-19 Transmission in Middle and High Schools in an Underserved Population through Qualitative Interviews Grace Yuan, Samantha Hayes, Sara Malone, Sewuese Akuse, Tremayne Watterson, Summer M Reyes, et al. (+8)
794 [GO] 2022―Dec―15 1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab Maria L Agostini, Gretja Schnell, Julia di Iulio, Anita Kohli, Adrienne E Shapiro, Elias H Sarkis, et al. (+7)
795 [GO] 2022―Dec―15 1149. Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1) Charlotte Hedskog, Lauren Rodriguez, John H Beigel, Walla Dempsey, Alexander L Greninger, Pavitra Roychoudhury, et al. (+10)
796 [GO] 2022―Dec―15 1138. Optimal Duration of Systemic Corticosteroids Use in COVID-19 Treatment: A Meta-analysis Nyein Yu, Paddy Ssentongo, David Ingram, Catharine I Paules
797 [GO] 2022―Dec―15 284. Post-Acute Sequelae of COVID-19 Two Years After Acute Infection Jennifer Logue, Nicholas M Franko, Megan M Kemp, Denise J McCulloch, Eric J Chow, Helen Y Chu
798 [GO] 2022―Dec―15 1959. Lower B-Cell Responses Rather Than Circulating Antibody Titres Are Associated With SARS-CoV-2 Infection Post Third Dose COVID-19 Vaccination Joanne Byrne, Lili Gu, Riya Negi, Alejandro Garcia-Leon, Dana Alalwan, Colette Marie Gaillard, et al. (+15)
799 [GO] 2022―Dec―15 1935. Cardiac Tamponade Following COVID-19 Vaccination Christopher B Murphy, Sabirah N Kasule, Holenarasipur R Vikram
800 [GO] 2022―Dec―15 1967. Receipt of Influenza Vaccination as Predictor of COVID-19 Vaccination among United States Veterans Gina Oda, Aditya Sharma, Cynthia A Lucero-Obusan, Patricia Schirmer, Mark Holodniy
801 [GO] 2022―Dec―15 1963. Peripartum Outcomes Associated With COVID-19 Vaccination during Pregnancy: A Systematic Review and Meta-analysis Atsuyuki Watanabe, Jun Yasuhara, Masao Iwagami, Yoshihisa Miyamoto, Yuji Yamada, Yukio Suzuki, et al. (+2)
802 [GO] 2022―Dec―15 1969. SARS-CoV-2 seroprevalence among patients with cancer and healthcare workers from an oncology referral center during the first year of COVID-19 vaccination in Mexico Rodrigo Villaseñor-Echavarri, Daniel De-la-Rosa-Martinez, Emmanuel Frias-Jimenez, Alexandra Martin-Onraet, Erika Ruiz-Garcia, Alonso Cruz-Cruz, et al. (+2)
803 [GO] 2022―Dec―15 1929. A Qualitative Analysis of COVID-19 Vaccination Intent and Recommendations to Increase Uptake Among Residents and Staff in Six Seattle Homeless Shelters Sarah N Cox, Nicholas Thuo, Julia H Rogers, Ashley A Meehan, Amy C Link, Natalie K Lo, et al. (+7)
804 [GO] 2022―Dec―15 433. COVID-19 Vaccination Uptake Among Health Care Workers (HCW) Requesting Medical Exemptions to Vaccination. Jana Shaw, Loren Brown, Stephen J Thomas, Lynn M Cleary, Jarrod Bagatell
805 [GO] 2022―Dec―15 1526. Time from last COVID-19 vaccination’s impact on rapidity of viral culture conversion following SARS-CoV-2 infection: a prospective cohort study Madison Gilbert, Atarere Joseph, Jacquelyn Turcinovic, Scott Seitz, Cole Sher-Jan, Laura F White, et al. (+12)
806 [GO] 2022―Dec―15 1979. Waning of humoral immunity depending on the types of COVID-19 vaccine So Yun Lim, Ji Yeon Kim, Jiwon Jung, Sung-Cheol Yun, Sung-Han Kim
807 [GO] 2022―Dec―15 LB746. Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States Germán Áñez, Lisa M Dunkle, Cynthia L Gay, Karen L Kotloff, Nita Patel, Joyce S Plested, et al. (+4)
808 [GO] 2022―Dec―15 1976. Using a Patient Portal as a Recruitment Tool to Diversify the Pool of Participants in COVID-19 Vaccine Clinical Trials Tiffany Yuh, Tuhina Srivastava, Danielle Fiore, Harald Schmidt, Ian Frank, David Metzger, Florence Momplaisir
809 [GO] 2022―Dec―15 1094. Multisystem Inflammatory Syndrome in Children (MIS-C) in Persons Fully Vaccinated with Two Doses of mRNA COVID-19 Vaccine Compared with Persons with Partial or No Vaccination Reported, U.S. National MIS-C Surveillance Anna R Yousaf, Allison D Miller, Katherine Lindsey, Michael J Wu, Michael Melgar, Laura D Zambrano, Angela P Campbell
810 [GO] 2022―Dec―15 1937. COVID-19 Vaccine Distribution in Massachusetts Jails Nicole Cassarino, Emma Smyth, Alysse Gail Wurcel
811 [GO] 2022―Dec―15 2297. COVID-19 Vaccine Effectiveness Among Pregnant People Ousseny Zerbo, G Thomas Ray, Kristin Goddard, Evan Layefsky, Bruce Fireman, Nicola P Klein
812 [GO] 2022―Dec―15 1956. Impact of an Implementation Science-Based Project to Address COVID-19 Vaccine Hesitancy Scott C Ratzan, Erin Hultgren, Jeffrey D Carter, Melissa Rodriguez, Laura Simone, Leah Molloy
813 [GO] 2022―Dec―15 1938. COVID-19 Vaccine Hesitancy among Adults Who Rely on Social Media for Health Care Information in Cameroon, Africa Kendall Baecher, Alexander Boutwell, Nuwan Gunawardhana, Nuwan Gunawardhana, Denis M Tebit, Jodie Dionne
814 [GO] 2022―Dec―15 1939. COVID-19 vaccine immunogenicity among CD19 receptor T-cell (CAR-T) therapy Muneerah M Aleissa, Jessica S Little, Sonya Davey, Isabel H Gonzalez-Bocco, Andrew Looka, Nicolas C Issa, et al. (+3)
815 [GO] 2022―Dec―15 224. Effect of a Mobile App Chatbot and an Interactive Small Group Webinar on COVID-19 Vaccine Intention and Confidence in Japan: A Randomized Clinical Trial Yuji Yamada, Hana Tomoi, Yuka Nishina, Ko Harada, Kyuto Tanaka, Shugo Sasaki, et al. (+10)
816 [GO] 2022―Dec―15 99. COVID-19 Vaccine related Attitudes and Beliefs among Black and/or Hispanic respondents in Brooklyn, NY: Lessons Learned Lalitha Parameswaran, Mark Mulligan, Yangjin Park
817 [GO] 2022―Dec―15 1950. Factors Influencing COVID-19 Vaccine Uptake among Reproductive-Aged Women in Jamaica Jodian A Pinkney, Kamali Carroll, Lenroy Bryan, Givana Witter, Dina Ashour, Fatma Shebl, et al. (+3)
818 [GO] 2022―Dec―15 1962. Perceptions of the COVID-19 Vaccine within the Sudanese-American Community Jonathan R Freese, Harlan R Sayles, Fatima Ahmed, Mujtaba Abdellatif, Nada Fadul
819 [GO] 2022―Dec―15 1947. Evaluating the Relationship Between Obesity and the Humoral Immune Response to COVID-19 Vaccines LaKesha Tables, Fatima Ali, Eric Gaines, Yul Eum Sim, Erica L Johnson, Lilly Immergluck
820 [GO] 2022―Dec―15 1944. Effectiveness of COVID-19 Vaccines Against Severe Disease and Death and its Durability Over Time Against the Omicron Variant Theodore Lytras, Kassiani Mellou, Kassiani Gkolfinopoulou, Gerasimos Gerolymatos, Dimitrios Paraskevis, Theoklis Zaoutis, Sotirios Tsiodras
821 [GO] 2022―Dec―15 1933. Assessment of Effectiveness of mRNA COVID-19 Vaccines Among Health Care Personnel: Monroe County, NY December 2020-March 2022 Savanah Russ, Christopher J Myers, Infectious Diseases, Erin Licherdell, Thomas Peer, Christine Hurley, et al. (+5)
822 [GO] 2022―Dec―15 1941. Describing the immune response kinetics to mRNA COVID-19 vaccines among previously SARS-CoV-2-infected and -uninfected nursing home residents, a prospective longitudinal observational cohort evaluation-Georgia, October 2020 - September 2021 Zeshan A Chisty, Melia Haile, Juliana DaSilva, M A Biology, Hollis Houston, Shoshona Le, et al. (+17)
823 [GO] 2022―Dec―15 1940. COVID-19 Vaccines and Related Adverse Effects among Health Sciences and Non-Health Sciences Students from Two Large Public Universities in Thailand Kanathip Jongmekwamsuk, Sirashat Hanvivattanakul, Jakapat Vanichanan, Thana Khawcharoenporn
824 [GO] 2022―Dec―15 584. Prospective Observational Cohort Study of Serological Responses to COVID-19 Vaccines in Pediatric Kidney Transplant Recipients at a Single Institution Kathryn P Goggin, Elizabeth Sun, Emily J Yun, Margret Kamel, Maria Perez, Hui-Mien Hsiao, et al. (+5)
825 [GO] 2022―Dec―15 84. One-month Humoral Response Following Two Doses of Covid-19 Vaccines in Specific populations - ANRS0001S COV POPART Cohort Study Paul LOUBET, L I nda Wittkop, Mathieu Chalouni, David-Axel Laplaud, Martine Laville, Bruno Laviolle, et al. (+10)
826 [GO] 2022―Dec―15 786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, Paula Abreu, Weihang Bao, Wayne Wisemandle, et al. (+4)
827 [GO] 2022―Dec―15 1877. COVID-19-Associated Hospitalizations among Long-Term Care Facility Residents Ages ≥65 Years - COVID-NET, 14 U.S. States, March 2020-January 2022 Christopher Taylor, Michael Whitaker, Onika Anglin, Huong Pham, Kadam Patel, Jennifer Milucky, et al. (+15)
828 [GO] 2022―Dec―15 783. Lung Transplantation for COVID-19-Associated Lung Injury (CALI): An International Registry Maha M Alamri, Rebecca Osborn, Reda Girgis, Nicholas Marschalk, Ryan Rivosecchi, Michael G Ison, et al. (+2)
829 [GO] 2022―Dec―15 478. Lung Hybrid Neutrophils and Subsequent Extracellular Traps Are Protective In COVID-19-Associated Pulmonary Aspergillosis Simon Feys, Sam Vanmassenhove, Sirima Kraisin, Seppe Cambier, Cato Jacobs, Bram Boeckx, et al. (+10)
830 [GO] 2022―Dec―15 247. Catching CAPA: The Healthcare Impact of COVID-19-Associated Pulmonary Aspergillosis in an Academic Medical Center Caroline Hamilton, Sarah Tran, Judy Dinh, Gina Askar, Gina Askar, Gina Askar, Gina Askar
831 [GO] 2022―Dec―15 1068. Prior SARS-CoV-2 infection and risk of subsequent COVID-19-related hospitalization: a test negative design Khalel De Castro, Ashley Tippett, Laila Hussaini, Luis W Salazar, Olivia D Reese, Meg Taylor, et al. (+11)
832 [GO] 2022―Dec―15 1908. Social Risk Factors for COVID-19-Related Hospitalizations in Adults Olivia D Reese, Ashley Tippett, Laila Hussaini, Luis W Salazar, Meg Taylor, Caroline R Ciric, et al. (+11)
833 [GO] 2022―Dec―15 348. Cell-free plasma next-generation sequencing assists in the evaluation of invasive mold infection in patients with COVID-19: a case series Joshua David, Bharadhwaj Kolipakkam, Megan M Morales, Nicole C Vissichelli
834 [GO] 2022―Dec―15 1893. Risk Categorization and Outcomes among Healthcare Workers Exposed to COVID-19: A Cohort Study from A Thai Tertiary-care Center Thana Khawcharoenporn, Watcharee Chancharoenrat, Sirinporn Sajak, Suphannee Phetsaen, Padcharadda Hanchai, Kanokporn Thongphubeth, Thanus Pienthong
835 [GO] 2022―Dec―15 1975. Trends in the parents’ intention to vaccinate their children against COVID-19: A comparative study in Peru Jose A Gonzales-Zamora, David Soriano-Moreno, Linda Ponce-Rosas, Mariano G Alarcón Parra, Noelia Morocho-Alburqueque, Valentina Murrieta-Ruiz, et al. (+6)
836 [GO] 2022―Dec―15 1404. Factors Associated to Decrease in Quality of Life After Mild-Moderate COVID-19: A Cross-Sectional Study. Alberto Ordinola Navarro, Hector Rivera Villegas, Bruno Ali Lopez Luis
837 [GO] 2022―Dec―15 LB1528A. Fluvoxamine for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial Matthew W McCarthy
838 [GO] 2022―Dec―15 LB1528B. Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial David R Boulware
839 [GO] 2022―Dec―15 1115. Effect of polymerized type I collagen in hyperinflammation of adult outpatients with symptomatic COVID-19: a double blind, randomised, placebo-controlled clinical trial Silvia Méndez-Flores, Angel Priego-Ranero, Daniel Azamar-Llamas, Héctor Olvera-Prado, Kenia Ilián Rivas-Redondo, Eric Ochoa-Hein, et al. (+13)
840 [GO] 2022―Dec―15 252. Clinical Outcomes and Risk Factor of Severe Disease in Young Adult Patients Compared with Middle-Aged Patients Who Infected with COVID-19: A Large Cohort Study in Tertiary Hospital Preudtipong Noopetch, Rutporn Benchamanon, Samerjan Kongsuwan, Chatree Chai-adisaksopha
841 [GO] 2022―Dec―15 292. Risk factor and clinical characteristics of pneumothorax and pneumomediastinum in COVID-19: a matched case-control study Se Ju Lee, Jinnam Kim, Ki Hyun Lee, Jung Ah Lee, Chang Hyup Kim, Su Hwan Lee, et al. (+6)
842 [GO] 2022―Dec―15 1153. Safety and Potential Efficacy of Exosomes Overexpressing CD24 (EXO-CD24) for the Prevention of Clinical Deterioration in Patients with Moderate or Severe COVID-19: A Phase II, Randomized, Single-blinded Study. Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Nadir Arber, Garyfallia Poulakou, et al. (+18)
843 [GO] 2022―Dec―15 244. Bacterial co-infection in COVID-19: an analysis of a National Cohort of Hospitalized U.S. Veterans Karim Khader, Haojia Li, Barbara E Jones, Michael Rubin, Candace Haroldsen, Tina M Willson, et al. (+3)
844 [GO] 2022―Dec―15 787. Predictors of Co-infection with Multidrug Resistant Organisms among Hospitalized Patients with COVID-19: An Exploratory Analysis Yue Zhang, Haojia Li, Barbara E Jones, Michael Rubin, Candace Haroldsen, Tina M Willson, et al. (+3)
845 [GO] 2022―Dec―15 2045. IVAC Plus in the Time of COVID-19: An Imperfect Metric? Camille Spears, Delvina Ford, Jose Martinez, Kelly R Reveles, Erica Beck, Lauren N Garza, et al. (+3)
846 [GO] 2022―Dec―15 1887. Hyperglycemia and COVID-19: An independent risk factor for disease severity and death in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Lisa Maria Castillo Mercado, Carlos Perdomo, Mariela Acosta
847 [GO] 2022―Dec―15 1781. Antibiotic Prescription Trends of Patients with COVID-19: Analysis of National Health Insurance Data in Republic of Korea Yunsang Choi, Minsun Kang, Dong Hoon Shin, Jongtak Jung, Seong Jin Choi, Nak-Hyun Kim, et al. (+5)
848 [GO] 2022―Dec―15 1294. Covid-19: Impacts on Medical Students’ Mental Health in Medical Education Center of Chaophya Abhaibhubejhr Hospital Subencha Pinsai, Chalalai Klaipim
849 [GO] 2022―Dec―15 226. Higher Doses of Adintrevimab, an Extended Half-Life Monoclonal Antibody, for the Treatment and Prevention of COVID-19: Preliminary Results from a Phase 1 Single Ascending-Dose Study Xia Pu, Jean Gong, Ed Campanaro, Kristin Narayan, Deepali Gupta, Frank Engler, et al. (+2)
850 [GO] 2022―Dec―15 1141. Phase 3 Trial (in progress) of the SYK Inhibitor Fostamatinib in Patients Hospitalized with COVID-19: Protocol and Study Implementation Updates Lucy Yan, Ziad Mallat, Suzana Margareth Lobo, Anuj Malik, Wolfgang Dummer
851 [GO] 2022―Dec―15 1349. Lesson Learned from Investigators of Clinical Trials to Identify Therapeutics for COVID-19: Qualitative Study Kazuaki Jindai, Hiroki Saito, Satoko Horii, Kazuhiro Kamata
852 [GO] 2022―Dec―15 308. Do lung ultrasound abnormalities change during hospitalization for COVID-19? Jimin Hwang, Paul W Blair, Trishul Siddarthan, Gigi Liu, Erjia Cui, Jiawei Bai, et al. (+18)
853 [GO] 2022―Dec―15 298. Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in an Immunocompromised Patient Victoria Overbeck, Jacquelyn Turcinovic, Xueting Qiu, Scott Seitz, John Connor, Beau Schaeffer, et al. (+3)
854 [GO] 2022―Dec―15 2318. A Composite Peptide Vaccine Comprised of Conserved SARS-CoV-2 and Influenza Epitopes Generated Antisera Reponses to Both Coronavirus and Influenza Nimisha Rikhi, Kevin Muema, Kellie Kroscher, Richard F Schuman, Aba Assiaw-Dufu, Clara J Sei, Gerald W Fischer
855 [GO] 2022―Dec―15 302. Using Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Antibody Serology in addition to the ISARIC 4C Risk Score to Better Discriminate Adverse Clinical Outcomes in Hospitalized Patients with Coronavirus Disease 2019. Wilson Goh, Jinghao Nicholas Ngiam, Srishti Chhabra, Meng Ying Sim, Paul Anantharajah Tambyah, Gail Brenda Cross, et al. (+2)
856 [GO] 2022―Dec―15 1080. Clinical Characteristics and Outcomes of 104 Pregnant Women with Coronavirus Disease 2019 during delta wave; single-center observational study Shin Hee Hong, Hye Jin Shi, Yoonseon Park, Joong Sik Eom
857 [GO] 2022―Dec―15 1038. Assessment of risk factors for coronavirus disease 2019 in healthcare workers: a nested case-control study, Bishkek, Kyrgyzstan, June 2020-May 2021 Venera Alymkulova, Dilyara Nabirova, Nasyat Kemelbek kyzy, Dinara Otorbaeva, Chynar Zhumalieva, Nazgul Abamuslimova
858 [GO] 2022―Dec―15 2041. Impact of Coronavirus Disease 2019 pandemic on healthcare-associated infections at intensive care unit in South Korea: Data from Korean National Healthcare-associated Infections Surveillance System (KONIS) Yu-Mi Lee, Dong Youn Kim, Eun Jin Kim, Ki-Ho Park, Mi Suk Lee
859 [GO] 2022―Dec―15 309. Genetic Diversity and Conservation of Envelope Gene of SARS-CoV-2 and its Variants B.1.1.7, B.1.351, P.1, B.1.617.2 and B.1.1.529 with comparison with other human coronaviruses Benjamin Liu
860 [GO] 2022―Dec―15 1943. Effect of Vaccination on Household Transmission of SARS-CoV-2 Julianne E Burns, Jonathan Altamirano, Jorge Salinas, Clea Sarnquist, Rasika Behl, Rosita Thiessen, et al. (+6)
861 [GO] 2022―Dec―15 1174. Liposomal Co-Formulation of MPL and QS-21 Favors the Development of T-helper 1 Cells and Promotes the Induction of CD8+ T Cells Against SARS-CoV-2 Simon D van Haren, Sanya Thomas, Ofer Levy, Guzman Sanchez-Schmitz, Simon Doss-Gollin, Yamile Lugo Rodriguez
862 [GO] 2022―Dec―15 1101. Spectrum of Disease in Children Infected with SARS-CoV-2 Sarah Gillen, Taylor Wells, Bazak Sharon
863 [GO] 2022―Dec―15 1048. Biological Determinants of Post-Acute Sequelae of SARS-CoV-2 Scott Lu, Khamal Anglin, Michel Tassetto, Miguel Garcia-Knight, Jesus Pineda-Ramirez, Ruth Diaz Sanchez, et al. (+19)
864 [GO] 2022―Dec―15 375. Performance Evaluation of RT-qPCR and RT-dPCR Platforms for the wastewater surveillance of SARS-CoV-2 Hosoon Choi, John David Coppin, Piyali Chatterjee, Jing Xu, Lynn Mayo, Emma Brackens, et al. (+4)
865 [GO] 2022―Dec―15 254. Clinical significance of antineutrophil cytoplasmic antibody positivity in patients infected with SARS-CoV-2 Lucy Eunju Lee, Wooyong Jeong, Yong-Beom Park, Su Jin Jeong, Sang-Won Lee
866 [GO] 2022―Dec―15 2301. Neurodevelopment in Infants with Antenatal or Early Neonatal Exposure to SARS-CoV-2 Sarah B Mulkey, Meagan E Williams, Nadia Jadeed, Anqing Zhang, Smitha Israel, Roberta L DeBiasi
867 [GO] 2022―Dec―15 1133. Investigation of Treatment-Emergent Amino Acid Substitutions in Nonstructural Protein 5 from Ph2a Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor Takao Sanaki, Keiko Baba, Atsuko Yamamoto, Haruaki Nobori, Shota Uehara, Yoko Kajiwara, et al. (+8)
868 [GO] 2022―Dec―15 1874. Comprehensive, longitudinal wastewater surveillance for SARS-CoV-2 across a university campus, demonstrates low levels of SARS-CoV-2 activity relative to the surrounding community Jangwoo Lee, Nicole Acosta, Jennifer Van Doorn, Kashtin Low, Paul Westlund, Maria Bautista Chavarriaga, et al. (+19)
869 [GO] 2022―Dec―15 1890. Molecular Biology of SARS-CoV-2 and its Evolution within the Princeton University Campus Community Jesse T Brewer, Qiqi Yang, Irina Aranovich, Wei Wang, Daniel Notterman, Irini Daskalaki
870 [GO] 2022―Dec―15 1060. Duration of Seroprevalence among Individuals Previously Infected with SARS-CoV-2 and their Household Contacts Jonathan Altamirano, Marcela Lopez, Marcela Lopez, Leanne X Chun, Grace K Tam, India Robinson, et al. (+10)
871 [GO] 2022―Dec―15 1958. Longitudinal SARS-COV-2 anti-spike antibody response in pregnant people with natural infection and variable vaccine uptake Sylvia M LaCourse, Morgan C Aurelio, Jaclyn N Escudero, Sascha R Ellington, Lauren B Zapata, Margaret C Snead, et al. (+6)
872 [GO] 2022―Dec―15 1072. SARS-CoV-2 Antibody Levels Associate with Neutrophil Activation Seth Warner, Rui Miao, Marcos J Ramos-Benitez, Xin Tian, Robert Reger, Peter D Burbelo, et al. (+10)
873 [GO] 2022―Dec―15 295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series. Ricardo Trigueros, Travis Denmeade, Danielle Pannebaker, Ryan C Maves
874 [GO] 2022―Dec―15 314. Performance of Saliva Compared to Nasopharyngeal Swab in Detection of SARS-CoV-2 at a Field Site in Rural Guatemala Using the Roche Cobas® Liat® Point-of-Care Assay Kareen Arias, Eliceo Díaz, Claudia Paiz, Neudy Rojop, Molly Lamb, Edgar Barrios, et al. (+6)
875 [GO] 2022―Dec―15 260. Corticosteroid treatment in influenza virus and SARS-CoV-2 co-infected patients Maaike C Swets, Clark Russell, Ewen Harrison, Annemarie Docherty, Nazir Lone, Michelle Girvan, et al. (+6)
876 [GO] 2022―Dec―15 2125. Determinants of Placental Transfer of HSV-specific Antibodies and the Impact of SARS-CoV-2 Coinfection Aakash Mahant Mahant, Fatima Estrada, Jennifer Aguilan, Simone Sidoli, Betsy Herold, Betsy Herold
877 [GO] 2022―Dec―15 1537. Influenza-Associated Hospitalization Rates and Proportion of Hospitalizations with Influenza and SARS-CoV-2 Coinfection, FluSurv-NET, October 1, 2021-April 23, 2022 Shikha Garg, Charisse N Cummings, Dawud Ujamaa, Pam Daily Kirley, Nisha B Alden, Maria Correa, et al. (+13)
878 [GO] 2022―Dec―15 253. Clinical Presentations of Hospitalized Adult Patients Infected with SARS-CoV-2 during the Omicron Variant Surge in South Florida Jianli Niu, Myeongji Kim, Ayesha T Jalal, Jessica E Goldberg, Elsa M Acevedo Martinez, Nathalie P Suarez Moscoso, et al. (+6)
879 [GO] 2022―Dec―15 1064. Intra-Host SARS-CoV-2 Evolution Dynamics Kim El Haddad, Frank Esper, Thamali Madhushani Adhikari Mudiyanselage, Jing Li, Tu Zheng, Yu-Wei Cheng, et al. (+7)
880 [GO] 2022―Dec―15 1143. Prophylactic and Therapeutic Activity of AZD7442 (Tixagevimab/Cilgavimab) in SARS-CoV-2 Hamster Challenge Models Yueh-Ming Loo, Andrew S Herbert, Ana I Kuehne, Patrick M McTamney, Richard Roque, Alicia M Moreau, et al. (+9)
881 [GO] 2022―Dec―15 296. SARS-CoV-2 Illness Severity and Early Hospitalization Outcomes in a Multicenter Prospective Cohort Study Among Veterans Jennifer M Ross, Jonathan D Sugimoto, Andrew Timmons, Kathryn Moore, Jonathan Adams, Deanna Wilson, et al. (+15)
882 [GO] 2022―Dec―15 86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020 Sandra N Bulens, Julian E Grass, Nadezhda Duffy, Jigsa Tola, Jesse T Jacob, Gillian Smith, et al. (+17)
883 [GO] 2022―Dec―15 1931. Antibodies to SARS-CoV-2 in a Medical School Department of Pediatrics Gabriela P Del Bianco, Roukaya Al Hammoud, Mary E Aitken, Anoma Somasunderam, Stacy Gomez Hernandez, Gilhen Rodriguez, et al. (+3)
884 [GO] 2022―Dec―15 2299. Longitudinal Serological Surveillance of SARS-CoV-2 in Children and Adolescents Using Serial At-Home Testing Amina Ahmed, Michael E DeWitt, Diane Uschner, William H Lagarde, DeAnna J Friedman-Klabanoff, Roberto P Santos, et al. (+3)
885 [GO] 2022―Dec―15 280. Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination Rosario Alessandro Cavasio, Neva Braccialarghe, Drieda Zaçe, Ilaria Spalliera, Luigi Coppola, Laura Campogiani, et al. (+6)
886 [GO] 2022―Dec―15 1880. Detection of Infectious SARS-CoV-2 in Specimens with High CT Values Is More Common for Omicron than for Delta Variants Michel Tassetto, Miguel Garcia-Knight, Khamal Anglin, Dan Kelly, Scott Lu, Jesus Pineda-Ramirez, et al. (+10)
887 [GO] 2022―Dec―15 1906. Impact of Mask Mandate Timing on Community Transmission of SARS-CoV-2 in the St. Louis Metropolitan Area Karthik W Rohatgi, Branson Fox, Khai Hoan Tram, Elvin Geng, Aaloke Mody
888 [GO] 2022―Dec―15 1873. Comparative performance of RTqPCR vs RTddPCR for the detection of SARS-CoV-2 in wastewater (WW) collected from a range of sites and scales across the sewer network of Calgary, Alberta Barbara Jean M. Waddell, Lisa Oberding, Nicole Acosta, Maria Bautista Chavarriaga, Janine McCalder, Noah Toppings, et al. (+16)
889 [GO] 2022―Dec―15 1081. Clinical Characteristics and Predictive Factors for the Development of Hypoxemia in SARS-CoV-2 Infected Women during Pregnancy Young Keun Kim, Eui Hyeok Kim, Hee Kyoung Choi
890 [GO] 2022―Dec―15 2133. Protective Factors Against Infant SARS-CoV-2 Infection Anne-Marie Rick, John Williams, Judith M Martin
891 [GO] 2022―Dec―15 1811. Use of Procalcitonin and Antimicrobial Stewardship Intervention to Limit Antibiotic Utilization in Patients Admitted to a Community Hospital with SARS-CoV-2 Infection Paula A Politis, Michael J Oravec, Lisa Hoisington, Michael J Tan, Shanu Agarwal, Thomas M File
892 [GO] 2022―Dec―15 1120. Descriptive Analysis of Monoclonal Antibody Administration for Pregnant Patients with SARS-CoV-2 Infection Praveen Kumar Vikraman, Kai Ming Chang, Thien-Ly Doan, Henry Donaghy
893 [GO] 2022―Dec―15 1129. Efficacy of a Polyclonal Ovine Fab (PR020) Against SARS-CoV-2 Infection Zainab Bascal, Aled Griffiths, Ellen Dentten, Christon Hill, Suzanne Ward
894 [GO] 2022―Dec―15 307. Diagnostic Test Kinetics, Infectivity, and Immunological Responses Among Unvaccinated Adults During Acute SARS-CoV-2 Infection Paul K Drain, Ronit Dalmat, Meagan Bemer, Elvira Budiawan, Jennifer F Morton, Linhui Hao, et al. (+16)
895 [GO] 2022―Dec―15 237. A Case-Control Study Investigating Household, Community, and Clinical Risk Factors Associated with Multisystem Inflammatory Syndrome in Children (MIS-C) after SARS-CoV-2 Infection Laura D Zambrano, Michael J Wu, Lora M Martin, Lacy Malloch, Margaret M Newhams, Mary Beth Son, et al. (+21)
896 [GO] 2022―Dec―15 1872. Clusters of SARS-CoV-2 infection across six schools for children with intellectual and developmental disabilities Michael P Gemmell, Tyler Walsh, Adwoa Imbeah, Kelly Bono, Megan Baldenweck, Michael R Sherby, et al. (+2)
897 [GO] 2022―Dec―15 310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody Test Performance During Acute SARS-CoV-2 Infection and Recovery Ronit Dalmat, Roshni Prabhu, Marie Bauer, Matthew H Ikuma, Daphne Hamilton, Elena A Rechkina, et al. (+3)
898 [GO] 2022―Dec―15 1082. Clinical Characteristics and Vertical Transmission of Pregnant Women with SARS-CoV-2 Infection and Their Neonates Jiyoung Lee, Mi-Young Lee, Euiseok Jung, Ji-Na Lee, SeongMan Bae, Jiwon Jung, et al. (+6)
899 [GO] 2022―Dec―15 1769. Characterizing Antibiotic Prescribing for Nursing Home Residents with SARS-CoV-2 Infection, April 2020-November 2021 Katryna A Gouin, Ronald M Clouse, Cameron C Mandley, Olakunle Lawal, Sarah H Yi, Qunna Li, et al. (+3)
900 [GO] 2022―Dec―15 1102. The Host Response to SARS-CoV-2 Infection Differs by Age Emily Parsons, Stephanie A Richard, Eric D Laing, Anthony C Fries, Jeffrey Livezey, Milissa Jones, et al. (+23)
901 [GO] 2022―Dec―15 LB1534. Cord blood and maternal cytokine levels following SARS-CoV-2 infection during pregnancy Ashwin Sunderraj, Sebastian Otero, Emily Miller, Elisheva D Shanes, Jeffery A Goldstein, Leena B Mithal
902 [GO] 2022―Dec―15 1866. Burden of Death Associated with SARS-CoV-2 Infection during the Pandemic in Flint, Michigan (MI): Mortality Trends over the 2-year time period Mariam Younas, Carlos Rios-Bedoya, Danielle Osterholzer, Ghassan Bachuwa, Ghassan Bachuwa, Philip McDonald, Elfateh Seedahmed
903 [GO] 2022―Dec―15 76. Clinical Features and Burden of Post-Acute Sequelae of SARS-CoV-2 Infection in Children and Adolescents Suchitra Rao, Grace Lee, Vitaly Lorman, Hanieh Razzaghi, Asuncion Mejias, Nathan Pajor, et al. (+7)
904 [GO] 2022―Dec―15 1095. Retrospective Review of SARS-CoV-2 Infection in Immunocompromised Children at a Single Pediatric Institution Aslam Khan, Roshni Mathew, Ayelet Rosenthal
905 [GO] 2022―Dec―15 1925. Prevalence of SARS-CoV-2 Infection in Immunocompromised Patients Following Receipt of Tixagevimab/Cilgavimab Sarah Lim, Keeley Morris, Lydia J Fess, Kathy Como-Sabetti, Ruth Lynfield
906 [GO] 2022―Dec―15 2137. Effectiveness of Four Vaccines in Preventing SARS-CoV-2 Infection in Kazakhstan Dilyara Nabirova, Roberta Horth, Gaukhar Nukenova, Manar Smagul, Aizhan Yesmagambetova, Daniel Singer, et al. (+2)
907 [GO] 2022―Dec―15 278. Long-term impact of pulmonary function among patients recovered from SARS-CoV-2 infection in Lima, Peru: a preliminary analysis of the FUNCTION cohort study Rodrigo Antonio A Cachay Figueroa, Takashi Watanabe, Katiuska Cuno, Carolina Coombes, Fernando Mejia, Felix Medina, et al. (+4)
908 [GO] 2022―Dec―15 2300. Neonates born to mothers with SARS-CoV-2 infection in pregnancy: a follow-up and serological study Concetta Marsico, Liliana Gabrielli, Santo Arcuri, Caterina Vocale, Caterina Borgatti, Tiziana Lazzarotto, et al. (+2)
909 [GO] 2022―Dec―15 1946. Efficacy of Approved versus Unapproved Vaccines for SARS-CoV-2 Infection in Randomised Blinded Clinical Trials Andrea Perez Navarro, Victoria Pilkington, Andrew Hill, Toby Pepperrell
910 [GO] 2022―Dec―15 1524. SARS-CoV-2 Infection Incidence Following Exposure Assessments for Healthcare Workers Alon Vaisman, Rob Cairns, Danielle De Graeve, Tamara Dus, Susy S Hota, John Granton
911 [GO] 2022―Dec―15 80. SARS-CoV-2 infection is associated with decreased reported physical fitness in a US military longitudinal cohort Stephanie A Richard, Ann Scher, Jennifer Rusiecki, Celia Byrne, Catherine M Berjohn, Anthony C Fries, et al. (+24)
912 [GO] 2022―Dec―15 312. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination. Grace Kenny, Sophie R O’Reilly, Riya Negi, Alejandro Garcia-Leon, Dana Alalwan, Colette Marie Gaillard, et al. (+12)
913 [GO] 2022―Dec―15 1047. Asymptomatic SARS-CoV-2 Infections, BNT162b2 mRNA COVID 19 Vaccine-Related Symptoms, and Correlates of Immunity in Post-Vaccination Breakthrough Infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study Emilie Goguet, Carol D Weiss, Cara Olsen, John H Powers, Si’Ana A Coggins, David Tribble, et al. (+26)
914 [GO] 2022―Dec―15 1084. Comparison of Pediatric SARS-CoV-2 Infections During Spring 2020 and Spring 2021 Lynda Ngo, Jessica E Ericson, Patrick Gavigan, Amanda Williams, Michelle Kwon, Leah Musser
915 [GO] 2022―Dec―15 1882. Effects of BA.1/BA.2 Subvariant, Vaccination, and Prior Infection on Infectiousness of SARS-CoV-2 Omicron Infections Suelen Qassim, Laith J Abu-Raddad, Hiam Chemaitelly, Sawsan AlMukdad
916 [GO] 2022―Dec―15 1052. Characteristics and Outcomes in Hospitalized Adult Patients Infected with the SARS-CoV-2 Omicron Variant at a Large Healthcare System in South Florida, January 1-14, 2022 Paula A Eckardt, Myeongji Kim, Ayesha T Jalal, Jessica E Goldberg, Elsa M Acevedo Martinez, Nathalie P Suarez Moscoso, et al. (+6)
917 [GO] 2022―Dec―15 273. Emergence of the SARS-CoV-2 Omicron Variant in the Pragmatic Assessment of Influenza Vaccine Effectiveness in the Department of Defense (PAIVED) Study Stephanie A Richard, Catherine M Berjohn, Limone Collins, Srihari Seshadri, Christina Spooner, Wesley R Campbell, et al. (+14)
918 [GO] 2022―Dec―15 2195. Etiologies of medically attended acute respiratory infections among young Ecuadorian children prior to the start of the 2020 SARS-CoV-2 pandemic Manika Suryadevara, Freddy A Pizarro Fajardo, Cinthya Cueva Aponte, Jorge Carrillo Aponte, Cynthia Bonville, Irene Torres, Joseph B Domachowske
919 [GO] 2022―Dec―15 1916. Evaluation of nasal swab collection methods on a university campus during the SARS-CoV-2 pandemic Jessica A O’Hanlon, Zack Acker, Julia C Bennett, Peter D Han, Devon McDonald, Tessa Wright, et al. (+12)
920 [GO] 2022―Dec―15 1331. Pneumococcal Colonization Among Children 5 years of Age and Younger During SARS-CoV-2 Pandemic Liset Olarte, Dithi Banerjee, Douglas S Swanson, Brian R Lee, Christopher J Harrison, Rangaraj Selvarangan
921 [GO] 2022―Dec―15 1103. Virologic and Immunologic Outcomes in People Living with HIV in a Correctional Setting During the SARS-CoV-2 Pandemic Dimple Patel, Sarah M Michienzi, Scott Borgetti, Mahesh C Patel, Anne Zheng, Michael Zhu, Melissa E Badowski
922 [GO] 2022―Dec―15 1904. Health Behavioral Trends and Absenteeism Associated with Acute Respiratory Illness Before and During the SARS-CoV-2 Pandemic in a Community Household Cohort, King County, Washington Erin Chung, Jessica Heimonen, Jessica A O’Hanlon, Yongzhe Wang Wang, Eric J Chow, Constance E Ogokeh, et al. (+7)
923 [GO] 2022―Dec―15 89. On-going impact of the SARS-CoV-2 pandemic on the evolution of carbapenemase-producing Enterobacterales in Ontario, Canada Mohammad Mozafarihashjin, Alainna J Jamal, Christopher Kandel, Philipp Kohler, Laura Mataseje, Michael Mulvey, et al. (+18)
924 [GO] 2022―Dec―15 1897. The Decline of Respiratory Viruses During the SARS-CoV-2 Pandemic: Public Health Interventions vs. Viral Competition? Waleed Malik, Ritche Hao, James Shepherd
925 [GO] 2022―Dec―15 1364. Providing preventative care during the SARS-CoV-2 pandemic: Street medicine interventions amongst those experiencing unsheltered homelessness in the City of Detroit Seema Joshi, Yasmeen Mann, Anneliese Petersen, Eliana Small, Iven T Ayyar, Justin R Abadejos, et al. (+7)
926 [GO] 2022―Dec―15 1099. SARS-CoV-2 Positive Pregnant Women Delivering in a Hospital From March 2020 - February 2021 in Three California Counties Brenna Hall, Jane E Lee, Pam Daily Kirley, Jeremy L Roland, Kareena Hundal
927 [GO] 2022―Dec―15 153. Molnupiravir Exhibits a High Barrier to the Development of SARS-CoV-2 Resistance in vitro Julie Strizki, Nicholas Murgolo, John Gaspar, John Howe, Beth Hutchins, Hiroshi Mohri, et al. (+3)
928 [GO] 2022―Dec―15 1902. Whole Genome Sequence analysis of early community transmission SARS-CoV-2 samples in the Philippines Geraldine Arevalo, Nina Theresa Dungca, Edsel Maurice Salvana, Brian Schwem
929 [GO] 2022―Dec―15 1899. The magnitude and durability of the antibody response to mRNA-based vaccination among SARS-CoV-2 seronegative and seropositive healthcare personnel Emily Ciccone, Deanna Zhu, Samuel Hawke, Rawan Ajeen, Annika Gunderson, Evans Lodge, et al. (+9)
930 [GO] 2022―Dec―15 1891. Repeated Assessment of SARS-CoV-2 Seroprevalence among Health Care Workers Early in the Pandemic: Relationship to Workplace Exposures Sherry Demian, Dominic O Awuah, Danielle Osterholzer, Lina Altameemi, Carlos Rios-Bedoya, Ahmad Taftaf, Hoang C Nguyen
931 [GO] 2022―Dec―15 1100. SARS-CoV-2 Seroprevalence in Kenyan Youth living with HIV Mary Boyle, Winstone Nyandiko, Allison DeLong, Ashley Chory, Josephine Aluoch, Celestine Ashimosi, et al. (+13)
932 [GO] 2022―Dec―15 1960. Mucosal rAd5 Immunization against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in African Green Monkeys Becca A Flitter, Sarah N Tedjakusuma, Colin A Lester, Elena D Neuhaus, Susan Johnson, Emery G Dora, et al. (+3)
933 [GO] 2022―Dec―15 2140. INO-4800, a DNA Plasmid Vaccine Encoding the Ancestral SARS-CoV-2 Spike Protein, Is Stable Over a Range of Temperatures Not Requiring Ultra-Cold Chain Storage Robert J Juba, Anthony Samawova, Katherine Seals, Peggy Kinney, E J Brandreth
934 [GO] 2022―Dec―15 1110. AZD7442 (Tixagevimab/Cilgavimab) Demonstrates Potent In Vitro Activity Against SARS-CoV-2 Spike Variants Identified in Circulation and in Prophylaxis Clinical Studies Kevin M Tuffy, Michael E Abram, Tiffany L Roe, Bahar Ahani, Tyler Brady, Nicolette Schuko, et al. (+9)
935 [GO] 2022―Dec―15 1527. Use of a SARS-CoV-2 Strand-specific Assay to detect Relapse or Ongoing Infection at a Tertiary Care Center, California 2020-2022 Gustavo A Contreras Anez, Jessica Ferguson, Caitlin A Contag, Lucy S Tompkins, John Shepard, Ayelet Rosenthal, et al. (+3)
936 [GO] 2022―Dec―15 1927. Use of a SARS-CoV-2 Strand-specific Assay to evaluate for Prolonged Viral Replication among Hospitalized Patients. Tertiary Care Center, California 2020-2022 Jessica Ferguson, Gustavo A Contreras Anez, Lucy S Tompkins, John Shepard, Ayelet Rosenthal, Aruna Subramanian, et al. (+2)
937 [GO] 2022―Dec―15 1358. Establishing Genomic SARS-CoV-2 Surveillance at the National Level: Germany, 2021 Djin-Ye Oh, Martin Hölzer, Sofia Paraskevopoulou, Maria Trofimova, Felix Hartkopf, Matthias Budt, et al. (+25)
938 [GO] 2022―Dec―15 1884. Evaluating SARS-CoV-2 Surveillance Strategies at the United States Naval Academy: A Comparison of Saliva and Dried Blood Spot Serosurveillance Against Molecular-Confirmed Case Detection Liana R Andronescu, Stephanie A Richard, Eric D Laing, Adam K Saperstein, Jitendrakumar Modi, Christopher D Heaney, et al. (+8)
939 [GO] 2022―Dec―15 1970. SARS-CoV-2 T-cell specific responses in allogeneic hematopoietic stem cell transplant recipients after second and third dose of BNT162b2 mRNA vaccine Iannetta Marco, Ilaria Spalliera, Flavia Mallegni, Lisa Mercante, Alessandra Imeneo, Angela Crea, et al. (+7)
940 [GO] 2022―Dec―15 311. Modeling Diagnostic Testing Strategies for SARS-CoV-2 to Minimize Societal Costs and Return People to Work Sofia Zavala, Gary M Cox, Robert W Belknap, Becky A Smith, Sarah S Lewis, Christopher R Polage, et al. (+2)
941 [GO] 2022―Dec―15 1920. Lack of SARS-CoV-2 transmission from a Healthcare Worker to a Cohort of Immunosuppressed Patients during the Omicron Surge, California, 2022 Abraar Karan, Jessica Ferguson, Jorge Salinas
942 [GO] 2022―Dec―15 1881. Detection of SARS-CoV-2 Transmission on a College Campus using a Combined Contact Tracing and Molecular Strategy Jesse T Brewer, Wei Wang, Irina Aranovich, Daniel Notterman, Irini Daskalaki
943 [GO] 2022―Dec―15 1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP) Katharina S Appel, Daniel Maier, Sina M Hopff, Lazar Mitrov, Melanie Stecher, Margarete Scherer, et al. (+40)
944 [GO] 2022―Dec―15 1974. Title: A novel low-dose self-amplifying mRNA vaccine (GRT-R910) induces strong and broad boost in cellular and humoral immune response following primary series with a chimpanzee adenovirus SARS-CoV-2 vaccination Tolga Turgut, Uzma Ahmed, Melissa Kachura, Lauren Kraemer, Charmaine Nganje, Meghan Hart, et al. (+11)
945 [GO] 2022―Dec―15 1971. Severity of Self-Reported Systemic Reactions Following SARS-CoV-2 Vaccination and Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) Wendy P Bannister
946 [GO] 2022―Dec―15 585. Safety and Immunogenicity of SARS-CoV-2 Vaccination in Children with a History of MIS-C Harrison L Howe, Justin Z Amarin, Haya Hayek, Rana Talj, Andrew J Spieker, Sophie E Katz, et al. (+13)
947 [GO] 2022―Dec―15 1949. Evaluation of cellular and humoral immune-responses at different times after SARS-COV-2 vaccination in health care workers cohort Chiara Dentone, Daniela Fenoglio, Matteo Cerchiaro, Marta Ponzano, Tiziana Altosole, Diego Franciotta, et al. (+14)
948 [GO] 2022―Dec―15 1932. Antibody Response to SARS-CoV-2 Vaccination in US Veterans Living with HIV Alexander Njoroge, Florence M Ford, George Psevdos
949 [GO] 2022―Dec―15 1395. COVID 19 Incidence rates were not different among high risk health-care workers and non-health workers after SARS-CoV-2 vaccination: a prospective study in Cali-Colombia. Fernando Rosso, Laura A Torres-Canchala, Isabel L Zapata-Vasquez, Julio Llanos-Torres, Eric Tafur, Jenny P Muñoz-Lombo, et al. (+2)
950 [GO] 2022―Dec―15 1955. Immunogenicity And Safety of a Virus-Like Particle (VLP) Protein Subunit SARS-CoV-2 Vaccine in Adults: a Phase 1/2 Study Robert Scott, Susan Thackwray, Nicholas Hourguettes, Huub Gelderblom, Niranjan Kanesa-thasan
951 [GO] 2022―Dec―15 1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT) Afoke Kokogho, Muneerah M Aleissa, Jun Bai Park Chang, Stephen R Walsh, Trevor A Crowell, Lindsey R Baden, Amy C Sherman
952 [GO] 2022―Dec―15 1525. The Impact of Traveler-Based Genomic Surveillance on SARS-CoV-2 Variant Detection in Arriving International Air Travelers- United States, November 29, 2021-April 24, 2022 Grace D Appiah, Teresa C Smith, Renee Wegrzyn, Robert C Morfino, Sarah Guagliardo, Scott Milford, et al. (+23)
953 [GO] 2022―Dec―15 1964. Pre-existing Population Immunity and SARS-CoV-2 Variant Dynamics in the United States: An Ecological Study Pierre Ankomah, Mark Siedner, Roby P Bhattacharyya
954 [GO] 2022―Dec―15 1135. Monoclonal Antibody Therapeutics in US Veterans against Delta and Omicron SARS-CoV-2 Variants Inderjit Mann, Morgan Froehlich, Audun J Lier, George Psevdos
955 [GO] 2022―Dec―15 246. Cardiac involvement in children with multisystem inflammatory syndrome (MIS-C) following infection with different SARS-CoV-2 variants Swetha Pinninti, Camden Hebson, Connie Trieu, Sushma Boppana, Markus Buchfellner, April Yarbrough, et al. (+5)
956 [GO] 2022―Dec―15 1896. Statewide Genomic Surveillance of SARS-CoV-2 Variants in Rhode Island Manjot Singh, Vladimir Novitsky, Mark Howison, Kristin Carpenter-Azevedo, Richard Huard, Ewa King, Rami Kantor
957 [GO] 2022―Dec―15 1096. Riding the Waves: Infection by SARS-CoV-2 Variants in Solid Organ Transplant Recipients at Texas Children’s Hospital Leanne Buffaloe, Claire Bocchini, Elizabeth A Moulton, Daniel Ruderfer, Kristen Valencia Deray, Flor M Munoz
958 [GO] 2022―Dec―15 1978. Vaccine effect on household transmission of omicron and delta SARS-CoV-2 variants in South Korea Yong Chan Kim, Bongyoung Kim, Nak-Hoon Son, Namwoo Heo, Yoon Soo Park, Heejung Kim
959 [GO] 2022―Dec―15 1057. Development of a Flow Cytometry-Based Micro-Neutralisation Assay to Evaluate Humoral Immunity Against SARS-CoV-2 Variants of Concern in Vaccine Trials Sophie R O’Reilly, Grace Kenny, Tamara Alrawahneh, Nathan Francois, Matthew Angeliadis, Valentin de Masson d’Autume, et al. (+9)
960 [GO] 2022―Dec―15 2164. Shared and Specific Systemic Cytokine Responses in Infants Hospitalized with SARS-CoV-2 versus RSV Infection Raquel Giacomelli Cao, Zhaohui Xu, Fang Ye, Sara Mertz, Shira H Cohen, Traci Pifer, et al. (+4)
961 [GO] 2022―Dec―15 243. Association Between SARS-CoV-2 Viral Load and Patient Symptoms and Clinical Outcomes Using Droplet Digital PCR Elizabeth Hastie, Harold Amogan, David Looney, Sanjay R Mehta
962 [GO] 2022―Dec―15 315. Standardized Measurement of SARS-CoV-2 Viral Load Over Time in Respiratory Compartments and in Response to Remdesivir Treatment Curt Beckwith, Soya Sam, Vladimir Novitsky, Jimin Shin, Kevin Lethbridge, Jon Steingrimsson, et al. (+11)
963 [GO] 2022―Dec―15 1056. Correlates of Omicron SARS-CoV-2 viral load: diagnostic and clinical implications Simon Pollett, Stephanie A Richard, Anthony C Fries, Allison M Malloy, Anuradha Ganesan, Jeffrey Livezey, et al. (+14)
964 [GO] 2022―Dec―15 2129. Maternal Transmission of SARS-CoV-2-specific Antibodies, but not Cytokines/Chemokines to Neonates Following Infection and Vaccination During Pregnancy Jonathon M Monroe, Sohan Punia, Huy Quang Quach, Elizabeth A Enninga, Yaroslav Fedyshyn, Bohdana Fedyshyn, et al. (+12)
965 [GO] 2022―Dec―15 1050. Breath Sample Collection from Individuals Infected with SARS-CoV-2: Biosafety Methodology Marcela Lopez, Marcela Lopez, Emma Stainton, Leanne X Chun, Grace K Tam, Rosita Thiessen, et al. (+11)
966 [GO] 2022―Dec―15 1930. Answering the Call: Inpatient Vaccination for SARS-CoV2 Infection in an Academic Hospital Benjamin Albrecht, Sarah B Green, Peter Moran, Morgan E Corkish, Carrie Tilton, Ashley Rizzo, et al. (+11)
967 [GO] 2022―Dec―15 2084. Importance of the Primary Care Physician in HIV PrEP Adherence During a Pandemic Isaac Daudelin, Bret McCarty, Shawn K Ahmad Chaustre, Diana Finkel
968 [GO] 2022―Dec―15 1760. Selection of appropriate inpatients for outpatient parenteral antimicrobial therapy (OPAT) during the COVID pandemic Angela Y McKnight, Angelike P Liappis, Ayne Adenew
969 [GO] 2022―Dec―15 1290. A Structural Intervention Improves ID Fellow Wellness Amid a Pandemic Michael Czapka, Christopher J Lehmann, Erica MacKenzie, Elizabeth Bell, John Flores, Aniruddha Hazra
970 [GO] 2022―Dec―15 950. Impact of the COVID 19 pandemic on antimicrobial stewardship program, broad-spectrum antibiotics consumption and Clostridioides difficile diarrhea incidence Jose Luis Lamas Ferreiro, Judith Álvarez Otero, Ana Sanjurjo Rivo, Ignacio Enríquez de Salamanca Holzinger, Jorge Cavero, Jose Carlos de Miguel Bouzas, et al. (+5)
971 [GO] 2022―Dec―15 1357. Collateral consequence of COVID pandemic: Increased incidence of cat scratch disease. Maria L Praino, Peditric Infectologist, Grigioni Julia, Peditric Infectologist, Soledad Tineo, Peditric Infectologist, et al. (+7)
972 [GO] 2022―Dec―14 Tale of the Titers: Serologic Testing for SARS-CoV-2 -Yes, No, and Maybe, with Clinical Examples from the IDSA Diagnostics Committee Robert Colgrove, Lou Ann Bruno-Murtha, Cody A Chastain, Kimberly E Hanson, Francesca Lee, Audrey R Odom John, Romney Humphries
973 [GO] 2022―Dec―07 Immune-based therapy for hospitalized patients with COVID-19 and risk of secondary infections: A systematic review and meta-analysis Dima Kabbani, Ashlesha Sonpar, Benson Weyant, Keith C K Lau, Mark Robbins, Sandra Campbell, et al. (+6)
974 [GO] 2022―Dec―01 Meeting the Challenges of Sepsis in Severe COVID-19: A Call to Arms Thomas J Walsh, Rick A Bright, Aparna Ahuja, Matthew W McCarthy, Richard A Marfuggi, Steven Q Simpson
975 [GO] 2022―Nov―30 Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection Lisa Tomasi, Anais Thiriard, Leo Heyndrickx, Daphnée Georges, Sigi Van den Wijngaert, Véronique Olislagers, et al. (+6)
976 [GO] 2022―Nov―28 High co-circulation of influenza and SARS-CoV-2 John T Kubale, Aaron M Frutos, Angel Balmaseda, Cristhiam Cerpas, Saira Saborio, Sergio Ojeda, et al. (+10)
977 [GO] 2022―Nov―24 Impact of COVID-19 Pandemic on Antiretroviral Therapy Initiation and Care Delivery for Newly Diagnosed HIV in an Integrated Health Care System Kurtis B Mohr, Christian Lee-Rodriguez, Zahra Samiezade-Yazd, Jennifer O Lam, Brandon M Imp, Mitchell N Luu
978 [GO] 2022―Nov―24 Statistical analysis of mortality rates of COVID-19 patients in Japan across the 4C mortality score risk groups, age groups, and epidemiological waves: A report from the nationwide COVID-19 cohort Hiroaki Baba, Saori Ikumi, Shotaro Aoyama, Tetsuo Ishikawa, Yusuke Asai, Nobuaki Matsunaga, et al. (+5)
979 [GO] 2022―Nov―24 Effectiveness of a third dose of COVID-19 mRNA vaccine during the Omicron BA.1- and BA.2-predominant periods in Japan: The VENUS Study Wataru Mimura, Chieko Ishiguro, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
980 [GO] 2022―Nov―22 Real-world evidence of novel treatments for COVID-19 on mortality: a nationwide comparative cohort study of hospitalized patients in the 1st, 2nd, 3rd and 4th wave in the Netherlands M A Slim, B Appelman, H Peters-Sengers, D A Dongelmans, N F de Keizer, R P Schade, et al. (+5)
981 [GO] 2022―Nov―21 Post Intensive Care Syndrome (PICS) among survivors in a safety net hospital in South Bronx -a comparison of patients with and without COVID-19 Sebastian Ocrospoma Heraud, Virali Shah, Victor Perez-Gutierez, Mohannad Al-Khateeb, Sebastian Gandarillas Fraga, Afsheen Afzal, et al. (+8)
982 [GO] 2022―Nov―20 Strong neutralizing antibody responses to SARS-CoV-2 variants following a single vaccine dose in subjects with previous SARS-CoV-2 infection Nina Ekström, Anu Haveri, Anna Solastie, Camilla Virta, Pamela Österlund, Hanna Nohynek, et al. (+8)
983 [GO] 2022―Nov―11 Predictors of SARS-CoV-2 RNA from nasopharyngeal swabs and concordance with other compartments in non-hospitalized adults with mild to moderate COVID-19 Carlee Moser, Jonathan Z Li, Joseph J Eron, Evgenia Aga, Eric S Daar, David A Wohl, et al. (+11)
984 [GO] 2022―Nov―11 Persistence of neutralizing antibodies and clinical protection up to 12 months after SARS-CoV-2 infection in elderly R Collarino, C Vauloup-Fellous, A Allemang-Trivalle, L Mouna, E P Baudouin, H Keravec, et al. (+10)
985 [GO] 2022―Nov―10 Subgenomic RNA abundance relative to total viral RNA among SARS-CoV-2 variants Maxwell Su, Sara Ping, Phuong-Vi Nguyen, Alejandra Rojas, Laila Hussaini, Ludy Registre Carmola, et al. (+8)
986 [GO] 2022―Nov―08 A Systematic Review of COVID-19 Vaccine Antibody Responses in People Living with HIV Helen M Chun, Kyle Milligan, Elfriede Agyemang, Nathan Ford, Ajay Rangaraj, Shalini Desai, et al. (+3)
987 [GO] 2022―Nov―07 Global emergence of resistance to fluconazole and voriconazole in Candida parapsilosis in tertiary hospitals in Spain during the COVID-19 pandemic Nuria Trevijano-Contador, Alba Torres-Cano, Cristina Carballo-González, Mireia Puig-Asensio, María Teresa Martín-Gómez, Emilio Jiménez-Martínez, et al. (+30)
988 [GO] 2022―Nov―03 Lung abnormalities in SARS-CoV-2 infection: An analysis of paired computed tomography scans before and after infection. Katrine K Iversen, Andreas Ronit, Thomas S Kristensen, Shoaib Afzal, Jelena Jankovic, Anna Kalhauge, et al. (+4)
989 [GO] 2022―Nov―02 Risk factors for severe COVID-19 among HIV-infected and-uninfected individuals in South Africa, April 2020- March 2022 - data from sentinel surveillance Sibongile Walaza, Stefano Tempia, Anne von Gottberg, Nicole Wolter, Jinal N Bhiman, Amelia Buys, et al. (+14)
990 [GO] 2022―Oct―31 Correction to: Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients
991 [GO] 2022―Oct―31 Genomic Investigation to Identify Sources of SARS-CoV-2 Infection Among Healthcare Personnel in an Acute Care Hospital Sarah E Sansom, Hannah Barbian, Mary K Hayden, Christine Fukuda, Nicholas M Moore, Lahari Thotapalli, et al. (+4)
992 [GO] 2022―Oct―31 Correction to: SARS-CoV-2 Surface Swabs in Locations With Public Access- Potential for Improved Source Control
993 [GO] 2022―Oct―27 Bebtelovimab for high-risk outpatients with early COVID-19 in a large US health system Scott Dryden-Peterson, Andy Kim, Mary-Ruth Joyce, Jennifer A Johnson, Arthur Y Kim, Lindsey R Baden, Ann E Woolley
994 [GO] 2022―Oct―22 Impact of the COVID-19 pandemic on the clinical features of pediatric RSV infection in Japan Shoko Ozeki, Jun-ichi Kawada, Daiki Yamashita, Chika Yasufuku, Takuya Akano, Masahiro Kato, et al. (+10)
995 [GO] 2022―Oct―22 Evaluation of SARS-CoV-2 nucleocapsid antigen in the blood as a diagnostic test for infection and infectious viral shedding Sujata Mathur, Michelle C Davidson, Khamal Anglin, Scott Lu, Sarah A Goldberg, Miguel Garcia-Knight, et al. (+21)
996 [GO] 2022―Oct―22 Comparison of SARS-CoV-2 viral loads in the nasal mucosa of patients infected with BA.1, BA.2 or BA.5 Omicron lineages Kyla Tozer, Calvin P Sjaarda, Emily Moslinger, Henry Wong, Samira Mubareka, Finlay Maguire, et al. (+4)
997 [GO] 2022―Oct―19 Prevalence and Factors Associated With Antigen Test Positivity Following SARS-CoV-2 Infection Among Health Care Workers in Los Angeles Paul C Adamson, Judith S Currier, Daniel Z Uslan, Omai B Garner
998 [GO] 2022―Oct―17 A multicenter comparison of prevalence and predictors of antimicrobial resistance in hospitalized patients before and during the SARS-CoV-2 pandemic Karri A Bauer, Laura A Puzniak, Kalvin C Yu, Kenneth P Klinker, Janet Watts, Pamela A Moise, et al. (+3)
999 [GO] 2022―Oct―17 Effect of SARS-CoV-2 vaccine booster on HIV reservoirs and immune markers M Ali Rai, Victoria Shi, Brooke D Kennedy, Jesse S Justement, Kathleen Gittens, Genevieve McCormack, et al. (+3)
1000 [GO] 2022―Oct―10 Viral co-infections in hospitalised COVID-19 patients recruited to the ISARIC WHO CCP-UK study Elen Vink, Chris Davis, Alasdair MacLean, David Pascall, Sarah E McDonald, Rory Gunson, et al. (+6)
1001 [GO] 2022―Oct―06 Host biomarkers reflect prognosis in patients presenting with moderate Covid-19 - a prospective cohort study Arjun Chandna, Raman Mahajan, Priyanka Gautam, Lazaro Mwandigha, Pragya Kumar, George M Varghese, et al. (+3)
1002 [GO] 2022―Oct―06 Demographics and outcomes of initial phase of COVID-19 Medicines Delivery Units across 4 UK centres during peak B1.1.529 omicron epidemic: a service evaluation. M Brown, J Saund, A Qureshi, M Plowright, K Drury, J Gahir, et al. (+11)
1003 [GO] 2022―Oct―06 Early outpatient treatment with remdesivir in patients at high risk for severe COVID-19: a prospective cohort study Sandra Rajme-López, Bernardo A Martinez-Guerra, Jessica Zalapa-Soto, Carla M Román-Montes, Karla M Tamez-Torres, María F González-Lara, et al. (+5)
1004 [GO] 2022―Oct―06 Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch Raymund R Razonable, Sidna M Tulledge-Scheitel, Sara N Hanson, Richard F Arndt, Leigh L Speicher, Teresa A Seville, et al. (+3)
1005 [GO] 2022―Oct―05 Relative Risks of COVID-19-Associated Hospitalizations and Clinical Outcomes by Age and Race/Ethnicity-March 2020-March 2021 Catherine H Bozio, Kristen Butterfield, Stephanie A Irving, Gabriela Vazquez-Benitez, Toan C Ong, Kai Zheng, et al. (+4)
1006 [GO] 2022―Oct―05 Misdiagnoses in the context of suspected pandemic influenza or COVID-19: A systematic review Lucy Bray, Katerina Meznikova, Daniel James, Razan Rislan, Rahul Shah, Pavan Mason, et al. (+4)
1007 [GO] 2022―Oct―05 At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area Ann E Woolley, Scott Dryden-Peterson, Andy Kim, Sarah Naz-McLean, Christina Kelly, Hannah H Laibinis, et al. (+9)
1008 [GO] 2022―Oct―01 Discriminatory ability of gas chromatography-ion mobility spectrometry to identify patients hospitalised with COVID-19 and predict prognosis Joshua Nazareth, Daniel Pan, Jee Whang Kim, Jack Leach, James G Brosnan, Adam Ahmed, et al. (+10)
1009 [GO] 2022―Oct―01 Evaluation of Bebtelovimab for Treatment of COVID-19 During the SARS-CoV-2 Omicron Variant Era Erin K McCreary, Kevin E Kip, Kevin Collins, Tami E Minnier, Graham M Snyder, Ashley Steiner, et al. (+12)
1010 [GO] 2022―Sep―30 Predictors of SARS-CoV-2 seropositivity prior to COVID-19 vaccination among children 0-4 years and their household members in the SEARCh Study Maria Garcia Quesada, Marissa K Hetrich, Scott Zeger, Jayati Sharma, Yu Bin Na, Vic Veguilla, et al. (+19)
1011 [GO] 2022―Sep―29 Population-based evaluation of post-acute COVID-19 chronic sequelae in patients who tested positive for SARS-CoV-2 Nicole H Goldhaber, W Scott Ogan, Andrew Greaves, Ming Tai-Seale, Amy Sitapati, Christopher A Longhurst, Lucy E Horton
1012 [GO] 2022―Sep―27 Podcast 39: Marginalized communities and the disproportionate impacts of AIDS, COVID-19, and monkeypox - An interview with Gregg Gonsalves
1013 [GO] 2022―Sep―27 mRNA vaccination decreases COVID-19-associated morbidity and mortality among organ transplant recipients: a contemporary cohort study Alexis Hope Lerner, Panos Arvanitis, Kendra Vieira, Elizabeth Jessica Klein, Dimitrios Farmakiotis
1014 [GO] 2022―Sep―27 Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis after SARS-CoV-2 mRNA-1273 (“Moderna”) Vaccine: A Case Report Jennifer Chen Li, Jonathan Siglin, Michael S Marshall, Anat Stemmer-Rachamimov, Seth M Bloom, Kimberly G Blumenthal
1015 [GO] 2022―Sep―23 Correlation of post-vaccination fever with specific antibody response to SARS-CoV-2 BNT162b2 booster and no significant influence of antipyretic medication Naoki Tani, Hideyuki Ikematsu, Takeyuki Goto, Kei Gondo, Takeru Inoue, Yuki Yanagihara, et al. (+9)
1016 [GO] 2022―Sep―21 Prediction of Symptomatic SARS-CoV-2 infection by Quantitative Digital PCR Normalized to International Units Diego R Hijano, Zhengming Gu, Jessica Brazelton de Cardenas, Haiqing Zhu, Sri Suganda, Heather L Glasgow, et al. (+10)
1017 [GO] 2022―Sep―20 Prolonged SARS-CoV-2 Delta Variant Shedding in a Patient with AIDS; Case Report and Review of the Literature Jillian L Peters, Amary Fall, Steven D Langerman, Margueritta El Asmar, Mari Nakazawa, Aishat Mustapha, et al. (+3)
1018 [GO] 2022―Sep―12 Oral Polio Vaccine (OPV) to mitigate the risk of illness and mortality during the COVID-19 pandemic: A cluster-randomised trial in Guinea-Bissau Ane B Fisker, Justiniano S D Martins, Line M Nanque, Andreas M Jensen, Elsi J C Ca, Sebastian Nielsen, et al. (+2)
1019 [GO] 2022―Sep―12 Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study Daniel Ayoubkhani, Matthew L Bosworth, Sasha King, Koen B Pouwels, Myer Glickman, Vahé Nafilyan, et al. (+4)
1020 [GO] 2022―Sep―11 Correlation of SARS-CoV-2 Nasopharyngeal CT-values to Viremia and Mortality in Adults Hospitalised with Covid-19 Karl Hagman, Magnus Hedenstierna, Jacob Oesman, Emelie Arvidsson, Berit Hammas, Lena Grillner, et al. (+3)
1021 [GO] 2022―Sep―11 Impact of a Pharmacist Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Healthcare Resource Utilization Andrew J FRATONI, Abigail K KOIS, Jessica L COLMERAUER, Kristin E LINDER, David P NICOLAU, Joseph L KUTI
1022 [GO] 2022―Sep―11 COVID-19 vaccine effectiveness against progression to in-hospital mortality in Zambia, 2021-2022 Duncan Chanda, Jonas Z Hines, Megumi Itoh, Sombo Fwoloshi, Peter A Minchella, Khozya D Zyambo, et al. (+11)
1023 [GO] 2022―Sep―07 Effectiveness of COVID-19 vaccines over time prior to Omicron emergence in Ontario, Canada: test-negative design study Hannah Chung, Peter C Austin, Kevin A Brown, Sarah A Buchan, Deshayne B Fell, Cindy Fong, et al. (+8)
1024 [GO] 2022―Sep―07 Feasibility of At-Home Virological and Serological Testing for SARS-CoV-2 in Children Amina Ahmed, Whitney Rossman, Lauren C Lu, Connell O Dunn, Anna M Harris, Jennifer S Priem, et al. (+6)
1025 [GO] 2022―Sep―02 High risk of secondary infections following thrombotic complications in patients with COVID-19 Marco Ripa, Laura Galli, Armando D’Angelo, Luca Apruzzi, Diego Palumbo, Corrado Campochiaro, et al. (+19)
1026 [GO] 2022―Sep―02 Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission from Donor Stool Christopher McChalicher, Ahmad Abdulaziz, S Steve Zhou, Mary Jane Lombardo, Brooke Hasson, John G Auniņš, et al. (+2)
1027 [GO] 2022―Sep―01 Using a cloud-based machine-learning classification tree analysis to understand the demographic characteristics associated with COVID-19 booster vaccination among adults in the United States Lu Meng, Hannah E Fast, Ryan Saelee, Elizabeth Zell, Bhavini Patel Murthy, Neil Chandra Murthy, et al. (+5)
1028 [GO] 2022―Aug―29 SARS-CoV-2 surface swabs in locations with public access - potential for improved source control Jacob PS Nielsen, Johannes R Madsen, Kamille Fogh, Emma H Mikkelsen, Emil Wolsk, Nikolai S Kirkby, et al. (+2)
1029 [GO] 2022―Aug―25 Dying at Home Due to COVID-19 Jessie K Edwards, Wohl David Alain
1030 [GO] 2022―Aug―25 Reduction in risk of death among patients admitted with COVID-19 between first and second epidemic waves in New York City Anthony Bowen, Jason Zucker, Yanhan Shen, Simian Huang, Qiheng Yan, Medini K Annavajhala, et al. (+4)
1031 [GO] 2022―Aug―25 Surge in Incidence and COVID-19 Hospital Risk of Death, United States, September 2020 to March 2021 Bela Patel, Robert E Murphy, Siddharth Karanth, Salsawit Shiffaraw, Richard M Peters, Samuel F Hohmann, Raymond S Greenberg
1032 [GO] 2022―Aug―25 Prevalence and Health Outcomes of Clostridioides difficile Infection during the COVID-19 Pandemic in a National Sample of United States Hospital Systems Kelly R Reveles, Alexa L Frei, Kelsey A Strey, Eric H Young
1033 [GO] 2022―Aug―25 Detection of viral infection and bacterial co- and superinfection in COVID-19 patients presenting to the emergency department using the 29-mRNA host response classifier BVN-3 - a multicenter study Wolfgang Bauer, Sven Gläser, Dorina Thiemig, Katrin Wanner, Alexander Peric, Steffen Behrens, et al. (+9)
1034 [GO] 2022―Aug―25 Description of Hospitalizations due to the SARS-CoV-2 Omicron Variant Based on Vaccination Status Matthew A Moffa, Nathan R Shively, Dustin R Carr, Derek N Bremmer, Carley Buchanan, Tamara L Trienski, et al. (+3)
1035 [GO] 2022―Aug―24 MR-proADM Biomarker Predicts COVID-19 Clinical Outcomes: a US-based Cohort Study Natalie J Atallah, Vahe S Panossian, Christine J Atallah, Andrej Schwabe, Sascha Johannes, Jan Wiemer, Michael K Mansour
1036 [GO] 2022―Aug―23 Sexually transmitted infection testing in the national Veterans Health Administration patient cohort during the COVID-19 pandemic Lauren A Beste, Shimrit Keddem, Joleen Borgerding, Elliott Lowy, Carolyn Gardella, Lorenzo McFarland, et al. (+7)
1037 [GO] 2022―Aug―22 Efficacy of Approved versus Unapproved Vaccines for SARS-CoV-2 Infection in Randomised Blinded Clinical Trials Andrea Perez Navarro, Victoria Pilkington, Toby Pepperrell, Manya Mirchandani, Jacob Levi, Andrew Hill
1038 [GO] 2022―Aug―20 Impact of innate immunity, endothelial damage, and metabolic biomarkers on COVID-19 severity and mortality Joseph M Rocco, Paola Laghetti, Mariantonietta Di Stefano, Irini Sereti, Ana Ortega-Villa, Jing Wang, et al. (+9)
1039 [GO] 2022―Aug―17 Nucleocapsid antigenemia in patients receiving anti-CD20 therapy with protracted COVID-19 Eli Wilber, Anne Piantadosi, Ahmed Babiker, Kaleb McLendon, William O’Sick, Eric Fitts, et al. (+11)
1040 [GO] 2022―Aug―17 Post Lung Transplantation Outcomes and Ex Vivo Histopathological Findings in Severe Post COVID-19 Pulmonary Disease - A Single Center Experience Hana Javaid, Masayuki Nigo, Bihong Zhao, Daniel Ocazionez Trujillo, Rodrigo Hasbun, Luis Ostrosky-Zeichner, et al. (+2)
1041 [GO] 2022―Aug―16 Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, controlled, phase 2 study Sue Ann Costa Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Filippo Pacciarini, Ping Li, et al. (+4)
1042 [GO] 2022―Aug―16 Immunogenicity of a three-dose primary series of mRNA COVID-19 vaccines in patients with lymphoid malignancies Amy C Sherman, Jennifer L Crombie, Chi An Cheng, Michaël Desjardins, Guohai Zhou, Omolola Ometoruwa, et al. (+13)
1043 [GO] 2022―Aug―09 Correction to: An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection
1044 [GO] 2022―Aug―09 Impact of age and symptom development on SARS-CoV-2 transmission in households with children-Maryland, New York, and Utah, August 2020-October 2021 Kelsey M Sumner, Ruth A Karron, Melissa S Stockwell, Fatimah S Dawood, Joseph B Stanford, Alexandra Mellis, et al. (+19)
1045 [GO] 2022―Aug―08 A Randomized Clinical Trial of Regdanvimab in High-Risk Patients with Mild-to-Moderate COVID-19 Jin Yong Kim, Oana Săndulescu, Liliana Lucia Preotescu, Norma E Rivera-Martínez, Marta Dobryanska, Victoria Birlutiu, et al. (+18)
1046 [GO] 2022―Aug―06 Correction to: SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
1047 [GO] 2022―Aug―05 Long COVID symptomatology after twelve months and its impact on quality of life according to initial COVID-19 disease severity Aurélie Fischer, Lu Zhang, Abir Elbéji, Paul Wilmes, Pauline Oustric, Therese Staub, et al. (+3)
1048 [GO] 2022―Aug―03 Prevalence of medical contraindications to nirmatrelvir/ritonavir in a cohort of hospitalized and non-hospitalized patients with COVID-19 Sarah Lim, Christopher J Tignanelli, Nicolas Hoertel, David R Boulware, Michael G Usher
1049 [GO] 2022―Aug―03 High-risk US international travelers seeking pretravel consultation during the COVID-19 pandemic Emily P Hyle, Mylinh H Le, Sowmya R Rao, Nora M Mulroy, Allison T Walker, Edward T Ryan, Regina C LaRocque
1050 [GO] 2022―Jul―30 Applying lessons learned from COVID-19 therapeutic trials to improve future ALI/ARDS trials Qun Wu, Meghan E Pennini, Julie N Bergmann, Marina L Kozak, Kristen Herring, Kimberly L Sciarretta, Kimberly L Armstrong
1051 [GO] 2022―Jul―29 Extended Remdesivir Infusion for Persistent COVID-19 Infection Mario A Martinez, Ting Yi Chen, Hosoon Choi, Munok Hwang, Dhammika Navarathna, Linhue Hao, et al. (+4)
1052 [GO] 2022―Jul―28 Correction to: Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections
1053 [GO] 2022―Jul―27 Correction to: 604. Impact of COVID-19 Pandemic on Telehealth Practices in Pediatric Infectious Diseases
1054 [GO] 2022―Jul―26 Cognitive Impairment 13 Months After Hospitalization for COVID-19 Knut Stavem, Gunnar Einvik, Christofer Lundqvist
1055 [GO] 2022―Jul―26 Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections Brian Grunau, Janessa Tom, Michael Asamoah-Boaheng, Sheila F O’Brien, Steven J Drews, Sadaf Sediqi, et al. (+3)
1056 [GO] 2022―Jul―25 Adjunctive Recombinant Human Plasma Gelsolin for Severe COVID-19 Pneumonia Mark J DiNubile, Sandra Parra, Antoni Castro Salomó, Susan L Levinson
1057 [GO] 2022―Jul―25 Aggregating human judgment probabilistic predictions of COVID-19 transmission, burden, and preventative measures Allison Codi, Damon Luk, David Braun, Juan Cambeiro, Tamay Besiroglu, Eva Chen, et al. (+3)
1058 [GO] 2022―Jul―25 Escape of SARS-CoV-2 variant Omicron to mucosal immunity in vaccinated subjects Emanuela MARTINUZZI, Jacques BOUTROS, Nicolas GLAICHENHAUS, Charles Hugo MARQUETTE, Paul HOFMAN, Jonathan BENZAQUEN
1059 [GO] 2022―Jul―22 Missed opportunity, the unseen driver for low COVID-19 vaccination rates in underserved patients Tania Campagnoli, Geetika Mohan, Nigist Taddese, Yaveen Santhiraj, Natasa Margeta, Saad Alvi, et al. (+4)
1060 [GO] 2022―Jul―20 Examination of Common Coronavirus Antibodies in SARS-CoV-2-Infected and Uninfected Participants in a Household Transmission Investigation Megan M Stumpf, Brandi Freeman, Lisa Mills, Sandra Lester, Victoria T Chu, Hannah L Kirking, et al. (+2)
1061 [GO] 2022―Jul―05 A More Accurate Measurement of the Burden of COVID-19 Hospitalizations Christina Vu, Eric S Kawaguchi, Cesar H Torres, Austin H Lee, Noah Wald-Dickler, Paul D Holtom, et al. (+3)
1062 [GO] 2022―Jul―04 Prevalence of and factors associated with post-COVID-19 condition in the 12 months following the diagnosis of COVID-19 in adults followed in general practices in Germany Karel Kostev, Lee Smith, Ai Koyanagi, Louis Jacob
1063 [GO] 2022―Jun―30 Risk Factors for Admission Within a Hospital-Based COVID-19 Home Monitoring Program Heather Sperring, Melissa Hofman, Heather E Hsu, Yian Xiao, Elizabeth A Keohane, Sara Lodi, et al. (+2)
1064 [GO] 2022―Jun―28 An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection Ann I Scher, Catherine M Berjohn, Celia Byrne, Rhonda E Colombo, Christopher J Colombo, Margaret Sanchez Edwards, et al. (+19)
1065 [GO] 2022―Jun―24 Comparative COVID-19 Vaccine Effectiveness over Time in Veterans Florian B Mayr, Victor B Talisa, Obaid Shaikh, Saad B Omer, Adeel A Butt, Sachin Yende
1066 [GO] 2022―Jun―23 Factors Associated with Hospitalization with Symptomatic COVID-19 Illness Among Pregnant Individuals: A Multi-Center Retrospective Cohort Study Carmen Sofia Arriola, De Kun Li, Flor Muñoz, Michael Daugherty, Caroline Doughty-Skierski, Sascha Ellington, et al. (+15)
1067 [GO] 2022―Jun―23 Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients Keun Hyung Park, Chan-Young Jung, Wonjeong Jeong, Gongmyung Lee, Jae Seok Yang, Chung Mo Nam, et al. (+2)
1068 [GO] 2022―Jun―17 US County-level COVID-19 Vaccine Uptake and Rates of Omicron Cases and Deaths John M McLaughlin, Timothy L Wiemken, Farid Khan, Luis Jodar
1069 [GO] 2022―Jun―15 Decreased Risk of COVID-19-Related Hospitalization Associated with Omicron Variant of SARS-CoV-2 Jessica P Ridgway, Samuel Tideman, Bill Wright, Ari Robicsek
1070 [GO] 2022―Jun―10 Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients with COVID-19 Infection Scott Schoninger, Yanina Dubrovskaya, Kassandra Marsh, Diana Altshuler, Prithiv Prasad, Eddie Louie, et al. (+4)
1071 [GO] 2022―Jun―07 Projected Effects of Disruptions to HIV Prevention Services During the COVID-19 Pandemic Among Black/African American Men Who Have Sex with Men in an Ending the HIV Epidemic Priority Jurisdiction Jennifer Labs, Amy S. Nunn, Philip A. Chan, S. Bessey, Carolyn J. Park, Brandon D. L. Marshall, et al. (+3)
1072 [GO] 2022―Jun―07 COVID-19 patient reported symptoms using FLU-PRO Plus in a cohort study: associations with infecting genotype, vaccine history, and return-to-health Stephanie A. Richard, Nusrat J. Epsi, David A. Lindholm, Allison M. W. Malloy, Ryan C. Maves, Catherine M. Berjohn, et al. (+23)
1073 [GO] 2022―Jun―07 Real-World Experience of Sotrovimab in High-Risk, Immunocompromised COVID-19 Patients Navina K. Birk, Saniya Jain, Louis Massoud, Diya Ramesh, Lea Monday, Bruce Muma, et al. (+3)
1074 [GO] 2022―Jun―07 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States: How did it change in 2021? Rena C. Moon, Ning A. Rosenthal
1075 [GO] 2022―Jun―07 Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis Nicola K Wills, Nikhil Nair, Kashyap Patel, Omaike Sikder, Marguerite Adriaanse, John Eikelboom, Sean Wasserman
1076 [GO] 2022―Jun―07 Characterization of early-onset SARS-CoV-2 infection in immunocompromised patients who received tixagevimab-cilgavimab prophylaxis Eloy E. Ordaya, Elena Beam, Joseph D. Yao, Raymund R. Razonable, Paschalis Vergidis
1077 [GO] 2022―Jun―06 The Politicization of Ivermectin Tweets during the COVID-19 Pandemic Marlon I. Diaz, John J. Hanna, Amy E. Hughes, Christoph U. Lehmann, Richard J. Medford
1078 [GO] 2022―May―31 Genomic surveillance of SARS-CoV-2 in a university community: insights into tracking variants, transmission, and spread of Gamma (P.1) variant Ilinca I. Ciubotariu, Jack Dorman, Nicole M. Perry, Lev Gorenstein, Jobin J. Kattoor, Abebe A. Fola, et al. (+5)
1079 [GO] 2022―May―31 Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients M Veronica Dioverti, David C Gaston, C Paul Morris, Carol Ann Huff, Tania Jain, Richard Jones, et al. (+5)
1080 [GO] 2022―May―23 Corrigendum to: Do Stay at Home Orders and Cloth Face Coverings Control COVID-19 in New York City? Results From a SIER Model Based on Real-world Data Jian Li, Yuming Wang, Jing Wu, Jing-Wen Ai, Hao-Cheng Zhang, Michelle Gamber, et al. (+3)
1081 [GO] 2022―May―20 Antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective cross-sectional study Min Hyung Kim, Yooju Nam, Nak-Hoon Son, Namwoo Heo, Bongyoung Kim, Eawha Kang, et al. (+6)
1082 [GO] 2022―May―20 COVID-19 vaccine uptake and factors associated with being unvaccinated among lesbian, gay, bisexual, transgender, queer, and other sexual identities (LGBTQ+) New Yorkers Andrea Low, Connor Wright, Joey Platt, Christiana Chang, Joanne E. Mantell, Emily Romero, et al. (+5)
1083 [GO] 2022―May―17 Ethnic differences in COVID-19 hospitalization and hospital outcomes in a multi-ethnic population in the Netherlands Didier Collard, Karien Stronks, Vanessa Harris, Liza Coyer, Kees Brinkman, Martijn Beudel, et al. (+8)
1084 [GO] 2022―May―16 Clerkship in infectious diseases for medical students during covid-19 Edward Chávez-Cruzado, Jose Galvez-Olortegui, Anderson Vilchez-Chávez, Alex Castañeda-Sabogal
1085 [GO] 2022―May―13 Transmission potential of the Omicron variant of SARS-CoV-2 in South Korea: From November 25, 2020 to January 8, 2022 Eunha Shim, Wongyeong Choi, Donghyok Kwon, Taeyoung Kim, Youngji Song
1086 [GO] 2022―May―13 CalScope: Monitoring SARS-CoV-2 Seroprevalence from Vaccination and Prior Infection in Adults and Children in California May 2021- July 2021 Megha L. Mehrotra, Esther Lim, Katherine Lamba, Amanda Kamali, Kristina W. Lai, Erika Meza, et al. (+12)
1087 [GO] 2022―May―11 Opaganib in COVID-19 pneumonia: Results of a randomized, placebo-controlled Phase 2a trial Kevin L. Winthrop, Alan W. Skolnick, Adnan M. Rafiq, Scott H. Beegle, Julian Suszanski, Guenther Koehne, et al. (+10)
1088 [GO] 2022―May―11 Quantification and progress over time of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with BNT162b2 Pfizer-BioNTech COVID-19 vaccine (LacCOVID) Erika Esteve-Palau, Araceli Gonzalez-Cuevas, M. Eugenia Guerrero, Clara Garcia-Terol, M. Carmen Alvarez, Geneva Garcia, et al. (+4)
1089 [GO] 2022―May―09 “Effectiveness of COVID-19 Vaccines in Preventing Infection, Hospital Admission and Death: A Historical Cohort Study Using Iranian Registration Data During Vaccination program” Alireza Mirahmadizadeh, Alireza Heiran, Kamran Bagheri Lankarani, Mohammadreza Serati, Mohammad Habibi, Owrang Eilami, et al. (+2)
1090 [GO] 2022―May―09 Clinical Features and Duration of Viral Shedding Individuals with SARS-CoV-2 Omicron Variant Infection Young R. Jang, Jeong-Min Kim, Jee E. Rhee, Dongju Kim, Nam-Joo Lee, Hyeokjin Lee, et al. (+3)
1091 [GO] 2022―May―07 The protective effect of covid-19 vaccination on post-acute sequelae of covid-19 (pasc): a multicenter study from a large national health research network Sokratis N. Zisis, Jared C. Durieux, Christian Mouchati, Jamie A. Perez, Grace A. McComsey
1092 [GO] 2022―May―07 Detection of SARS-CoV-2 by Canine Olfaction: A Pilot Study Maureen Maurer, Todd Seto, Claire Guest, Amendeep Somal, Catherine Julian
1093 [GO] 2022―May―07 SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection Christian Gaebler, Justin DaSilva, Eva Bednarski, Frauke Muecksch, Fabian Schmidt, Yiska Weisblum, et al. (+8)
1094 [GO] 2022―May―05 Risk of SARS-CoV-2 transmission through solid organ transplantation and outcomes of COVID-19 among recent transplant recipients Rebecca J. Free, Pallavi Annambhotla, Ricardo M. La Hoz, Lara Danziger-Isakov, Jefferson M. Jones, Lijuan Wang, et al. (+7)
1095 [GO] 2022―May―05 COVID-19 vaccine dosage in children, adolescents, and young adults - is less more? Nicole H. Tobin, Otto O. Yang
1096 [GO] 2022―May―05 COVID-19 Vaccine Hesitancy Among Healthcare Workers in Four Healthcare Systems in Atlanta Sheetal Kandiah, Onyinye Iheaku, Mirza Farrque, Jasmah Hanna, Kalisha Bonds Johnson, Zanthia Wiley, et al. (+5)
1097 [GO] 2022―May―05 Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission Katharine A Relph, Clark D Russell, Cameron J Fairfield, Lance Turtle, Thushan I de Silva, Matthew K Siggins, et al. (+362)
1098 [GO] 2022―May―05 Initial SARS-CoV-2 viral load is associated with disease severity: a retrospective cohort study Dennis Souverein, Karlijn van Stralen, Steven van Lelyveld, Claudia van Gemeren, Milly Haverkort, Dominic Snijders, et al. (+9)
1099 [GO] 2022―Apr―28 Unravelling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2 Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, Vincent C. Marconi, Corri B. Levine, Hana M. El Sahly, et al. (+13)
1100 [GO] 2022―Apr―28 Mission, Organization and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies Jane C Figueiredo, Fred R Hirsch, Lawrence H Kushi, Wendy N Nembhard, James M Crawford, Nicholas Mantis, et al. (+91)
1101 [GO] 2022―Apr―21 Population-based assessment of contact tracing operations for COVID-19 in Pirkanmaa hospital district, Finland Juha Rannikko, Hanna Viskari, Simo Sirkeoja, Pekka Tamminen, Ville Kaila, Anni Ala-Mursula, et al. (+4)
1102 [GO] 2022―Apr―19 The collapse of infectious disease diagnoses commonly due to communicable respiratory pathogens during the COVID-19 pandemic: A time series and hierarchical clustering analysis Ali Zhang, Matthew D. Surette, Kevin L. Schwartz, James I. Brooks, Dawn M.E. Bowdish, Roshanak Mahdavi, et al. (+5)
1103 [GO] 2022―Apr―19 Bamlanivimab and etesevimab improve symptoms and associated outcomes in ambulatory patients at increased risk for severe COVID-19: results from the placebo-controlled double-blind Phase 3 BLAZE-1 trial Peter Chen, Gerhard Behre, Corey Hebert, Princy Kumar, Lisa Farmer Macpherson, Peita Louise Graham-Clarke, et al. (+6)
1104 [GO] 2022―Apr―18 A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease Melissa M Higdon, Brian Wahl, Carli B Jones, Joseph G Rosen, Shaun A Truelove, Anurima Baidya, et al. (+7)
1105 [GO] 2022―Apr―15 SARS-CoV-2 mRNA vaccine effectiveness in healthcare workers by dosing interval and time since vaccination: test negative design, British Columbia, Canada Shiraz El Adam, Macy Zou, Shinhye Kim, Bonnie Henry, Mel Krajden, Danuta M Skowronski
1106 [GO] 2022―Apr―14 Health care workers’ sick leave due to COVID-19 vaccination in context with SARS-CoV-2 infection and quarantine - a multicenter cross-sectional survey Stilla Bauernfeind, Gunnar Huppertz, Karolina Mueller, Florian Hitzenbichler, Loredana Hardmann, Sylvia Pemmerl, et al. (+12)
1107 [GO] 2022―Apr―14 Outcomes of B-cell-depleted Patients with Coronavirus Disease 2019 Treated with Anti-spike Monoclonal Antibodies Zachary A. Yetmar, Ryan B. Khodadadi, Maria Teresa Seville, Lisa Brumble, John C. O’Horo, Ravindra Ganesh, Raymund R. Razonable
1108 [GO] 2022―Apr―13 Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, Laura L. Gibson, Chad J. Achenbach, Sally McFall, et al. (+37)
1109 [GO] 2022―Apr―12 EFFECTIVENESS OF CASIRIVIMAB-IMDEVIMAB MONOCLONAL ANTIBODY TREATMENT AMONG HIGH-RISK PATIENTS WITH SARS-CoV-2 B.1.617.2 (COVID-19 DELTA VARIANT) INFECTION Mohanad MM. Al-Obaidi, Ahmet B. Gungor, Saman Nematollahi, Tirdad T. Zangeneh, Edward J. Bedrick, Katherine M. Johnson, et al. (+11)
1110 [GO] 2022―Apr―12 Performance of a Triage Protocol for Monoclonal Antibodies in a Mixed Vaccinated and Unvaccinated Cohort of Covid-19 Patients Treated with Intravenous Infusion or Subcutaneous Injection Emily B. Rubin, Mofei Liu, Anita Giobbie-Hurder, Lauren A. Canha, C. Elizabeth Keleher, Keri M. Sullivan, Michael Dougan
1111 [GO] 2022―Apr―10 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for 
Real-Time Pandemic Surveillance Sally B Coburn, Yukari C Manabe, Oliver Laeyendecker, Susan G Sherman, Owen R Baker, Thomas C Quinn, et al. (+11)
1112 [GO] 2022―Apr―08 Avoidance of Emergency Care in the Southeastern United States During the COVID-19 Pandemic Erin Gettler, Rebecca Stern, Bin Ni, Heather M Munro, Mark Steinwandel, David M Aronoff, et al. (+4)
1113 [GO] 2022―Apr―07 Barriers to worldwide access for Paxlovid, a new treatment for COVID-19 Toby Pepperrelll, Leah Ellis, Junzheng Wang, Andrew Hill
1114 [GO] 2022―Apr―05 Pathogen Species is Associated With Mortality in Nosocomial Bloodstream Infection in Patients with COVID-19 Juan Gago, D Filardo Thomas, Sarah Conderino, Samuel J Magaziner, Yanina Dubrovskaya, Kenneth Inglima, et al. (+9)
1115 [GO] 2022―Apr―05 Rheumatic symptoms following COVID-19: a chronic post COVID-19 condition Dan Cui, Yeming Wang, Lixue Huang, Xiaoying Gu, Zhisheng Huang, Shengrui Mu, et al. (+2)
1116 [GO] 2022―Apr―02 Vaccinated individuals with prior COVID-19 have likely lower risk of incident SARS-CoV-2 infection when compared to vaccinated individuals without prior infection N Kojima, A Roshani, A Baca, J D Klausner
1117 [GO] 2022―Mar―29 Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications Derek R MacFadden, Kevin Brown, Sarah A Buchan, Hannah Chung, Rob Kozak, Jeffrey C Kwong, et al. (+3)
1118 [GO] 2022―Mar―25 Population attributable fractions of underlying medical conditions for COVID-19 diagnosis and COVID-19 hospitalizations, ventilations, and deaths among adults in the United States Jennifer L Nguyen, Tamuno Alfred, Maya Reimbaeva, Deepa Malhotra, Farid Khan, David Swerdlow, Frederick J Angulo
1119 [GO] 2022―Mar―25 Ibrutinib for Hospitalized Adults with Severe COVID-19 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study Steven E Coutre, Christopher Barnett, Olayemi Osiyemi, Daanish Hoda, Moti Ramgopal, Alexander C Fort, et al. (+6)
1120 [GO] 2022―Mar―25 Singing Is a Risk Factor for SARS-CoV-2 Infection: A Case-control Study of Karaoke-related COVID-19 Outbreaks in Two Cities in Hokkaido, Japan, Linked by Whole Genome Analysis Manami Nakashita, Yuta Takagi, Hiroyuki Tanaka, Haruna Nakamura, Yusuke Serizawa, Tomohiko Ukai, et al. (+27)
1121 [GO] 2022―Mar―25 SARS-CoV-2 humoral and cellular immune responses of patients with HIV after vaccination with BNT162b2 mRNA COVID-19 vaccine in the Tel-Aviv Medical Center Luba Tau, Dan Turner, Amos Adler, Rotem Marom, Svetlana Ahsanov, Natasha Matus, et al. (+8)
1122 [GO] 2022―Mar―25 High and rapid increase in seroprevalence for SARS-CoV-2 in Conakry, Guinea: results from three successive cross-sectional surveys (ANRS COV16-ARIACOV) Abou Aissata Soumah, Mamadou Saliou Kalifa Diallo, Emilande Guichet, David Maman, Guillaume Thaurignac, Alpha Kabinet Keita, et al. (+9)
1123 [GO] 2022―Mar―25 Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas Joshua L Kennedy, J Craig Forrest, Sean G Young, Benjamin Amick, Mark Williams, Laura James, et al. (+22)
1124 [GO] 2022―Mar―18 Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected with the SARS-CoV-2 Delta Variant Charlotte B Acharya, John Schrom, Anthea M Mitchell, David A Coil, Carina Marquez, Susana Rojas, et al. (+10)
1125 [GO] 2022―Mar―16 Viral burden and clearance in asymptomatic COVID-19 Patients Avanka B Gunatilaka, Nicholas Marco, Graham H Read, Maggie Sweeney, Greg Regan, Cynthia Tsang, et al. (+9)
1126 [GO] 2022―Mar―16 A Tale of Three Pandemics - SARS-CoV-2, HCV, and HIV in an Urban Emergency Department in Baltimore, Maryland Yu-Hsiang Hsieh, Richard E Rothman, Sunil S Solomon, Mark Anderson, Michael Stec, Oliver Laeyendecker, et al. (+9)
1127 [GO] 2022―Mar―16 Confirmed SARS-CoV-2 reinfections after a second wave with predominance of Lambda in Lima and Callao, Peru Luis Pampa-Espinoza, Carlos Padilla-Rojas, Javier Silva-Valencia, Victor Jimenez-Vasquez, Iris Silva, Orson Mestanza, et al. (+15)
1128 [GO] 2022―Mar―13 Clinical outcomes in hospitalized vaccine-breakthrough COVID-19 cases compared with contemporary unvaccinated hospitalized adults Marcelo Wolff, Margarita Gilabert, Rodrigo Hernández
1129 [GO] 2022―Mar―10 COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective Jasmine R Marcelin, Audrey Pettifor, Holly Janes, Elizabeth R Brown, James G Kublin, Kathryn E Stephenson
1130 [GO] 2022―Mar―09 Increased risk of herpes zoster in adults ≥50 years old diagnosed with COVID-19 in the United States Amit Bhavsar, Germain Lonnet, Chengbin Wang, Konstantina Chatzikonstantinidou, Raunak Parikh, Yves Brabant, et al. (+4)
1131 [GO] 2022―Mar―07 Risk factors associated with hospitalization and death in COVID-19 breakthrough infections Geehan Suleyman, Raef Fadel, Indira Brar, Rita Kassab, Rafa Khansa, Nicholas Sturla, et al. (+7)
1132 [GO] 2022―Mar―07 New Onset Dementia Among Survivors of Pneumonia Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Adnan I Qureshi, William I Baskett, Wei Huang, S Hasan Naqvi, Chi-Ren Shyu
1133 [GO] 2022―Mar―03 Coronavirus disease 2019 (COVID-19) associated pulmonary aspergillosis (CAPA): Re-framing the debate Cornelius J Clancy, M Hong Nguyen
1134 [GO] 2022―Mar―03 Characteristics and Risk Factors for Mortality by COVID-19 Pandemic Waves in Fulton County, Georgia: A Cohort Study March 2020-February 2021 Nathaniel Chishinga, Neel R Gandhi, Udodirim N Onwubiko, Carson Telford, Juliana Prieto, Sasha Smith, et al. (+5)
1135 [GO] 2022―Mar―02 Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community-Based Serological Study Thomas W McDade, Amelia Sancilio, Richard D’Aquila, Brian Mustanski, Lauren A Vaught, Nina L Reiser, et al. (+6)
1136 [GO] 2022―Feb―25 Long-term outcomes and recovery of patients who survived COVID-19: LUNG INJURY COVID-19 Study Gianna Vargas Centanaro, Myriam Calle Rubio, José Luis Álvarez-Sala Walther, Fernando Martinez-Sagasti, Andrea Albuja Hidalgo, Rafael Herranz Hernández, Juan Luis Rodríguez Hermosa
1137 [GO] 2022―Feb―24 Serologic and cytokine signatures in children with multisystem inflammatory syndrome (MIS-C) and COVID-19 Stacey A Lapp, Joseph Abrams, Austin T Lu, Laila Hussaini, Carol M Kao, David A Hunstad, et al. (+23)
1138 [GO] 2022―Feb―22 Corrigendum to: 204. Mucosal Cytokine Profiles in Children with COVID-19 Ana M Quintero, Shira H Cohen, Cameron Mertz, Rebecca M Glowinski, Sara Mertz, Fang Ye, et al. (+10)
1139 [GO] 2022―Feb―21 Impact of Casirivimab-Imdevimab on SARS-CoV-2 delta variant nasopharyngeal virus load and Spike quasispecies Camille Vellas, Arnaud Del Bello, Géraldine Gaube, Pauline Tremeaux, Nicolas Jeanne, Noémie Ranger, et al. (+4)
1140 [GO] 2022―Feb―20 Vaccination against SARS-CoV-2 is associated with a lower viral load and likelihood of systemic symptoms Carolyn T Bramante, Jennifer L Proper, David R Boulware, Amy Karger, Thomas Murray, Via Rao, et al. (+22)
1141 [GO] 2022―Feb―18 Quantifying the Population-level Effect of the COVID-19 Mass Vaccination Campaign in Israel: a Modeling Study Ido Somekh, Wasiur R KhudaBukhsh, Elisabeth Dowling Root, Lital Keinan Boker, Grzegorz Rempala, Eric A F Simões, Eli Somekh
1142 [GO] 2022―Feb―14 Coinfections in Patients with Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study Gowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, Elizabeth J Klein, Maheen Abidi, Shailesh M Advani, et al. (+51)
1143 [GO] 2022―Feb―14 Comparative efficacy of early Covid-19 monoclonal antibody therapies: a retrospective analysis Savanna San Filippo, Brynna Crovetto, John Bucek, Ronald G Nahass, Marc Milano, Luigi Brunetti
1144 [GO] 2022―Feb―14 Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults Lacy M Simons, Ramon Lorenzo-Redondo, Meg Gibson, Sarah L Kinch, Jacob P Vandervaart, Nina L Reiser, et al. (+12)
1145 [GO] 2022―Feb―14 Prospective assessment of symptoms to evaluate asymptomatic S